Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
9d72920fc45ecef6fcc14d2fd8f2e25d7096d86d6c2db95b3801ba804e936ac8.png
simple
<table><tr><td></td><td>Stroke/TIA Patients</td><td>Control Subjects</td><td>Significance</td></tr><tr><td>Age, yr</td><td>53.9&#177;9.3</td><td>53.8&#177;9.0</td><td>ns.</td></tr><tr><td>Males, n (%)</td><td>21 (52.5)</td><td>21 (52.5)</td><td>ns.</td></tr><tr><td>Body mass index, kg/m<sup>2</sup></td><td>28.7&#177;4.8</td><td>25.3&#177;4.1</td><td>0.002</td></tr><tr><td>Body surface area, m<sup>2</sup></td><td>2.0&#177;0.2</td><td>1.8&#177;0.2</td><td>0.033</td></tr><tr><td>Caucasian race, n (%)</td><td>40 (100.0)</td><td>40 (100.0)</td><td>ns.</td></tr><tr><td>Hypertension, n (%)</td><td>16 (40.0)</td><td>0 (0.0)</td><td>&lt;0.001</td></tr><tr><td>Hyperlipidemia, n (%)</td><td>14 (35.0)</td><td>16 (40.0)</td><td>ns.</td></tr><tr><td>Diabetes, n (%)</td><td>0 (0.0)</td><td>0 (0.0)</td><td>ns.</td></tr><tr><td>Left ventricle ejection fraction, %</td><td>66.0&#177;10.2</td><td>63.7&#177;7.7</td><td>ns.</td></tr><tr><td>Left ventricle dysfunction, n (%)</td><td>0 (0.0)</td><td>0 (0.0)</td><td>ns.</td></tr><tr><td>Smokers, n (%)</td><td>0 (0.0)</td><td>1 (2.5)</td><td>ns.</td></tr></table>
cc58b74577b77ed3c260167f43de2f2c4719657ad38af267bc797037fc2fed91.png
simple
<table><tr><td>Characteristics</td><td>n = 10</td></tr><tr><td>Age</td><td>63.8&#177;12.0</td></tr><tr><td>Body Mass Index</td><td>27.1&#177;3.7</td></tr><tr><td>Parity</td><td>2 (1-3)</td></tr><tr><td>Health problems</td><td>6</td></tr><tr><td>SUI</td><td>2</td></tr><tr><td>Previous hysterectomy</td><td>5</td></tr><tr><td>Previous POP surgery</td><td>10</td></tr><tr><td>POP</td><td>10</td></tr><tr><td>Point C/D POPQ median (range)</td><td>3 (2-4)</td></tr><tr><td>Central compartment prolapse stage &#8805; 3</td><td>10</td></tr><tr><td>Cystocele stage &#8805; 2</td><td>9</td></tr><tr><td>Rectocele stage &#8805; 2</td><td>7</td></tr><tr><td>Enterocele stage &#8805; 2</td><td>0</td></tr><tr><td>Concomitant procedure</td><td>6</td></tr><tr><td>Anterior colporrhaphy</td><td>4</td></tr><tr><td>Posterior colporrhaphy</td><td>2</td></tr><tr><td>MUS</td><td>0</td></tr></table>
b71407253c36229d2d33f1c8fdd4ad42ac21f08bcc82beebe19dfaf4e577a6eb.png
complex
<table><tr><td rowspan="2">Solvents</td><td colspan="3">Time</td><td rowspan="2">Means</td></tr><tr><td>30 min</td><td>60 min</td><td>90 min</td></tr><tr><td colspan="5">FRAP (theaflavin)&#956;mol Fe2<sup>+</sup>/g</td></tr><tr><td> Ethanol</td><td>811.67 &#177; 10.21</td><td>958.33 &#177; 8.48</td><td>799.33 &#177; 12.31</td><td>856.44 &#177; 9.06a</td></tr><tr><td> Methanol</td><td>698.67 &#177; 10.36</td><td>704.00 &#177; 8.65</td><td>658.67 &#177; 11.32</td><td>687.11 &#177; 12.03b</td></tr><tr><td> Water</td><td>489.67 &#177; 10.56</td><td>612.25 &#177; 8.23</td><td>586.67 &#177; 13.01</td><td>562.86 &#177; 11.01c</td></tr><tr><td></td><td>666.67 &#177; 10.54c</td><td>758.19 &#177; 8.21a</td><td>681.55 &#177; 9.06b</td><td></td></tr><tr><td colspan="5">FRAP (thearubigins)&#956;mol Fe2<sup>+</sup>/g</td></tr><tr><td> Ethanol</td><td>690.02 &#177; 1.23</td><td>845.01 &#177; 7.45</td><td>701.33 &#177; 12.23</td><td>745.44 &#177; 8.21a</td></tr><tr><td> Methanol</td><td>538.67 &#177; 1.56</td><td>665.00 &#177; 7.49</td><td>591.67 &#177; 11.32</td><td>598.44 &#177; 11.20b</td></tr><tr><td> Water</td><td>429.67 &#177; 10.23</td><td>537.33 &#177; 7.52</td><td>503.67 &#177; 10.25</td><td>490.22 &#177; 12.20c</td></tr><tr><td></td><td>552.70 &#177; 10.21c</td><td>682.40 &#177; 12.23a</td><td>598.89 &#177; 9.12b</td><td></td></tr><tr><td colspan="5">Glucose diffusion (theaflavin)%</td></tr><tr><td> Ethanol</td><td>90.37 &#177; 3.60</td><td>95.99 &#177; 6.34</td><td>90.88 &#177; 4.13</td><td>91.74 &#177; 4.16</td></tr><tr><td> Methanol</td><td>89.87 &#177; 4.21</td><td>93.69 &#177; 4.21</td><td>89.22 &#177; 6.12</td><td>89.96 &#177; 2.31</td></tr><tr><td> Water</td><td>87.30 &#177; 2.62</td><td>90.36 &#177; 5.32</td><td>88.40 &#177; 3.21</td><td>87.02 &#177; 3.12</td></tr><tr><td></td><td>89.18 &#177; 5.20</td><td>93.34 &#177; 3.12</td><td>89.50 &#177; 4.13</td><td></td></tr><tr><td colspan="5">Glucose diffusion (thearubigins)%</td></tr><tr><td> Ethanol</td><td>85.27 &#177; 2.3</td><td>89.99 &#177; 2.9</td><td>87.88 &#177; 4.2</td><td>87.71 &#177; 6.12</td></tr><tr><td> Methanol</td><td>83.87 &#177; 1.3</td><td>87.69 &#177; 3.2</td><td>83.22 &#177; 3.6</td><td>84.92 &#177; 6.42</td></tr><tr><td> Water</td><td>81.30 &#177; 3.6</td><td>85.36 &#177; 2.9</td><td>82.40 &#177; 4.2</td><td>83.02 &#177; 7.12</td></tr><tr><td></td><td>83.48 &#177; 4.32</td><td>87.68 &#177; 4.13</td><td>84.50 &#177; 6.34</td><td></td></tr></table>
260a7d5be1b4d71c207213f4d7f7352cc4b2f4455a9dc4a63731ba50ca5aa877.png
complex
<table><tr><td> </td><td>Infection-associated EHPM (+)</td><td>Infection-associated EHPM (&#8722;)</td><td>Odds ratio (95% CI)</td><td><i>P</i> value</td></tr><tr><td>HCV Ab (+)</td><td>27</td><td>240</td><td rowspan="2">3.15 (1.19&#8211;8.37)</td><td rowspan="2">0.0194</td></tr><tr><td>HCV Ab (&#8722;)</td><td>5</td><td>140</td></tr><tr><td>HBs Ag (+)</td><td>4</td><td>61</td><td rowspan="2">11.31 (2.03&#8211;63.11)</td><td rowspan="2">0.0067</td></tr><tr><td>HBs Ag (&#8722;)</td><td>2</td><td>345</td></tr><tr><td>No viral infection</td><td>4</td><td>67</td><td rowspan="2">20.30 (2.23&#8211;184.46)</td><td rowspan="2">0.0036</td></tr><tr><td>Any viral infection </td><td>1</td><td>340</td></tr></table>
bce227280ce4f314e18bc37995285754fe745904e0eb6b92ddf9ba67c550c7da.png
simple
<table><tr><td>miRNAs</td><td>Known functional effect</td><td>Targets</td><td>References</td></tr><tr><td>mir-15a, miR-15b, miR-16, and miR-195</td><td>Pancreas development, beta-cells fate and regeneration</td><td>Neurog3</td><td>[33] </td></tr><tr><td>miR-375</td><td>Beta- and alpha-cells expansion</td><td> </td><td>[42]</td></tr><tr><td>miR-7a</td><td>Beta-cell proliferation</td><td>mTOR pathway components</td><td>[44, 45, 48]</td></tr><tr><td>miR-124a</td><td>Pancreas development</td><td>Foxa2</td><td>[33]</td></tr></table>
b3771b412cc9e733a85f8b5a3dbce4587943626e769d801e2549ad142efe639d.png
complex
<table><tr><td>Patient/source</td><td>Our patient</td><td>Patients TB/LB from Joyce et al. [13]</td><td>Patient DP from Monk et al. [17]</td><td>Patients HC/AC from Monk et al. [16]</td><td>Patient from Eggermann et al. [6] (decipher 285981)</td><td>Decipher 289205</td><td>Decipher 276327</td><td>ISCA nssv579045</td></tr><tr><td>Genomic location (hg19)</td><td>chr7:50654827-5122921</td><td>chr7:42029531&#8211;51138357(D7S691-D7S242)</td><td>chr7:40742989&#8211;50861159 (D7S1769-GRB10)</td><td>chr7:41392336&#8211;54000000 (RP5-953B5-7p11.2)</td><td>chr7:47034222&#8211;52175639</td><td>chr7:50713413-50982532</td><td>chr7:43566637-51282735</td><td>chr7:33367924-61831899</td></tr><tr><td>Duplication size</td><td>574Kb</td><td>~10 cM</td><td>~10 cM</td><td>&gt;10 cM</td><td>5.1 Mb</td><td>270Kb</td><td>7.72 Mb</td><td>28.5 Mb</td></tr><tr><td rowspan="2">Inheritance/orign</td><td rowspan="2"><i>de novo</i>/maternal</td><td>LB: maternal</td><td rowspan="2"><i>de novo/</i>maternal</td><td>AC: maternal</td><td rowspan="2">de novo/paternal</td><td rowspan="2">inherited/paternal</td><td rowspan="2"><i>de novo</i>/unknown</td><td rowspan="2">unknown</td></tr><tr><td>TB: paternal</td><td>HC: unknown</td></tr><tr><td>Phenotype</td><td>SRS</td><td>SRS</td><td>SRS</td><td>SRS-like</td><td>overgrowth, DD, microcephaly, seizure</td><td>hypotonia, GDD</td><td>muscular hypotonia</td><td>FTT, GDD, large eyes, microcephaly, short stature, triangular face</td></tr><tr><td>Detection method</td><td>array</td><td>karyotype/FISH</td><td>karyotype/FISH</td><td>karyotype/FISH</td><td>array</td><td>array</td><td>array</td><td>array</td></tr><tr><td>Genes involved (Refseq)</td><td><i>GRB10</i> and part of <i>COBL</i></td><td>&gt;50 genes</td><td>&gt;50 genes</td><td>&gt;50 genes</td><td>&gt;20 genes</td><td>Part of <i>GRB10</i></td><td>&gt;40 genes</td><td>&gt;180 genes</td></tr></table>
130939985ea8abd941252c2f6f92ecf2f44321e66c883345c3e361e8acb39c65.png
complex
<table><tr><td>Characteristics</td><td>Total</td><td>Men</td><td>Women</td><td><i>P</i></td></tr><tr><td>Cases, <i>n</i> (%)</td><td>1587</td><td>1272 (29.5)</td><td>315 (15.1)</td><td>&#8211;</td></tr><tr><td>Age, year, mean (SD)</td><td>64.41 (11.40)</td><td>64.17 (11.42)</td><td>65.40 (11.28)</td><td>0.087</td></tr><tr><td colspan="5">OCSP, <i>n</i> (%)</td></tr><tr><td> PACI</td><td>895 (56.4)</td><td>728 (57.2)</td><td>167 (53.0)</td><td>0.177</td></tr><tr><td> TACI</td><td>83 (5.2)</td><td>62 (4.9)</td><td>21 (6.7)</td><td>0.201</td></tr><tr><td> LACI</td><td>104 (6.6)</td><td>81 (6.4)</td><td>23 (7.3)</td><td>0.549</td></tr><tr><td> POCI</td><td>505 (31.8)</td><td>401 (31.5)</td><td>104 (33.0)</td><td>0.006</td></tr><tr><td colspan="5">Stroke severity</td></tr><tr><td> Mild</td><td>1093 (68.9)</td><td>889 (69.9)</td><td>204 (64.8)</td><td>&lt;0.001</td></tr><tr><td> Moderate</td><td>367 (23.1)</td><td>289 (22.7)</td><td>78 (24.8)</td><td>0.442</td></tr><tr><td> Severe</td><td>127 (8.0)</td><td>94 (7.4)</td><td>33 (10.5)</td><td>0.071</td></tr><tr><td colspan="5">Neurological function<sup>a</sup></td></tr><tr><td> NIHSS</td><td>5 (7)</td><td>5 (7)</td><td>6 (7)</td><td>0.006</td></tr><tr><td> BI</td><td>60 (50)</td><td>65 (50)</td><td>55 (50)</td><td>0.004</td></tr><tr><td> mRS</td><td>3 (2)</td><td>3 (2)</td><td>3 (2)</td><td>0.007</td></tr><tr><td colspan="5">Risk factors, <i>n</i> (%)</td></tr><tr><td> Hypertension</td><td>1162 (73.2)</td><td>908 (71.4)</td><td>254 (80.6)</td><td>0.001</td></tr><tr><td> Diabetes</td><td>472 (29.7)</td><td>366 (28.8)</td><td>106 (33.7)</td><td>0.090</td></tr><tr><td> Atrial fibrillation</td><td>71 (4.5)</td><td>52 (4.1)</td><td>19 (6.0)</td><td>0.135</td></tr><tr><td> Artery stenosis</td><td>416 (26.2)</td><td>341 (26.8)</td><td>75 (23.8)</td><td>0.279</td></tr><tr><td> Obesity</td><td>157 (9.9)</td><td>100 (7.9)</td><td>57 (18.1)</td><td>&lt;0.001</td></tr><tr><td> Current smoking</td><td>669 (42.2)</td><td>628 (49.4)</td><td>41 (13.0)</td><td>&lt;0.001</td></tr><tr><td> Alcohol drinking</td><td>339 (21.4)</td><td>335 (26.3)</td><td>4 (1.3)</td><td>&lt;0.001</td></tr></table>
d157fb75c8873280af662cd3d509b841a902f917546ca19d14f4d0037d928316.png
complex
<table><tr><td>Group</td><td>Treatment (mg/kg) once daily orally</td><td></td><td>Study 1</td><td>Study 2</td></tr><tr><td rowspan="2">A</td><td rowspan="2">None (placebo, control)</td><td>Cohort 1</td><td>4 f</td><td>2 m &amp; 2 f</td></tr><tr><td>Cohort 2</td><td>4 m</td><td>2 m &amp; 2 f</td></tr><tr><td rowspan="2">B</td><td rowspan="2">Benazepril (0.5&#8211;1.0)</td><td>Cohort 1</td><td>4 f</td><td>2 m &amp; 2 f</td></tr><tr><td>Cohort 2</td><td>4 m</td><td>2 m &amp; 2 f</td></tr><tr><td rowspan="2">C</td><td rowspan="2">Robenacoxib (1.0&#8211;2.4)</td><td>Cohort 1</td><td>4 f</td><td>2 m &amp; 2 f</td></tr><tr><td>Cohort 2</td><td>4 m</td><td>2 m &amp; 2 f</td></tr><tr><td rowspan="2">D</td><td rowspan="2">Benazepril (0.5&#8211;1.0) + Robenacoxib (1.0&#8211;2.4)</td><td>Cohort 1</td><td>4 f</td><td>2 m &amp; 2 f</td></tr><tr><td>Cohort 2</td><td>4 m</td><td>2 m &amp; 2 f</td></tr></table>
57a337344e9878b018372679406c98e1807af0c518cc5fe7fa40fc843b215cc4.png
complex
<table><tr><td rowspan="2">Variables</td><td colspan="3">Weekly work hours</td><td rowspan="2">Total</td><td rowspan="2">p-value</td></tr><tr><td>Short*</td><td>Reference&#8224;</td><td>Long&#8225;</td></tr><tr><td>Total</td><td>100(4.9)</td><td>1209(59.2)</td><td>735(36.0)</td><td>2044</td><td> </td></tr><tr><td colspan="6">Age (years)</td></tr><tr><td>25-34</td><td>7(7.0)</td><td>353(29.2)</td><td>220(29.9)</td><td>580</td><td>&lt;.0001</td></tr><tr><td>35-44</td><td>24(24.0)</td><td>414(34.2)</td><td>259(35.2)</td><td>697</td><td> </td></tr><tr><td>45-54</td><td>39(39.0)</td><td>305(25.2)</td><td>173(23.5)</td><td>517</td><td> </td></tr><tr><td>55-64</td><td>30(30.0)</td><td>137(11.3)</td><td>83(11.3)</td><td>250</td><td> </td></tr><tr><td colspan="6">Marital status</td></tr><tr><td>Married</td><td>68(68.0)</td><td>934(77.3)</td><td>545(74.2)</td><td>1547</td><td>0.056</td></tr><tr><td>Unmarried</td><td>32(32.0)</td><td>275(22.8)</td><td>190(25.9)</td><td>497</td><td> </td></tr><tr><td colspan="6">Education</td></tr><tr><td>&#8804;Junior high school</td><td>46(46.0)</td><td>122(10.2)</td><td>110(15.0)</td><td>278</td><td>&lt;.0001</td></tr><tr><td>High school</td><td>27(27.0)</td><td>372(30.8)</td><td>305(41.5)</td><td>704</td><td> </td></tr><tr><td>&#8805;College</td><td>27(27.0)</td><td>715(59.1)</td><td>320(43.5)</td><td>1062</td><td> </td></tr><tr><td colspan="6">Occupation</td></tr><tr><td>Non-manual</td><td>22(22.0)</td><td>666(55.1)</td><td>248(33.7)</td><td>936</td><td>&lt;.0001</td></tr><tr><td>Manual</td><td>78(78.0)</td><td>543(44.9)</td><td>487(66.3)</td><td>1108</td><td> </td></tr><tr><td colspan="6">Employment type</td></tr><tr><td>Precarious</td><td>84(84.0)</td><td>254(21.0)</td><td>130(17.7)</td><td>468</td><td>&lt;.0001</td></tr><tr><td>Non-precarious</td><td>16(16.0)</td><td>955(79.0)</td><td>605(82.3)</td><td>1576</td><td> </td></tr><tr><td>Tenure (years) (Mean&#177;S.D)</td><td>7.1&#177;8.6</td><td>8.7&#177;8.1</td><td>6.4&#177;6.4</td><td> </td><td>&lt;.0001</td></tr><tr><td colspan="6">Shift work</td></tr><tr><td>Yes</td><td>1(1.0)</td><td>108(8.9)</td><td>151(20.5)</td><td>260</td><td>&lt;.0001</td></tr><tr><td>No</td><td>99(99.0)</td><td>1101(91.1)</td><td>584(79.5)</td><td>1784</td><td> </td></tr><tr><td>Job satisfaction</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Low</td><td>35(35.0)</td><td>102(8.4)</td><td>102(13.9)</td><td>239</td><td>&lt;.0001</td></tr><tr><td>Average</td><td>44(44.0)</td><td>550(45.5)</td><td>376(51.2)</td><td>970</td><td> </td></tr><tr><td>High</td><td>21(21.0)</td><td>557(46.1)</td><td>257(35.0)</td><td>835</td><td> </td></tr><tr><td colspan="6">Smoking in 2007</td></tr><tr><td>Yes</td><td>65(65.0)</td><td>629(52.0)</td><td>441(60.0)</td><td>1135</td><td>0.001</td></tr><tr><td>No</td><td>35(35.0)</td><td>580(48.0)</td><td>294(40.0)</td><td>909</td><td> </td></tr><tr><td colspan="6">Smoking in 2008</td></tr><tr><td>Yes</td><td>66(66.0)</td><td>670(55.4)</td><td>451(61.4)</td><td>1187</td><td>0.019</td></tr><tr><td>No</td><td>34(34.0)</td><td>539(44.6)</td><td>284(38.6)</td><td>857</td><td> </td></tr><tr><td colspan="6">Alcohol drinking</td></tr><tr><td>Yes</td><td>87(87.0)</td><td>1023(84.6)</td><td>627(85.3)</td><td>1737</td><td>0.776</td></tr><tr><td>No</td><td>13(13.0)</td><td>186(15.4)</td><td>108(14.7)</td><td>307</td><td> </td></tr></table>
3cd782bf3b25f74b19cb9b30417647c28dceeba1c5d3df44946112fbd621f724.png
complex
<table><tr><td></td><td>%T0</td><td>%24-hour</td><td>Fold change</td><td><i>P</i> value</td></tr><tr><td colspan="5">a.) The most abundant members at time zero</td></tr><tr><td>Oxalobacteraceae</td><td>38.63</td><td>0.96</td><td>&#8722;40.21</td><td>0.0002</td></tr><tr><td>Pseudomonadaceae</td><td>10.62</td><td>1.36</td><td>&#8722;7.79</td><td>0.0158</td></tr><tr><td>Flavobacteriaceae</td><td>7.33</td><td>0.22</td><td>&#8722;33.12</td><td>0.0002</td></tr><tr><td>Comamonadaceae</td><td>5.03</td><td>2.43</td><td>&#8722;2.07</td><td>0.1982</td></tr><tr><td>Xanthomonadaceae</td><td>4.11</td><td>0.87</td><td>&#8722;4.72</td><td>0.0154</td></tr><tr><td>Rhizobiaceae</td><td>3.57</td><td>0.13</td><td>&#8722;27.76</td><td>0.0002</td></tr><tr><td>Methylobacteriaceae</td><td>3.50</td><td>0.03</td><td>&#8722;140.14</td><td>0.0002</td></tr><tr><td>Micrococcaceae</td><td>2.52</td><td>0.01</td><td>&#8722;176.45</td><td>0.0002</td></tr><tr><td>Sphingomonadaceae</td><td>2.28</td><td>0.03</td><td>&#8722;79.78</td><td>0.0002</td></tr><tr><td>Weeksellaceae</td><td>2.20</td><td>0.07</td><td>&#8722;33.30</td><td>0.0002</td></tr><tr><td>Rhodobacteraceae</td><td>2.11</td><td>0.03</td><td>&#8722;73.74</td><td>0.0002</td></tr><tr><td>Microbacteriaceae</td><td>2.06</td><td>0.02</td><td>&#8722;104.63</td><td>0.0002</td></tr><tr><td>[Exiguobacteraceae]</td><td>1.84</td><td>6.20</td><td>3.37</td><td>0.0002</td></tr><tr><td>Caulobacteraceae</td><td>1.58</td><td>0.03</td><td>&#8722;55.16</td><td>0.0002</td></tr><tr><td>Rickettsiales</td><td>1.32</td><td>0.01</td><td>&#8722;92.45</td><td>0.0002</td></tr><tr><td>Sphingobacteriaceae</td><td>1.29</td><td>0.08</td><td>&#8722;17.20</td><td>0.0002</td></tr><tr><td>Enterobacteriaceae</td><td>1.14</td><td>3.59</td><td>3.13</td><td>0.0288</td></tr><tr><td>Aurantimonadaceae</td><td>1.01</td><td>0.01</td><td>&#8722;93.98</td><td>0.0002</td></tr><tr><td>Paenibacillaceae</td><td>0.99</td><td>1.51</td><td>1.52</td><td>0.1238</td></tr><tr><td>Rhizobiales;Other</td><td>0.62</td><td>0.04</td><td>&#8722;14.56</td><td>0.0002</td></tr><tr><td>Bacillaceae</td><td>0.61</td><td>3.08</td><td>5.01</td><td>0.0002</td></tr><tr><td>Cytophagaceae</td><td>0.60</td><td>0.01</td><td>&#8722;111.36</td><td>0.0002</td></tr><tr><td colspan="5">b.) The most abundant members after a 24-hour mBPW enrichment</td></tr><tr><td>Peptostreptococcaceae</td><td>0.01</td><td>40.79</td><td>2957.09</td><td>0.0002</td></tr><tr><td>Planococcaceae</td><td>0.31</td><td>19.49</td><td>62.11</td><td>0.0002</td></tr><tr><td>Clostridiaceae</td><td>0.03</td><td>13.54</td><td>490.93</td><td>0.0002</td></tr><tr><td>[Exiguobacteraceae]</td><td>1.84</td><td>6.20</td><td>3.37</td><td>0.0002</td></tr><tr><td>Enterobacteriaceae</td><td>1.14</td><td>3.59</td><td>3.13</td><td>0.0288</td></tr><tr><td>Bacillaceae</td><td>0.61</td><td>3.08</td><td>5.01</td><td>0.0002</td></tr><tr><td>Comamonadaceae</td><td>5.03</td><td>2.43</td><td>&#8722;2.07</td><td>0.1982</td></tr><tr><td>Lachnospiraceae</td><td>0.00</td><td>1.82</td><td>527.18</td><td>0.0002</td></tr><tr><td>Paenibacillaceae</td><td>0.99</td><td>1.51</td><td>1.52</td><td>0.1238</td></tr><tr><td>Clostridiales;Other</td><td>0.00</td><td>1.50</td><td>&#8734;</td><td>0.0002</td></tr><tr><td>Pseudomonadaceae</td><td>10.62</td><td>1.36</td><td>&#8722;7.79</td><td>0.0158</td></tr><tr><td>Oxalobacteraceae</td><td>38.63</td><td>0.96</td><td>&#8722;40.21</td><td>0.0002</td></tr><tr><td>Xanthomonadaceae</td><td>4.11</td><td>0.87</td><td>&#8722;4.72</td><td>0.0154</td></tr><tr><td>Aeromonadaceae</td><td>0.00</td><td>0.57</td><td>164.68</td><td>0.0002</td></tr></table>
caf9e5e3fd8712f63abb2a41bf6d0128b60522b7cfbc7d410bd3fca3a72ee5f3.png
complex
<table><tr><td colspan="6">Extract of questionnaire</td></tr><tr><td colspan="6">Frequency of muscle pain that was reported in clinical trials on statins:</td></tr><tr><td></td><td colspan="2">Statins</td><td colspan="2">Placebo</td><td><i>p</i>-value</td></tr><tr><td> Cochrane 2013 <i>N</i> = 37,938, primary prevention</td><td colspan="2">9.5 %</td><td colspan="2">9.2 %</td><td>0.40</td></tr><tr><td> Finegold 2014 <i>N</i> = 46,262, primary prevention</td><td colspan="2">7.9 %</td><td colspan="2">7.6 %</td><td>0.407</td></tr><tr><td> Finegold 2014 <i>N</i> = 37,618, secondary prevention</td><td colspan="2">4.8 %</td><td colspan="2">4.6 %</td><td>0.558</td></tr><tr><td colspan="6">Question: If 100 patients take this statin &#8211; in how many of them does the intake of this statin cause muscle pain?<sup>a</sup></td></tr><tr><td> Responses (No)</td><td rowspan="2">0</td><td rowspan="2">1</td><td rowspan="2">&gt;1</td><td rowspan="2">&gt;10</td><td rowspan="2">No response</td></tr><tr><td> Format multiple choice</td></tr><tr><td> Group 6 (<i>n</i> = 87) Pharmacy group</td><td>10 (12 %)</td><td>12 (14 %)</td><td>48 (55 %)</td><td>14 (16 %)</td><td>3 (3 %)</td></tr></table>
4221c0d4791f3b69b82f049956e760ba818039dfd984b7da9c6c8d54a53dfd7b.png
complex
<table><tr><td>Themes</td><td>Subthemes</td><td>Representative statements</td></tr><tr><td rowspan="2">Cultural and linguistic barriers </td><td>Major barriers in terms of language and culture result in older adults' dependency on others when it comes to medical visits</td><td>&#8220;The biggest problem is the language barrier. We feel helpless since we do not speak English, and we cannot resolve matters without English. Even if you understand English you would not comprehend their technical terms.&#8221; &#8220;The people I contact are few. I don't want to bother my children.&#8221;</td></tr><tr><td>Immediate family support may not always be available to assist older adults with medical visits</td><td>&#8220;If you need your son to bring you to the doctor's clinic, he would have no time because he has to work. If you cannot find someone else, then you just have to wait until he comes home.&#8221; &#8220;To ride the bus you need to know how to get there... you need to draw it on a piece of paper with the directions. I was to take bus no. 4, and it would transfer three times. But still I did not make it (to the hospital). I was lucky to return home from the final bus stop.&#8221; </td></tr><tr><td rowspan="2">Affordability of services </td><td>The health care system is poorly understood. The utilization and degree of satisfaction differ depending on older adults' insurance coverage and length of residence</td><td>&#8220;As new comers, we have nothing. My mother-in-law is old, and, moreover, I am old too, I am sixty eight years old. As we age, the most critical thing is medical treatment and benefits. Getting your white card, it would not be a big deal even if you are sick. We depend on the medical supply by mail. It is tough to see a doctor. Besides it is far away. And not knowing English, it is difficult to visit a doctor. The medical expenses are high.&#8221; &#8220;It's like we have to pay for everything. We have nothing and yet we need to pay for the medication expenses.&#8221; </td></tr><tr><td>For those who are fully insured, they feel fortunate compared to that of their counterparts in China</td><td>&#8220;Buying insurance is now only getting started in China. Previously, I bought insurance. Now I apply for low-income status. So I do not have to buy insurance and it is so much better. America is definitely taking that route. You have no money. The government helps out with a low income status. If you apply, it will not cost you any money.&#8221; &#8220;I think the most pleasant thing for me in the US is what happened to my two legs. My legs were broken twice in the US if that happened in China, my children and I would not be able to afford the surgeries. Here in the US, I do not have to pay a single cent. They even provided me the walking equipment and the toilet pans. I think this is the best thing happened to me. I feel very happy and thankful for that.&#8221; </td></tr><tr><td rowspan="2">Availability of services </td><td>The long wait and inflexibility of health care services often frustrated participants</td><td>&#8220;I think the waiting period to see a doctor is too long. It takes several hours and you are not seeing your doctor right away. Definitely it is too long.&#8221; &#8220;I think there is something that America is not comparable to China. That is the appointment system. They are not letting you see the doctor today, unless you are going to the emergency room! They will not let you see the doctor right away; it would take a week. Then you need to go to the emergency room. I think that situation is not good.&#8221; </td></tr><tr><td>The expectation toward medical visits is often compared to older participants' experience in China where quick improvement is anticipated</td><td>&#8220;In Shanghai, if I do not feel good, I can go to see the doctor right away. Over here, this appointment thing, you would need two weeks to see your family physician. He has his vacations and you need to wait two weeks. But hey, I am sick... I have this illness and I need to see the doc right away. I think over here, you need to go to the hospital, the UIC Hospital. It is because of the insurance that requires you to visit the hospital. Today you can visit this hospital and tomorrow you can visit that hospital. And that is OK.&#8221; &#8220;Like suffering from nerve pain... if you are in China, you just visit the clinic to get a pain killer shot. Over here the waiting period is not fast. I went there and took several hours. Going to the hospital for minor ailments is not convenient.&#8221;.</td></tr></table>
75414b8d6a92198ac397c4f434303170087494946dbcb626479c4b797769b7bf.png
complex
<table><tr><td>Performance parameter</td><td colspan="2">Melody type</td></tr><tr><td></td><td>Simple</td><td>Complex</td></tr><tr><td>8th note onset</td><td>0.57</td><td>0.49</td></tr><tr><td>16th note onset</td><td>0.38</td><td>0.54</td></tr><tr><td>Micro-timing onset</td><td>0.14</td><td>&#8722;0.12</td></tr><tr><td>8th note offset</td><td>0.48</td><td>0.09</td></tr><tr><td>16th note offset</td><td>0.23</td><td>0.26</td></tr><tr><td>Micro-timing offset</td><td>&#8722;0.09</td><td>&#8722;0.02</td></tr><tr><td>8th note duration</td><td>&#8722;0.37</td><td>&#8722;0.35</td></tr><tr><td>16th note duration</td><td>&#8722;0.17</td><td>&#8722;0.23</td></tr><tr><td>Micro-timing duration</td><td>&#8722;0.05</td><td>&#8722;0.08</td></tr><tr><td>Density</td><td>0.51</td><td>0.38</td></tr><tr><td><i>R</i><sup>2</sup> (variance explained)</td><td>0.562</td><td>0.532</td></tr></table>
0d445dd53aa72e44857c634e9b412c33c3dc13dfca002fb51eef45d5fb93283e.png
simple
<table><tr><td>Construct name</td><td>Primer combination</td></tr><tr><td>NbPDS (2046 bp)</td><td>NbPDSfor1 &#215; NbPDSrev1</td></tr><tr><td>NbPDS (1661 bp)</td><td>NbPDSfor2 &#215; NbPDSrev1</td></tr><tr><td>NbPDS (1304 bp)</td><td>NbPDSfor3 &#215; NbPDSrev1</td></tr><tr><td>NbPDS (959 bp)</td><td>NbPDSfor4 &#215; NbPDSrev1</td></tr><tr><td>NbPDS (610 bp)</td><td>NbPDSfor5 &#215; NbPDSrev1</td></tr><tr><td>NbPDS (257 bp)</td><td>NbPDSfor6 &#215; NbPDSrev1</td></tr><tr><td>NbPDS (345 bp)</td><td>NbPDSfor3 &#215; NbPDSrev2</td></tr><tr><td>NbPDS (192 bp)</td><td>NbPDSfor7 &#215; NbPDSrev3</td></tr><tr><td>NbPDS (103 bp)</td><td>NbPDSfor7 &#215; NbPDSrev4</td></tr><tr><td>NbPDS (54 bp)</td><td>NbPDSfor8 &#215; NbPDSrev5</td></tr><tr><td>NbPDS (385 bp)</td><td>NbPDSfor1 &#215; NbPDSrev6</td></tr><tr><td>NbPDS (357 bp)</td><td>NbPDSfor2 &#215; NbPDSrev7</td></tr><tr><td>NbPDS (349 bp)</td><td>NbPDSfor4 &#215; NbPDSrev8</td></tr><tr><td>NbPDS (353 bp)</td><td>NbPDSfor5 &#215; NbPDSrev9</td></tr><tr><td>NbPDS (2046 bp + polyA)</td><td>NbPDSfor1 &#215; NbPDSrev6</td></tr><tr><td>NbPDS (1661 bp + polyA)</td><td>NbPDSfor2 &#215; NbPDSrev6</td></tr><tr><td>NbPDS (1304 bp + polyA)</td><td>NbPDSfor3 &#215; NbPDSrev6</td></tr><tr><td>NbPDS (959 bp + polyA)</td><td>NbPDSfor4 &#215; NbPDSrev6</td></tr><tr><td>NbPDS (610 bp + polyA)</td><td>NbPDSfor5 &#215; NbPDSrev6</td></tr><tr><td>NbPDS (257 bp + polyA)</td><td>NbPDSfor6 &#215; NbPDSrev6</td></tr><tr><td>NbPDS (345 bp + polyA)</td><td>NbPDSfor7 &#215; NbPDSrev7</td></tr><tr><td>NbPDS (345 bp + polyG)</td><td>NbPDSfor7 &#215; NbPDSrev8</td></tr></table>
cd2559b1bb6cf12c299418b2a57acb98eb21aed2bb1b7ac52532e0b799570945.png
simple
<table><tr><td></td><td>Set1</td><td>Set2</td><td>All ARs</td></tr><tr><td>Set1</td><td>1</td><td>0.80 &#177; 0.35<sup>*</sup></td><td>0.89 &#177; 0.26</td></tr><tr><td>Set2</td><td>0.83 &#177; 0.31</td><td>1</td><td>0.92 &#177; 0.19</td></tr><tr><td>All ARs</td><td>0.81 &#177; 0.35</td><td>0.80 &#177; 0.37</td><td>1</td></tr></table>
472f05731832e3fa7d4393fc7b142d15338eddd87709ff4727beda7fcc6fd00d.png
simple
<table><tr><td>CAT item</td><td>Comorbidity</td><td>p value</td><td>Cumulative R<sup>2</sup></td></tr><tr><td>Cough</td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>None</td><td> </td><td> </td></tr><tr><td>Phlegm</td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>None</td><td> </td><td> </td></tr><tr><td>Chest tightness</td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>GERD (FSSG &#8805; 8)</td><td>&lt;0.001</td><td>0.0901</td></tr><tr><td> </td><td>Depression (HAD-D &#8805; 11)</td><td>0.0033</td><td>0.123</td></tr><tr><td>Breathlessness</td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>GERD (FSSG &#8805; 8)</td><td>&lt;0.001</td><td>0.0705</td></tr><tr><td> </td><td>Osteoporosis</td><td>0.0355</td><td>0.0876</td></tr><tr><td>Activity limitation</td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>GERD (FSSG &#8805; 8)</td><td>&lt;0.001</td><td>0.0926</td></tr><tr><td> </td><td>Depression (HAD-D &#8805; 11)</td><td>&lt;0.001</td><td>0.1452</td></tr><tr><td> </td><td>Arrhythmia</td><td>0.0026</td><td>0.1773</td></tr><tr><td> </td><td>Osteoporosis</td><td>0.0222</td><td>0.1954</td></tr><tr><td>Confidence to leave home</td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>GERD (FSSG &#8805; 8)</td><td>&lt;0.001</td><td>0.0631</td></tr><tr><td> </td><td>Depression (HAD-D &#8805; 11)</td><td>&lt;0.001</td><td>0.107</td></tr><tr><td> </td><td>Osteoporosis</td><td>&lt;0.001</td><td>0.1337</td></tr><tr><td> </td><td>Hypertension</td><td>0.0109</td><td>0.1571</td></tr><tr><td> </td><td>Arrhythmia</td><td>0.0445</td><td>0.1714</td></tr><tr><td>Sleep</td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>Depression (HAD-D &#8805; 11)</td><td>&lt;0.001</td><td>0.0807</td></tr><tr><td> </td><td>GERD (FSSG &#8805; 8)</td><td>0.0033</td><td>0.1134</td></tr><tr><td> </td><td>Anxiety (HAD-A &#8805; 11)</td><td>0.01</td><td>0.1378</td></tr><tr><td> </td><td>Arrhythmia</td><td>0.0404</td><td>0.153</td></tr><tr><td>Energy</td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>GERD (FSSG &#8805; 8)</td><td>&lt;0.001</td><td>0.1191</td></tr><tr><td> </td><td>Depression (HAD-D &#8805; 11)</td><td>&lt;0.001</td><td>0.1972</td></tr><tr><td> </td><td>Arrhythmia</td><td>&lt;0.001</td><td>0.2487</td></tr><tr><td> </td><td>Anxiety (HAD-A &#8805; 11)</td><td>0.0333</td><td>0.263</td></tr></table>
d61940473483a294c6a68d6836ff163c2747be8799a1ee2e5393099539c635ad.png
complex
<table><tr><td></td><td></td><td colspan="4">Estimated value of K</td><td></td></tr><tr><td>ParameterV</td><td>True value ofK</td><td>&#963;<sup>2</sup>= 0</td><td>&#963;<sup>2 </sup>= 0.1</td><td>&#963;<sup>2</sup>= 0.5</td><td>&#963;<sup>2 </sup>= 1</td><td>&#963;<sup>2 </sup>= 10</td></tr><tr><td>V = 1</td><td>K = 1</td><td>0.895860924</td><td>1.198924271</td><td>2.060871616</td><td>2.392641064</td><td>2.2417669</td></tr><tr><td>V = 1</td><td>K = 10</td><td>9.942624719</td><td>9.417099524</td><td>5.18899955</td><td>3.041348517</td><td>2.3984733</td></tr><tr><td>V = 1</td><td>K = 50</td><td>49.84538377</td><td>50.3653591</td><td>49.79822957</td><td>48.21724047</td><td>17.612567</td></tr><tr><td>V = 1</td><td>K = 100</td><td>99.57735594</td><td>100.5475019</td><td>98.86122817</td><td>95.19722428</td><td>35.651171</td></tr><tr><td>V = 1</td><td>K = 500</td><td>499.7813772</td><td>498.9833568</td><td>495.3510638</td><td>501.8771493</td><td>450.50892</td></tr><tr><td>V = 1</td><td>K = 1000</td><td>999.2728579</td><td>997.8776983</td><td>995.7044492</td><td>988.870943</td><td>891.65597</td></tr><tr><td>V = 10</td><td>K = 1</td><td>0.970450637</td><td>1.006078611</td><td>1.094535769</td><td>1.282321201</td><td>2.1026316</td></tr><tr><td>V = 10</td><td>K = 10</td><td>9.975237184</td><td>9.997279446</td><td>9.847326837</td><td>9.531280999</td><td>5.3013845</td></tr><tr><td>V = 10</td><td>K = 50</td><td>50.05571987</td><td>49.87267536</td><td>49.91859144</td><td>50.0966008</td><td>49.055078</td></tr><tr><td>V = 10</td><td>K = 100</td><td>99.87386748</td><td>99.92057687</td><td>100.6109818</td><td>99.56079265</td><td>97.374093</td></tr><tr><td>V = 10</td><td>K = 500</td><td>500.0809047</td><td>499.7714225</td><td>499.802065</td><td>500.2063382</td><td>497.87452</td></tr><tr><td>V = 10</td><td>K = 1000</td><td>999.5597507</td><td>999.5670495</td><td>1000.211577</td><td>1001.028307</td><td>996.15873</td></tr></table>
06a327d8a99c96d6e409b448ef49231b3378ef1dbbad623a2ec56f38516ad644.png
simple
<table><tr><td></td><td>ELBW</td><td>NBW</td></tr><tr><td>Sex</td><td>54 males; 67 females</td><td>56 males; 72 females</td></tr><tr><td>Birth weight in grams</td><td>841.91 (123.91)<sup>*</sup></td><td>3380.10 (492.63)<sup>*</sup></td></tr><tr><td>Mother's highest level of education</td><td>5.61 (1.91)</td><td>6.02 (1.98)</td></tr><tr><td>Young adult's highest level of education</td><td>4.42 (1.33)</td><td>4.70 (1.37)</td></tr><tr><td>Full scale WISC-R</td><td>92.41 (14.66)<sup>*</sup></td><td>103.78 (12.44)<sup>*</sup></td></tr><tr><td>Verbal IQ WISC-R</td><td>91.74 (14.23)<sup>*</sup></td><td>101.30 (12.85)<sup>*</sup></td></tr><tr><td>Performance IQ WISC-R</td><td>94.83 (16.05)<sup>*</sup></td><td>106.02 (12.90)<sup>*</sup></td></tr><tr><td>General information WISC-R</td><td>9.16 (3.07)<sup>*</sup></td><td>10.11 (2.80)<sup>*</sup></td></tr><tr><td>Similarities WISC-R</td><td>9.16 (3.38)<sup>*</sup></td><td>10.66 (3.13)<sup>*</sup></td></tr><tr><td>Arithmetic WISC-R</td><td>8.12 (2.68)<sup>*</sup></td><td>10.53 (2.66)<sup>*</sup></td></tr><tr><td>Vocabulary WISC-R</td><td>8.45 (3.08)<sup>*</sup></td><td>10.01 (2.94)<sup>*</sup></td></tr><tr><td>Comprehension WISC-R</td><td>8.63 (2.68)<sup>*</sup></td><td>10.08 (2.42)<sup>*</sup></td></tr><tr><td>Picture completion WISC-R</td><td>9.12 (2.68)<sup>*</sup></td><td>11.40 (2.26)<sup>*</sup></td></tr><tr><td>Picture arrangement WISC-R</td><td>9.74 (4.12)<sup>*</sup></td><td>11.28 (3.00)<sup>*</sup></td></tr><tr><td>Block design WISC-R</td><td>9.21 (3.11)<sup>*</sup></td><td>11.13 (2.96)<sup>*</sup></td></tr><tr><td>Object assembly WISC-R</td><td>9.41 (3.06)<sup>*</sup></td><td>10.90 (2.76)<sup>*</sup></td></tr><tr><td>Coding WISC-R</td><td>8.71 (3.38)<sup>*</sup></td><td>9.83 (2.65)<sup>*</sup></td></tr><tr><td>RCPM</td><td>40.05 (26.53)<sup>*</sup></td><td>55.11 (29.12)<sup>*</sup></td></tr><tr><td>ADHD rating scale inattentive score</td><td>3.70 (2.97)</td><td>3.06 (2.88)</td></tr><tr><td>ADHD rating scale hyperactivity/impulsivity score</td><td>4.34 (2.97)</td><td>4.38 (2.91)</td></tr><tr><td>ADHD rating scale total score</td><td>8.04 (5.41)</td><td>7.45 (5.10)</td></tr><tr><td>YASR attention problems</td><td>2.83 (2.35)</td><td>2.45 (2.05)</td></tr></table>
cade74f3c28d0d3fba2a3e1d6aebd44134ccbe2e890f94fab07fe55f7efe0e0e.png
simple
<table><tr><td>Variables</td><td><i>N</i> (%)</td></tr><tr><td>Experienced an occupational injury</td><td>13 (32.5)</td></tr><tr><td>Knows other workers who have been injured</td><td>21 (52.5)</td></tr><tr><td>Major types of injury (<i>N</i> = 13)</td><td> </td></tr><tr><td>Broken bone</td><td>3 (23.1)</td></tr><tr><td>Inhalation</td><td>3 (23.1)</td></tr><tr><td>Accidental injection/needle stab</td><td>3 (23.1)</td></tr><tr><td>Muscle sprain or strain</td><td>3 (23.1)</td></tr><tr><td>Part of body injured</td><td> </td></tr><tr><td>Leg, knee, or hip</td><td>4 (30.8)</td></tr><tr><td>Hand or wrist</td><td>3 (23.1)</td></tr><tr><td>Eyes</td><td>2 (15.4)</td></tr><tr><td>Head or neck</td><td>1 (7.7)</td></tr><tr><td>Back</td><td>1 (7.7)</td></tr><tr><td>Arms or shoulders</td><td>1 (7.7)</td></tr><tr><td>Fingers</td><td>1 (7.7)</td></tr><tr><td>Cause of injury</td><td> </td></tr><tr><td>Animal</td><td>10 (76.9)</td></tr><tr><td>Machine</td><td>2 (15.4)</td></tr><tr><td>Other</td><td>1 (7.7)</td></tr><tr><td>Lost time due to injury</td><td> </td></tr><tr><td>No time lost</td><td>8 (61.5)</td></tr><tr><td>2-6 days lost</td><td>1 (7.7)</td></tr><tr><td>More than 30 days lost</td><td>4 (30.8)</td></tr><tr><td>Have health problems due to working with hogs</td><td>11 (28.2)</td></tr><tr><td>Type of occupational health problems</td><td> </td></tr><tr><td>Allergies</td><td>3 (7.5)</td></tr><tr><td>Asthma</td><td>2 (5.0)</td></tr><tr><td>Bronchitis</td><td>2 (5.0)</td></tr><tr><td>Coughing</td><td>7 (17.5)</td></tr><tr><td>Eyes burning</td><td>10 (25.0)</td></tr><tr><td>Headaches</td><td>7 (17.5)</td></tr><tr><td>Hearing problems</td><td>2 (5.0)</td></tr><tr><td>Infections</td><td>1 (2.5)</td></tr><tr><td>Muscular pain</td><td>9 (22.5)</td></tr><tr><td>Nausea</td><td>4 (10.0)</td></tr><tr><td>Nasal congestion</td><td>4 (10.0)</td></tr><tr><td>Sneezing</td><td>6 (15.0)</td></tr><tr><td>Skin disorders</td><td>1 (2.5)</td></tr><tr><td>Pain in throat</td><td>3 (7.5)</td></tr></table>
d5dd9a582d0bcea09d55d8e518a623d154732ba4ee7245e3401368e50cdba96b.png
simple
<table><tr><td>Disease</td><td>Trimester</td><td>Aminotransferases</td><td>Bilirubin</td><td>INR</td><td>Treatment</td><td>Prognosis*</td></tr><tr><td>Hyperemesis gravidarum</td><td>First</td><td>Up to 2-3 times upper limit of normal</td><td>&lt;4</td><td>Always normal</td><td>Supportive</td><td>Excellent</td></tr><tr><td>Intrahepatic cholestasis of pregnancy</td><td>Second/third</td><td>Elevated sometimes rarely &gt;1000</td><td>Elevated but &lt;6</td><td>Typically normal</td><td>Ursodeoxycholic acid</td><td>Good</td></tr><tr><td>AFLP</td><td>Third</td><td>Elevated usually &lt;1000</td><td>Elevated</td><td>Usually elevated</td><td>Delivery</td><td>Guarded</td></tr><tr><td>HELLP</td><td>Third</td><td>Elevated, variable, 5-20 times upper limit of normal</td><td>&gt;1.2</td><td>Sometimes elevated</td><td>IV magnesium, BP control, delivery</td><td>Guarded</td></tr><tr><td>Acetaminophen</td><td>Any</td><td>&gt;50 times upper limit of normal</td><td>Elevated usually &lt;10</td><td>Usually elevated</td><td>NAC</td><td>Good if NAC administered promptly</td></tr><tr><td>Ischemia</td><td>Any</td><td>&gt;50 times upper limit of normal</td><td>Elevated usually &lt;4</td><td>Usually elevated (&lt;3)</td><td>Supportive</td><td>Variable, depends on underlying disease</td></tr><tr><td>Viral</td><td>Any</td><td>&gt;25 times upper limit of normal</td><td>Elevated</td><td>Variable</td><td>Supportive</td><td>Variable</td></tr><tr><td>Drug-induced</td><td>Any</td><td>&gt;25 times upper limit of normal</td><td>Elevated</td><td>Variable</td><td>Supportive</td><td>Variable</td></tr><tr><td>Autoimmune</td><td>Any</td><td>5-10 times upper limit of normal</td><td>Normal</td><td>Variable</td><td>Corticosteroids, azathioprine</td><td>Variable</td></tr></table>
808cc3ba454dab8cb8a151aae0165078c44729112e9741d529546c57e582444a.png
complex
<table><tr><td>Scenario</td><td>Skin Area</td><td>Months</td><td>Time</td></tr><tr><td>S1</td><td>35% (face, hands, forearms, lower legs)</td><td>March&#8211;September</td><td>Constant</td></tr><tr><td rowspan="2">S2</td><td>35% (face, hands, forearms, lower legs)</td><td>June&#8211;August</td><td rowspan="2">Constant</td></tr><tr><td>10% (face and hands)</td><td>March&#8211;May, September</td></tr><tr><td>S3</td><td>10% (face and hands)</td><td>March&#8211;September</td><td>Constant</td></tr><tr><td>S4</td><td>35% (face, hands, forearms, lower legs)</td><td>June&#8211;August</td><td>Varies with latitude (equivalent to 1 SED) *</td></tr></table>
f04c470f601dbe8ce3d0387e120b63ed257b5b73e4930b62811cb6629a7eb73c.png
complex
<table><tr><td>Affective words</td><td>Answer</td><td colspan="5">Categories of associated words</td></tr><tr><td></td><td></td><td>Synonyms</td><td>Antonym</td><td>Life event</td><td>Relative behavior</td><td>Others</td></tr><tr><td>Happiness</td><td>Number</td><td>36</td><td>2</td><td>42</td><td>7</td><td>3</td></tr><tr><td></td><td>Frequency (%)</td><td>40.45</td><td>2.24</td><td>47.19</td><td>7.87</td><td>3.37</td></tr><tr><td>Sadness</td><td>Number</td><td>21</td><td>0</td><td>47</td><td>17</td><td>4</td></tr><tr><td></td><td>Frequency (%)</td><td>23.60</td><td>0</td><td>52.81</td><td>19.10</td><td>4.49</td></tr><tr><td>Anger</td><td>Number</td><td>25</td><td>1</td><td>45</td><td>10</td><td>8</td></tr><tr><td></td><td>Frequency (%)</td><td>28.09</td><td>1.12</td><td>50.56</td><td>11.24</td><td>8.99</td></tr><tr><td>Fear</td><td>Number</td><td>29</td><td>0</td><td>52</td><td>6</td><td>1</td></tr><tr><td></td><td>Frequency (%)</td><td>32.58</td><td>0</td><td>58.43</td><td>6.74</td><td>1.12</td></tr></table>
28692702a029805eb1eafb7947b65c36406e81e74e3e73c461f9cd345d87debd.png
simple
<table><tr><td>country</td><td>summarized area characteristics</td><td>number of species</td><td>references</td></tr><tr><td>Africa</td><td>continent-wide estimate (insects only)</td><td>600</td><td>DeFoliart (1992)</td></tr><tr><td>Africa</td><td>sub-Saharan Africa (insects only)</td><td>250</td><td>van Huis (2003)</td></tr><tr><td>Africa</td><td>Central and West Africa (plants only)</td><td>1500</td><td>Chege (1994)</td></tr><tr><td>Botswana</td><td>Tyua grow crops and use wild plants, animals, birds, fish and insects</td><td>171</td><td>Hitchcock (1999)</td></tr><tr><td>Congo</td><td>Mbuti Pygmies of forest: cultivators of cassava and plantain plus users of 230 animal and 100 plant species</td><td>330</td><td>Ishikawa (1999)</td></tr><tr><td>Ethiopia</td><td>subsistence agriculture, animal husbandry, semi-arid to humid</td><td>44</td><td>Fentahun &amp; Hager (2009)</td></tr><tr><td>Ethiopia</td><td>country-wide estimate</td><td>203</td><td>Asfaw &amp; Tadesse (2001)</td></tr><tr><td>Ethiopia</td><td>country-wide estimate</td><td>300</td><td>Asfaw (2009)</td></tr><tr><td>Ethiopia</td><td>agricultural, arid, open woodland (50% of plants in region edible)</td><td>25</td><td>Becker (1983)</td></tr><tr><td>Ethiopia</td><td>humid to semi-arid; forest to savannah, three ethnic groups in south Ethiopia</td><td>66</td><td>Balemie &amp; Kebebew (2006)</td></tr><tr><td>Kenya</td><td>country-wide estimate for agricultural communities (plants only)</td><td>800</td><td>Maundu (1996)</td></tr><tr><td>Kenya</td><td>Turkana agro-pastoralists and rural fishing communities, arid and semi-arid</td><td>14</td><td>Levine &amp; Crosskey (2006)</td></tr><tr><td>Madagascar</td><td>forest-dwelling, swidden cultivation in tropical forest</td><td>150</td><td>Styger <i>et al</i>. (1999)</td></tr><tr><td>Namibia</td><td>agriculture and livestock; tropical wetland, swamp and woodland in Caprivi</td><td>21</td><td>Mulonga (2003)</td></tr><tr><td>Nigeria</td><td>agricultural, savanna, semi-arid</td><td>121</td><td>Harris &amp; Mohammed (2003)</td></tr><tr><td>Tanzania</td><td>agricultural, tropical forest, East Usambara mountains</td><td>28</td><td>Kessey (1998)</td></tr><tr><td>Tanzania</td><td>agricultural, tropical forest, East Usambara mountains</td><td>46</td><td>Ha&#778;rko&#776;nen &amp; Vainio-Mattila (1998)</td></tr><tr><td>Tanzania</td><td>Batemi agropastoralists, semi-arid (with 35 wild species cultivated)</td><td>44</td><td>Johns <i>et al</i>. (1996)</td></tr><tr><td>Uganda</td><td>agricultural households in southwest Uganda (some wild species cultivated and gathered from the wild)</td><td>94</td><td>Musinguzi <i>et al</i>. (2006)</td></tr><tr><td>Zambia</td><td>country-wide estimate</td><td>15&#8211;25</td><td>Pegler &amp; Piearce (1980)</td></tr></table>
af6a813008bca9389bc5626fd5f3af5903296ed9b38e32ddcd8cccffbad490b8.png
complex
<table><tr><td colspan="6">Summary of clinical data of the study group consisting of colon cancer patients, pre-malignant adenoma patients and healthy control patients</td></tr><tr><td>Parameter</td><td>Value</td><td>Colon cancer (CC) patients</td><td>Healthy control (H) patients</td><td>Adenoma (A) patients</td><td>P-value</td></tr><tr><td> </td><td> </td><td>(n = 164)</td><td>(n = 119)*</td><td>(n = 34)</td><td> </td></tr><tr><td>Sex</td><td>Female</td><td>68 (41.5%)</td><td>67 (56.3%)</td><td>16 (47.1%)</td><td>0.738</td></tr><tr><td> </td><td>Male</td><td>96 (58.5%)</td><td>52 (43.7%)</td><td>18 (52.9%)</td><td> </td></tr><tr><td>Age</td><td>Range</td><td>40.5 &#8211; 99.1</td><td>19.5 &#8211; 90.8</td><td>28.1 &#8211; 86.1</td><td>0.144 (A vs H)</td></tr><tr><td>(years)</td><td>Mean</td><td>69.59</td><td>62.41</td><td>63.65</td><td>0.004 (CC vs H)</td></tr></table>
63e566e105f7aaa2132c6246b80d009c39d32f62493b3290513c33cc999caf55.png
simple
<table><tr><td>Gene</td><td>Primer</td><td>Sequence</td><td>Annealing temperature/elongation time</td><td>Literature</td></tr><tr><td>16S, <i>rrnA</i></td><td>pF1</td><td>AGAGTTTGATCCTGGCTCAG</td><td>55&#176;C/60 sec</td><td>[32]</td></tr><tr><td> </td><td>pR4</td><td>CCAGCAGCCGCGGTAATAC</td><td> </td><td>[33]</td></tr><tr><td><i>sodA</i></td><td>sodA-F</td><td>TRCAYCATGAYAARCACCAT</td><td>50&#176;C/60 sec</td><td>[34]</td></tr><tr><td> </td><td>sodA-R</td><td>ARRTARTAMGCRTGYTCCCARACRTC</td><td> </td><td>[34]</td></tr><tr><td><i>groEL</i></td><td>StreptogroELd</td><td>GAHGTNGTIGAAGGIATGCA</td><td>52&#176;C/60 sec</td><td>[35]</td></tr><tr><td> </td><td>StreptogroELr</td><td>ATTTGRCGIAYWGGYTCTTC</td><td> </td><td>[35]</td></tr><tr><td><i>gdh</i></td><td>GDHsoralisF</td><td>ATGGACAAACCAGCTAGCTT</td><td>55&#176;C/60 sec</td><td>[6]</td></tr><tr><td> </td><td>GDHsoralisR</td><td>GCTTGTGGTCCCATGCTTCC</td><td> </td><td>[6]</td></tr><tr><td><i>gtfR</i></td><td>gtfRSoralisF</td><td>TCCCGGTCAGCAAACTCCAGCC</td><td>52&#176;C/60 sec</td><td>[36]</td></tr><tr><td> </td><td>gtfRSoralisR</td><td>GCAACCTTTGGATTTGCAAC</td><td> </td><td>[36]</td></tr><tr><td><i>cshA-</i>like</td><td>CshA-F</td><td>AAGTACAAGGTGCAGATG</td><td>46&#176;C/40 sec</td><td>This study</td></tr><tr><td> </td><td>CshA-R</td><td>CATTTGCAGTAGCTATCG</td><td> </td><td>This study</td></tr><tr><td><i>rib-</i>like</td><td>RibF</td><td>GTGACYTACCCAGATGG</td><td>47&#176;C/30 sec</td><td>This study</td></tr><tr><td> </td><td>RibR1</td><td>CAATWGAATCTTCWGCC</td><td> </td><td>This study</td></tr><tr><td><i>pitA</i>-like</td><td>pitAF</td><td>ATTWSTCCAATTCAGGGGC</td><td>55&#176;C/45 sec</td><td>This study</td></tr><tr><td> </td><td>pitAR</td><td>AATGCCCGCGTCCATACC</td><td> </td><td>This study</td></tr><tr><td><i>integrase</i></td><td>InGraF</td><td>CTCATGATGTCAAAGAG</td><td>46&#176;C/40 sec</td><td>This study</td></tr><tr><td> </td><td>InGraR</td><td>GATTTGGAAYCGTGTGG</td><td> </td><td>This study</td></tr><tr><td><i>hyl</i>A-like</td><td>hylAF</td><td>CAGCAAAGGGATGCCAAG</td><td>60&#176;C /60 sec</td><td>This study</td></tr><tr><td> </td><td>hylAR</td><td>CCTTCCAGTTCCTGGTTTAAC</td><td> </td><td>This study</td></tr><tr><td>Tigurinus <i>16S</i>, <i>rRNA</i></td><td>TIGF<sub>CTT</sub></td><td>AGAACGCTGAAGCTTGGT</td><td>55&#176;C /30 sec</td><td>This study</td></tr><tr><td> </td><td>TIGF<sub>AGA</sub></td><td>GTAGAACGCTGAAGAGAGG</td><td> </td><td>This study</td></tr><tr><td> </td><td>TIGR</td><td>ATTATCATGCGATAATCAATT</td><td> </td><td>This study</td></tr><tr><td>Mitis-group <i>sodA</i></td><td>sodA-MSF</td><td>GCMAAYGCAGCTCTTGAA</td><td>58&#176;C /35 sec</td><td>This study</td></tr><tr><td> </td><td>sodA-MSR</td><td>ACCAACCAHGCCCATCCA</td><td> </td><td>This study</td></tr></table>
c0b3d225f0c6d37fbee0b350fcad9518817b2746a16d0c0a1d3d04d69e54e625.png
simple
<table><tr><td>GR Operation</td><td>Operation Zone</td><td>Total Population</td><td>Total Populated Households</td><td>Total Households</td><td>Total Structures</td></tr><tr><td>GR1:Outer Islands, Temotu Province</td><td>Duff Islands</td><td>556</td><td>118</td><td>158</td><td>399</td></tr><tr><td></td><td>Reef Islands</td><td>5958</td><td>1179</td><td>1468</td><td>3746</td></tr><tr><td></td><td>Utupua</td><td>1300</td><td>259</td><td>330</td><td>770</td></tr><tr><td></td><td>Vanikolo</td><td>1602</td><td>308</td><td>399</td><td>938</td></tr><tr><td></td><td>GR1: Total</td><td>9416</td><td>1864</td><td>2355</td><td>5853</td></tr><tr><td>GR2: Santa Cruz, Temotu Province</td><td>Santa Cruz East</td><td>3950</td><td>717</td><td>881</td><td>1873</td></tr><tr><td></td><td>Santa Cruz West</td><td>8162</td><td>1563</td><td>1970</td><td>4046</td></tr><tr><td></td><td>GR2: Total</td><td>12112</td><td>2280</td><td>2851</td><td>5919</td></tr><tr><td>GR3: Tanna IRS Zone, Tafea Province</td><td>Health Zone 1</td><td>5363</td><td>1064</td><td>1283</td><td>5214</td></tr><tr><td></td><td>Health Zone 2</td><td>9395</td><td>1863</td><td>2196</td><td>7299</td></tr><tr><td></td><td>Health Zone 3</td><td>3096</td><td>653</td><td>773</td><td>2923</td></tr><tr><td></td><td>Health Zone 4</td><td>4115</td><td>866</td><td>1001</td><td>3455</td></tr><tr><td></td><td>GR3: Total</td><td>21969</td><td>4446</td><td>5253</td><td>18891</td></tr></table>
3cedf82bf6d82386e9353b765e196cc86c2509933d32166e065504c2192bfe59.png
simple
<table><tr><td> </td><td>ENINBSC study</td><td>CRONICAS study</td></tr><tr><td> </td><td>(<i>n</i> = 2,472)</td><td>(<i>n</i> = 2,945)</td></tr><tr><td><i>Demographic variables</i></td><td> </td><td> </td></tr><tr><td> Sex (% females)</td><td>1,209 (48.9%)</td><td>1,500 (50.9%)</td></tr><tr><td> Age (mean (SD))</td><td>50.5 (12.1)</td><td>55.3 (12.7)</td></tr><tr><td> Education in years (mean (SD))</td><td>7.8 (4.9)</td><td>8.0 (4.9)</td></tr><tr><td><i>Behavioural variables</i></td><td> </td><td> </td></tr><tr><td> Current smoking (%)</td><td>391 (15.9%)</td><td>369 (11.5%)</td></tr><tr><td> Alcohol use (%)</td><td>2,323 (94.1%)</td><td>1,600 (54.3%)</td></tr><tr><td> Family history of diabetes (%)</td><td>268 (11.2%)</td><td>351 (11.9%)</td></tr><tr><td> Physical activity (% low level)</td><td>606 (24.5%)</td><td>938 (31.9%)</td></tr><tr><td><i>Anthropometric measures</i></td><td> </td><td> </td></tr><tr><td> Body mass index (mean (SD))</td><td>25.7 (4.5)</td><td>27.6 (4.6)</td></tr><tr><td> Waist circumference (mean (SD))</td><td>91.0 (11.4)</td><td>91.5 (11.0)</td></tr><tr><td> Waist-to-height ratio (mean (SD))</td><td>0.58 (0.08)</td><td>0.59 (0.07)</td></tr><tr><td> Systolic blood pressure (mean (SD))</td><td>114.5 (18.5)</td><td>117.2 (18.9)</td></tr><tr><td> Diastolic blood pressure (mean (SD))</td><td>71.1 (11.9)</td><td>73.4 (11.1)</td></tr><tr><td> Hypertension (%)</td><td>579 (23.8%)</td><td>705 (24.0%)</td></tr><tr><td> Total cholesterol (mean (SD))</td><td>174.2 (36.9)</td><td>199.7 (39.6)</td></tr><tr><td> HDL-cholesterol (mean (SD))</td><td>43.5 (5.3)</td><td>41.7 (11.5)</td></tr></table>
6f1ee6301208ce41c8cb0096a1ec87848d69844df8d40d9e0c8cd63b5047c12c.png
complex
<table><tr><td>Chromosome number</td><td>Number of SNPs</td><td>Number of significant SNPs</td><td colspan="4">Markers with largest risk and protective effects</td></tr><tr><td></td><td></td><td></td><td colspan="2">Largest risk effect</td><td colspan="2">Largest protective effect</td></tr><tr><td></td><td></td><td></td><td>Marker</td><td>Effect size</td><td>Marker</td><td>Effect size</td></tr><tr><td>1</td><td>40929</td><td>142</td><td>rs7519615</td><td>1.73638</td><td>rs2275864</td><td>-1.41482</td></tr><tr><td>2</td><td>44090</td><td>140</td><td>rs655783</td><td>0.91779</td><td>rs938869</td><td>-2.3145</td></tr><tr><td>3</td><td>36690</td><td>138</td><td>rs7616866</td><td>202.447</td><td>rs9288967</td><td>-4.23478</td></tr><tr><td>4</td><td>32628</td><td>133</td><td>rs768063</td><td>155.04</td><td>rs6816684</td><td>-2.31044</td></tr><tr><td>5</td><td>33612</td><td>90</td><td>rs344156</td><td>1.46745</td><td>rs6899062</td><td>-1.68164</td></tr><tr><td>6</td><td>35574</td><td>82</td><td>rs6935937</td><td>3.06767</td><td>rs1856363</td><td>-2.18496</td></tr><tr><td>7</td><td>29244</td><td>130</td><td>rs9632680</td><td>96.105</td><td>rs4732523</td><td>-2.41344</td></tr><tr><td>8</td><td>30990</td><td>130</td><td>rs7006628</td><td>0.577914</td><td>rs2853259</td><td>-1.50527</td></tr><tr><td>9</td><td>26128</td><td>125</td><td>rs6478815</td><td>154.845</td><td>rs1387292</td><td>-3.12822</td></tr><tr><td>10</td><td>28331</td><td>131</td><td>rs2388121</td><td>0.777184</td><td>rs1909668</td><td>-1.36459</td></tr><tr><td>11</td><td>26477</td><td>119</td><td>rs1879445</td><td>123.081</td><td>rs7932437</td><td>-6.04313</td></tr><tr><td>12</td><td>26365</td><td>129</td><td>rs1146114</td><td>1.43868</td><td>rs7300982</td><td>-1.59685</td></tr><tr><td>13</td><td>20242</td><td>129</td><td>rs2323883</td><td>4.76091</td><td>rs9740397</td><td>-3.53682</td></tr><tr><td>14</td><td>17951</td><td>124</td><td>rs4296166</td><td>1.53678</td><td>rs4983565</td><td>-2.02512</td></tr><tr><td>15</td><td>16166</td><td>121</td><td>rs7183817</td><td>0.814795</td><td>rs3743372</td><td>-2.60765</td></tr><tr><td>16</td><td>16460</td><td>111</td><td>rs4238802</td><td>0.66247</td><td>rs4783187</td><td>-1.98159</td></tr><tr><td>17</td><td>14027</td><td>123</td><td>rs2880328</td><td>92.8919</td><td>rs9747823</td><td>-1.31507</td></tr><tr><td>18</td><td>16450</td><td>123</td><td>rs2303508</td><td>78.2526</td><td>rs1982040</td><td>-2.32656</td></tr><tr><td>19</td><td>9236</td><td>101</td><td>rs3810256</td><td>1.11899</td><td>rs10404348</td><td>-3.04764</td></tr><tr><td>20</td><td>13843</td><td>114</td><td>rs6513195</td><td>3.13637</td><td>rs6138601</td><td>-4.63256</td></tr><tr><td>21</td><td>8051</td><td>102</td><td>rs2823819</td><td>0.971309</td><td>rs1539902</td><td>-1.08918</td></tr><tr><td>22</td><td>8205</td><td>90</td><td>rs761917</td><td>1.46745</td><td>rs17406434</td><td>-1.68164</td></tr><tr><td>Total</td><td>531689</td><td>2627</td><td></td><td></td><td></td><td></td></tr></table>
329a7259864dce7d942ce30061f9ece76db851840c98ee7af76f51ea7fb392f0.png
simple
<table><tr><td>Gene</td><td></td><td>Sequence</td><td>Product size</td><td>Annealling temperature</td></tr><tr><td>MMP-2</td><td>Sense</td><td>5'-GGATGATGCCTTTGCTCG-3'</td><td>487 bp</td><td>55&#176;C</td></tr><tr><td></td><td>Anti-sense</td><td>5'-ATAGGATGTGCCCTGGAA-3'</td><td></td><td></td></tr><tr><td>MMP-7</td><td>Sense</td><td>5'-CTTCAGGCAGAACATCCA-3'</td><td>220 bp</td><td>49&#176;C</td></tr><tr><td></td><td>Anti-sense</td><td>5'-ATTTATTGACATCTACCCAC-3'</td><td></td><td></td></tr><tr><td>MMP-9</td><td>Sense</td><td>5'-AGGACGGCAATGCTGATC-3'</td><td>127 bp</td><td>58&#176;C</td></tr><tr><td></td><td>Anti-sense</td><td>5'-TCGTAGTTGGCGGTGGTG-3'</td><td></td><td></td></tr><tr><td>MT1-MMP</td><td>Sense</td><td>5'-CCTGCGTCCATCAACACT-3'</td><td>481 bp</td><td>57&#176;C</td></tr><tr><td></td><td>Anti-sense</td><td>5'-TCACCTCCGTCTCCTCCTC-3'</td><td></td><td></td></tr><tr><td>SFRP5</td><td>Sense</td><td>5'-AGGGTAAGGGAAAGGTGGAG-3'</td><td>379 bp</td><td>60&#176;C</td></tr><tr><td></td><td>Anti-sense</td><td>5'-GAGAAGCAGAGGCTGAGGAA-3'</td><td></td><td></td></tr><tr><td>GAPDH</td><td>Sense</td><td>5'-GGGAAACTGTGGCGTGAT-3'</td><td>309 bp</td><td>56&#176;C</td></tr><tr><td></td><td>Anti-sense</td><td>5'-AAAGGTGGAGGAGTGGGT-3'</td><td></td><td></td></tr></table>
5a62877f84604efc3fe3e939d5e34bb2a6bec6dbde4d2dc9654297314a698037.png
complex
<table><tr><td>Variables</td><td>No. of cases</td><td>NQO1 strongly positive cases (%)</td><td><i>&#967;</i><sup><i>2</i></sup></td><td><i>P</i>value</td></tr><tr><td>Age</td><td></td><td></td><td rowspan="3">0.161</td><td rowspan="3">0.689</td></tr><tr><td>&#8805;48</td><td>97</td><td>57 (58.8%)</td></tr><tr><td>&lt;48</td><td>63</td><td>35 (55.6%)</td></tr><tr><td>Menopausal status</td><td></td><td></td><td rowspan="3">0.050</td><td rowspan="3">0.823</td></tr><tr><td>Premenopausal</td><td>76</td><td>43 (56.6%)</td></tr><tr><td>Postmenopausal</td><td>84</td><td>49 (58.3%)</td></tr><tr><td>Histological grade</td><td></td><td></td><td rowspan="4">19.056</td><td rowspan="4">0.000**</td></tr><tr><td>Grade-1</td><td>37</td><td>10 (27.0%)</td></tr><tr><td>Grade-2</td><td>47</td><td>29 (61.7%)</td></tr><tr><td>Grade-3</td><td>76</td><td>53 (69.7%)</td></tr><tr><td>FIGO stage</td><td></td><td></td><td rowspan="3">26.458</td><td rowspan="3">0.000**</td></tr><tr><td>I-II</td><td>92</td><td>37 (40.2%)</td></tr><tr><td>III-IV</td><td>68</td><td>55 (80.9%)</td></tr></table>
0d0fee24d45d8c5c8101e6e5b22a29ccf249215630bfec867f7e223fd78a5de3.png
simple
<table><tr><td>Node</td><td>2</td><td>3</td><td>5</td><td>6</td></tr><tr><td>2</td><td><i>&#8211;</i></td><td>0.001<sup>&#8727;</sup></td><td>0.506</td><td>0.928</td></tr><tr><td>3</td><td>0.001<sup>&#8727;</sup></td><td>&#8211;</td><td>0.075</td><td>0.004<sup>&#8727;</sup></td></tr><tr><td>5</td><td>0.506</td><td>0.075</td><td>&#8211;</td><td>0.563</td></tr><tr><td>6</td><td>0.928</td><td>0.004<sup>&#8727;</sup></td><td>0.563</td><td>&#8211;</td></tr></table>
fc7ae7e5c37a9e1aa6e2df1de4e1369a67fe264f367b8485d95bfc9619161b86.png
simple
<table><tr><td>Effect</td><td>SS</td><td>df</td><td>MS</td><td>F</td><td><i>p</i> value</td></tr><tr><td>Intercept</td><td>23,302.85</td><td>1</td><td>23,302.85</td><td>89.56418</td><td>0.000000</td></tr><tr><td>Species</td><td>1446.16</td><td>2</td><td>723.08</td><td>2.77915</td><td>0.080571</td></tr><tr><td>Treatment</td><td>10,626.36</td><td>1</td><td>10,626.36</td><td>40.84227</td><td>0.000001</td></tr><tr><td>Error</td><td>6764.69</td><td>26</td><td>260.18</td><td></td><td></td></tr></table>
9e0a4246e265321b25389744489f4390dbd2a0d3fb8058cdaeba18c6ff3cd8cf.png
simple
<table><tr><td>Community</td><td>Type</td><td>MBR <i>Culex spp.</i></td><td>MBR <i>A. gambiae s.l.</i></td><td>EIR <i>A. gambiae s.l.</i></td></tr><tr><td>Dzorwulu</td><td>UA</td><td>234.4 (180.0&#8211;305.2)</td><td>11.7 (7.9&#8211;17.3)</td><td>27.82</td></tr><tr><td>Korle Bu</td><td>UA</td><td>141.4 (99.2&#8211;201.8)</td><td>2.6 (1.5&#8211;4.4)</td><td>6.07</td></tr><tr><td>Kotobabi</td><td>UA</td><td>127.8 (94.4&#8211;173.1)</td><td>18.8 (9.4&#8211;37.7)</td><td>44.72</td></tr><tr><td>Kaneshie</td><td>U</td><td>48.5 (26.9&#8211;87.3)</td><td>10.6 (6.0&#8211;18.9)</td><td>25.15</td></tr><tr><td>La</td><td>U</td><td>38.4 (19.2&#8211;76.8)</td><td>2.1 (1.4&#8211;3.1)</td><td>4.94</td></tr><tr><td>Ushertown</td><td>U</td><td>36.9 (16.6&#8211;81.9)</td><td>1.1 (1.0&#8211;1.2)</td><td>2.57</td></tr></table>
c912492dc96d9c3cd1357105ef2f23c352a303e23e763d856a4be453eb421d5d.png
simple
<table><tr><td>Year</td><td>First author</td><td>Type of study</td><td>Number and type of patients considered</td><td>Patients with solitary splenic metastases from NPC</td><td>Patient&#8217;s age, sex (M, F)</td><td>Comorbidity</td><td>Primary treatment for NPC</td><td>Disease-free survival after primary treatment</td><td>Methods of detection of splenic metastasis</td><td>Treatment for solitary splenic metastasis</td><td>Confirmatory histology of NPC splenic metastases</td><td>Overall survival (status at last follow-up)</td><td>Relapse after splenic surgery</td></tr><tr><td>2000</td><td>Lam &amp; Tang [3]</td><td>CS</td><td>92 patients with splenic metastases</td><td>1 (1.1 %)</td><td>M</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>- Splenectomy</td><td>UCNT</td><td>NS</td><td>NS</td></tr><tr><td>2013</td><td>Suh et al. [38]</td><td>CR</td><td>1 non-keratinizing NPC</td><td>1</td><td>35 years old, M</td><td>EBV</td><td>- Neoadjuvant chemotherapy (cysplatin and 5-fluorouracil)- Left medial maxillectomy with left modified radical neck dissection- Adjuvant radiochemotherapy (cysplatin and 63 Gy)</td><td>7 months</td><td>FDG-PET/CT FNA biopsy</td><td>- Systemic chemotherapy (docetaxel and cysplatin)- Laparoscopic splenectomy</td><td>UCNT</td><td>5 months (alive)</td><td>Nil</td></tr><tr><td>2015</td><td>Abu-Zaid et al. [27]</td><td>CR</td><td>1 NPC</td><td>1</td><td>26 years old, M</td><td>NS</td><td>- Surgical resection- Adjuvant radiochemotherpay</td><td>6 years</td><td>CTFNA biopsy</td><td>- Splenectomy</td><td>UCNT</td><td>12 months (alive)</td><td>Nil</td></tr><tr><td>2015</td><td>Present study</td><td>CR</td><td>1 NPC</td><td>1</td><td>56 years old, M</td><td>Smoker, EBV</td><td>- Neoadjuvant chemotherapy (docetaxel, carboplatin, and 5-Fluorouracil)- Radiotherapy (70 Gy)</td><td>3 months</td><td>PET/CT</td><td>- Laparoscopic splenectomy</td><td>UCNT</td><td>4 months (alive)</td><td>Nil</td></tr></table>
3b7a5cbe8b7f59fc6e584611f737821328862149c3b12cecb856b2740c91d67b.png
simple
<table><tr><td>Health Effects</td><td>US</td><td>EU</td><td>Canada</td><td>Australia</td><td>New Zealand</td></tr><tr><td><i>Mortality:</i></td><td></td><td></td><td>1,042</td><td></td><td>1,296,552 (premature death) [198]</td></tr><tr><td>VSL: Adults</td><td>6,300,000</td><td>2,247,191</td><td>3,480,000</td><td>1,439,394</td><td>1,717,241 (1,724,138) [198]</td></tr><tr><td>VSL: Children</td><td>2 &#215; adult</td><td>4088764 (infant)</td><td></td><td></td><td></td></tr><tr><td>VSLY</td><td></td><td>134,831</td><td></td><td>70,455</td><td>118,621</td></tr><tr><td><i>Morbidity:</i></td><td></td><td></td><td></td><td>1929.55 (average cost/separation) [199]</td><td></td></tr><tr><td>Morbidity: children</td><td>2 &#215; adults</td><td></td><td></td><td></td><td></td></tr><tr><td>Chronic bronchitis</td><td>340,000</td><td>213,483</td><td></td><td></td><td></td></tr><tr><td>Chronic asthma</td><td>39,000</td><td></td><td></td><td></td><td></td></tr><tr><td>Respiratory hospital admission</td><td>14,000</td><td>2,247</td><td>1,032</td><td></td><td>2,069</td></tr><tr><td>CVD hospital admission</td><td>21,000</td><td>2,247</td><td>1,052</td><td></td><td>2,759</td></tr><tr><td>Emergency room visit</td><td>300 (asthma)</td><td></td><td>541 (respiratory) 562 (CVD)</td><td></td><td></td></tr><tr><td>Doctor's visit</td><td></td><td>60</td><td></td><td></td><td></td></tr><tr><td>RAD</td><td>106</td><td>92 (working age) 78 (young, elderly)</td><td>22</td><td></td><td>53</td></tr><tr><td>MRAD</td><td>50</td><td>43</td><td></td><td></td><td></td></tr><tr><td>Acute respiratory symptom</td><td>3&#8211;24</td><td></td><td></td><td></td><td></td></tr><tr><td>Use of respiratory medication</td><td></td><td>1.12</td><td></td><td></td><td></td></tr><tr><td>Asthma day</td><td>32&#8211;74</td><td>43</td><td>15</td><td></td><td></td></tr><tr><td><i>References:</i></td><td>[54]</td><td>[127]</td><td>[200]</td><td>[128]*</td><td>[129]</td></tr></table>
2368cc9703180c7e228c995d193d3c817846b7b2f0a44e8eaa7a23dce305a17e.png
simple
<table><tr><td></td><td>Non-Misusers</td><td>Misusers</td><td>p-value</td><td>RR (95% CI)</td></tr><tr><td>Age</td><td>54</td><td>48</td><td>&lt; 0.001</td><td></td></tr><tr><td>% Male</td><td>38</td><td>59.7</td><td>0.005</td><td>1.56 (1.16 &#8211; 2.11)</td></tr><tr><td>CES-D</td><td>22.5</td><td>26.0</td><td>0.080</td><td></td></tr><tr><td>PDI</td><td>45.1</td><td>45.6</td><td>0.838</td><td></td></tr><tr><td>REALM</td><td>50.7</td><td>53.5</td><td>0.492</td><td></td></tr><tr><td>% Current Smoker</td><td>50</td><td>71</td><td>0.007</td><td>1.41 (1.12 &#8211; 1.79)</td></tr><tr><td>% History of Ethanol Abuse</td><td>23</td><td>44</td><td>0.004</td><td>1.95 (1.25 &#8211; 3.03)</td></tr><tr><td>% History of Cocaine Abuse</td><td>21</td><td>68</td><td>&lt; 0.001</td><td>3.30 (2.17 &#8211; 4.99)</td></tr><tr><td>% Positive Urine Cannabinoids</td><td>12</td><td>33</td><td>0.001</td><td>2.70 (1.5 &#8211; 4.85)</td></tr><tr><td>% Multiple Drug Convictions</td><td>1</td><td>11</td><td>0.001</td><td>15.13 (1.90 &#8211; 120)</td></tr><tr><td>% Drug or DUI Convictions</td><td>11</td><td>40</td><td>0.001</td><td>3.60 (2.05 &#8211; 6.34)</td></tr></table>
7b46a561fd05a8d6bba78db2bdd7a69d1e35aa44dec3f9afe7f4fe9ce08c31ad.png
simple
<table><tr><td>Register</td><td>Data available</td><td>Register holder</td><td>Ref.</td></tr><tr><td>Medical Birth Register</td><td>Mother&#8217;s health data (incl. Smoking habits prior to and during pregnancy, other risk factors, interventions), pregnancy, delivery, live and stillbirths, GD, BMI, infant health data by age of 7 days</td><td>THL</td><td>[30]</td></tr><tr><td>Register of Induced Abortions</td><td>Data on mother, indication for induced abortion, diagnoses</td><td>THL</td><td>[38]</td></tr><tr><td>Register of Congenital Malformations</td><td>Mother&#8217;s health data, pregnancy, foetus/child, congenital anomalies and birth defects, diagnoses (ICD codes)</td><td>THL</td><td>[31]</td></tr><tr><td>Care Register for Health Care</td><td>Data from hospitals and special health care, diagnoses</td><td>THL</td><td>[33]</td></tr><tr><td>Register of Primary Health Care Visits</td><td>Data outpatient health care visits, diagnoses (available since 2011)</td><td>THL</td><td>[34]</td></tr><tr><td>Cancer Register</td><td>Persons with cancer, data on cancer type and death certificate</td><td>THL</td><td>[32]</td></tr><tr><td>Cause-of-Death Register</td><td>Causes of death, death certificates</td><td>Statistics Finland</td><td>[36]</td></tr><tr><td>Register of reimbursements for Prescription Medicines</td><td>Purchases of prescription medication eligible for reimbursement</td><td>KELA<sup>a</sup></td><td>[35]</td></tr><tr><td>Finnish Maternity Cohort</td><td>Serum bank, data on mother, sampling date, expected due date, previous pregnancies</td><td>THL<sup>b</sup></td><td>[42]</td></tr><tr><td>Population Register</td><td>Address history</td><td>Population Register Center</td><td>[37]</td></tr></table>
dd879c8cc51d8c0015b628de9b51271e0b21b8a9d709a3a8261bf18667b97e98.png
simple
<table><tr><td>Serogroup</td><td>Serotype</td><td>Serosubtype</td><td>Number</td><td>Percentage</td></tr><tr><td>B</td><td>1</td><td>P1.4</td><td>4</td><td>1.8</td></tr><tr><td></td><td></td><td>P1.16</td><td>4</td><td>1.8</td></tr><tr><td></td><td></td><td>NT</td><td>3</td><td>1.4</td></tr><tr><td></td><td></td><td>Other</td><td>1</td><td>0.5</td></tr><tr><td></td><td>2A</td><td></td><td>3</td><td>1.4</td></tr><tr><td></td><td>4</td><td>P1.4</td><td>57</td><td>26</td></tr><tr><td></td><td></td><td>P1.6</td><td>3</td><td>1.4</td></tr><tr><td></td><td></td><td>P1.7</td><td>3</td><td>1.4</td></tr><tr><td></td><td></td><td>P1.9</td><td>4</td><td>1.8</td></tr><tr><td></td><td></td><td>P1.10</td><td>4</td><td>1.8</td></tr><tr><td></td><td></td><td>P1.15</td><td>5</td><td>2.3</td></tr><tr><td></td><td></td><td>NT</td><td>28</td><td>12.8</td></tr><tr><td></td><td></td><td>Other</td><td>13</td><td>5.9</td></tr><tr><td></td><td>NT</td><td>P1.1</td><td>6</td><td>2.7</td></tr><tr><td></td><td></td><td>P1.4</td><td>8</td><td>3.7</td></tr><tr><td></td><td></td><td>NT</td><td>8</td><td>3.7</td></tr><tr><td></td><td></td><td>Other</td><td>4</td><td>1.8</td></tr><tr><td></td><td>Other</td><td></td><td>17</td><td>7.8</td></tr><tr><td>C</td><td>2A</td><td>P1.2</td><td>12</td><td>5.5</td></tr><tr><td></td><td></td><td>P1.5</td><td>9</td><td>4.1</td></tr><tr><td></td><td></td><td>P1.7</td><td>1</td><td>0.5</td></tr><tr><td></td><td></td><td>NT</td><td>7</td><td>3.2</td></tr><tr><td></td><td>2B</td><td>P1.1</td><td>1</td><td>0.5</td></tr><tr><td></td><td></td><td>P1.2</td><td>7</td><td>3.2</td></tr><tr><td></td><td>4</td><td>P1.4</td><td>3</td><td>1.4</td></tr><tr><td></td><td>NT</td><td></td><td>2</td><td>0.9</td></tr><tr><td></td><td>Other</td><td></td><td>2</td><td>0.9</td></tr></table>
d24f1579029ac7b4fa2cf6facf33fedba458401acefe8e2292120ad7bc347432.png
simple
<table><tr><td> </td><td>Number (%)</td><td>Number (%) with smear completion rate &lt;90%</td><td>Bivariable Odds Ratio<sup>a</sup></td><td>95%CI</td><td>P<sup>b</sup></td><td>Multi-variable Odds Ratio<sup>a</sup></td><td>95%CI</td><td>P<sup>b</sup></td></tr><tr><td>Overall</td><td>88 (100%)</td><td>43 (48.9%)</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Category of health facility</td><td> </td><td> </td><td> </td><td> </td><td>0.025</td><td> </td><td> </td><td> </td></tr><tr><td>Health centre</td><td>69 (78.4%)</td><td>30 (43.5%)</td><td>1</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Hospital</td><td>19 (21.6%)</td><td>13 (68.4%)</td><td>2.0</td><td>1.1-3.7</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Location of health facility</td><td> </td><td> </td><td> </td><td> </td><td>0.008</td><td> </td><td> </td><td> </td></tr><tr><td>Rural</td><td>60 (68.2%)</td><td>25 (41.7%)</td><td>1</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Urban</td><td>28 (31.8%)</td><td>18 (64.3%)</td><td>2.1</td><td>1.2-3.8</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Health facility status</td><td> </td><td> </td><td> </td><td> </td><td>0.311</td><td> </td><td> </td><td> </td></tr><tr><td>Mission/private</td><td>40 (45.5%)</td><td>19 (47.5%)</td><td>1</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Public</td><td>48 (54.5%)</td><td>24 (50.0%)</td><td>1.3</td><td>0.8-2.3</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Most recent on-the-job training for TB staff</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Before 2006 or none at all</td><td>47 (53.4%)</td><td>22 (46.8%)</td><td>1</td><td> </td><td>0.643</td><td> </td><td> </td><td> </td></tr><tr><td>2006</td><td>41 (46.6%)</td><td>21 (51.2%)</td><td>1.1</td><td>0.7-2.0</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Location of facilities (Province)</td><td> </td><td> </td><td> </td><td> </td><td>0.045</td><td> </td><td> </td><td> </td></tr><tr><td>East</td><td>13 (14.8%)</td><td>8 (61.5%)</td><td>1</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Kigali</td><td>17 (19.3%)</td><td>11 (64.7%)</td><td>1.4</td><td>0.6-3.6</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>North</td><td>18 (20.5%)</td><td>4 (22.2%)</td><td>0.4</td><td>0.1-1.0</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>West</td><td>22 (25.0%)</td><td>11 (50.0%)</td><td>0.9</td><td>0.3-2.2</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>South</td><td>18 (20.5%)</td><td>9 (50.0%)</td><td>1.0</td><td>0.4-2.5</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Number of new PTB cases in 6-month period</td><td> </td><td> </td><td> </td><td> </td><td>0.001</td><td> </td><td> </td><td>0.001</td></tr><tr><td>1-5</td><td>32 (36.4%)</td><td>9 (28.1%)</td><td>1</td><td> </td><td> </td><td>1</td><td> </td><td> </td></tr><tr><td>6-14</td><td>27 (30.7%)</td><td>14 (51.9%)</td><td>2.0</td><td>0.9-4.4</td><td> </td><td>2.0</td><td>0.9-4.4</td><td> </td></tr><tr><td>&#8805;15</td><td>29 (33.0%)</td><td>20 (69.0%)</td><td>4.1</td><td>1.9-8.8</td><td> </td><td>4.1</td><td>1.9-8.8</td><td> </td></tr></table>
123a9fafd060dad4632cd6a7ef9c6911700a4f811efd763fc7ba19adac17075f.png
simple
<table><tr><td>Muscle</td><td>Mean polarization</td><td>Skewness</td><td>Kurtosis*</td></tr><tr><td>WT-RLC (standard)</td><td>0.321 &#177; 0.033</td><td>2.886 &#177; 0.574</td><td>7.749 &#177; 3.734</td></tr><tr><td>A13T-non-mutated (standard)</td><td>0.314 &#177; 0.028</td><td>2.383 &#177; 0.260</td><td>4.610 &#177; 1.259</td></tr><tr><td>A13T-mutated (non-standard)</td><td>0.250 &#177; 0.037</td><td>1.623 &#177; 0.262</td><td>1.450 &#177; 1.021</td></tr></table>
cf18e9cd528865ae569ba3253ddc4c4119e116cf3efba36d21ffa88b354e617c.png
complex
<table><tr><td></td><td></td><td colspan="2">Frequency in <i>patients</i>: Percent (%)in four categories of severity</td></tr><tr><td>Severity of complaints</td><td>Population % Standard</td><td><underline>Before</underline> therapy %</td><td><underline>After</underline> therapy %</td></tr><tr><td>Total score</td><td></td><td></td><td></td></tr><tr><td>No or little (-4)</td><td>48</td><td>26.4</td><td>86.8</td></tr><tr><td>Mild (5&#8211;8)</td><td>25</td><td>18.2</td><td>8.4</td></tr><tr><td>Moderate (9&#8211;15)</td><td>20</td><td>27.8</td><td>4.0</td></tr><tr><td>Severe (16+)</td><td>8</td><td>27.6</td><td>0.8</td></tr><tr><td>Psychological score</td><td></td><td></td><td></td></tr><tr><td>No or little (-1)</td><td>48</td><td>30.7</td><td>82.5</td></tr><tr><td>Mild (2&#8211;3)</td><td>23</td><td>17.0</td><td>10.4</td></tr><tr><td>Moderate (4&#8211;6)</td><td>20</td><td>22.2</td><td>5.5</td></tr><tr><td>Severe (7+)</td><td>9</td><td>30.1</td><td>1.6</td></tr><tr><td>Somatic score</td><td></td><td></td><td></td></tr><tr><td>No or little (-2)</td><td>53</td><td>35.7</td><td>93.0</td></tr><tr><td>Mild (3&#8211;4)</td><td>24</td><td>22.7</td><td>5.1</td></tr><tr><td>Moderate (5&#8211;7)</td><td>15</td><td>25.5</td><td>1.6</td></tr><tr><td>Severe (8+)</td><td>8</td><td>16.1</td><td>0.3</td></tr><tr><td>Sexual score</td><td></td><td></td><td></td></tr><tr><td>No or little (0)</td><td>64</td><td>37.3</td><td>76.8</td></tr><tr><td>Mild (1)</td><td>13</td><td>13.3</td><td>11.6</td></tr><tr><td>Moderate (2&#8211;3)</td><td>16</td><td>22.2</td><td>8.7</td></tr><tr><td>Severe (4+)</td><td>7</td><td>27.3</td><td>2.9</td></tr></table>
d0fd6f1a11d4a692c61323b1a802f2fc9a71628d4b2b2a24931b697413dc78dc.png
complex
<table><tr><td>Attributes</td><td colspan="2">SED Group</td><td colspan="2">SEA Group</td><td>Unadjusted</td></tr><tr><td></td><td><i>N<sup>a</sup></i></td><td>%</td><td><i>N<sup>a</sup></i></td><td>%</td><td>OR (95% CI)</td></tr><tr><td>SOCIODEMOGRAPHIC</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Marital Status</td><td>213</td><td></td><td>424</td><td></td><td></td></tr><tr><td> Has partner</td><td></td><td>79</td><td></td><td>99</td><td>0.05 (0.02&#8211;0.13)</td></tr><tr><td>Education</td><td>212</td><td></td><td>432</td><td></td><td></td></tr><tr><td> Less than high school</td><td></td><td>25</td><td></td><td>5</td><td>2.25 (1.93&#8211;2.63)</td></tr><tr><td>Cultural Identity</td><td>211</td><td></td><td>428</td><td></td><td></td></tr><tr><td> Canadian</td><td></td><td>50</td><td></td><td>61</td><td>0.61 (0.44&#8211;0.85)</td></tr><tr><td>Language Spoken at Home</td><td>217</td><td></td><td>431</td><td></td><td></td></tr><tr><td> English</td><td></td><td>63</td><td></td><td>82</td><td>0.37 (0.26&#8211;0.49)</td></tr><tr><td>Country of Birth</td><td>215</td><td></td><td>421</td><td></td><td></td></tr><tr><td> Canada</td><td></td><td>45</td><td></td><td>70</td><td>0.35 (0.25&#8211;0.49)</td></tr><tr><td>WOMAN'S HEALTH</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Overall Health</td><td>215</td><td></td><td>431</td><td></td><td></td></tr><tr><td> Very good/Excellent</td><td></td><td>41</td><td></td><td>59</td><td>0.48 (0.35&#8211;0.67)</td></tr><tr><td>Symptoms of Postpartum Depression</td><td>211</td><td></td><td>426</td><td></td><td></td></tr><tr><td> EPDS &#8805; 12</td><td></td><td>19</td><td></td><td>8</td><td>2.7 (1.64&#8211;4.4)</td></tr><tr><td>Hospital Readmission</td><td>216</td><td></td><td>431</td><td></td><td></td></tr><tr><td> YES</td><td></td><td>3</td><td></td><td>2</td><td>1.57 (0.57&#8211;4.28)</td></tr><tr><td>PHYSICIAN</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Has Family Doctor</td><td>215</td><td></td><td>430</td><td></td><td></td></tr><tr><td> YES</td><td></td><td>96</td><td></td><td>97</td><td>0.74 (0.3&#8211;1.84)</td></tr></table>
7ef2d5b53f02b40d6fc05db4fae8b286159921491245c720a9c88ef00e825110.png
simple
<table><tr><td>Compounds</td><td>Range (ng/mL)</td><td>Linear regression equation</td><td>Correlation coefficient</td><td>LOD (ng mL<sup>&#8722;1</sup>)</td><td>LOQ (ng mL<sup>&#8722;1</sup>)</td></tr><tr><td>Nootkatone</td><td>2.00-1000.00</td><td>Y = 5910X + 2790</td><td>0.9979</td><td>0.60</td><td>2.00</td></tr><tr><td>Yakuchinone A</td><td>2.00-1000.00</td><td>Y = 7090X + 12100</td><td>0.9997</td><td>0.60</td><td>2.00</td></tr><tr><td>Yakuchinone B</td><td>2.00-1000.00</td><td>Y = 8100X + 6050</td><td>0.9901</td><td>0.60</td><td>2.00</td></tr><tr><td>Oxyphyllacinol</td><td>5.83-1165.00</td><td>Y = 763X + 1130</td><td>0.9903</td><td>1.75</td><td>5.83</td></tr><tr><td>Tectochrysin</td><td>2.07-1135.00</td><td>Y = 16300X + 8780</td><td>0.9973</td><td>0.62</td><td>2.07</td></tr><tr><td>Izalpinin</td><td>5.00-1000.00</td><td>Y = 2160X + 2190</td><td>0.9908</td><td>1.50</td><td>5.00</td></tr><tr><td>Chrysin</td><td>2.00-1000.00</td><td>Y = 5010X + 3010</td><td>0.9919</td><td>0.60</td><td>2.00</td></tr><tr><td>Kaempferide</td><td>2.16-1080.00</td><td>Y = 1040X + 1470</td><td>0.9885</td><td>0.65</td><td>2.16</td></tr><tr><td>Apigenin-7,4<sup>&#8242;</sup>-dimethylether</td><td>5.00-1000.00</td><td>Y = 165X + 375</td><td>0.9861</td><td>1.50</td><td>5.00</td></tr></table>
d0215f5a0ee8acd18f3b6b03324f1d2244fc61555cf80471a214348cd5271579.png
complex
<table><tr><td rowspan="3">Image</td><td rowspan="3">Diameter Measurement Method</td><td colspan="3">Error (%) Relative to MD in Image LS</td></tr><tr><td>Min</td><td>Average</td><td>Max</td></tr><tr><td rowspan="2">LS</td><td>MAL-F2</td><td>0.1</td><td>1.2</td><td>3.8</td></tr><tr><td>MD</td><td>0.5</td><td>5.8</td><td>16</td></tr><tr><td rowspan="2">IS</td><td>MAL-F1</td><td>0.8</td><td>5.6</td><td>12.2</td></tr><tr><td>MAL-F2</td><td>0.2</td><td>15.0</td><td>60.5</td></tr></table>
498b37db3ca1a9e931d9ef0446c49f9309358f32f6de2aa38ae93ed0fe84e9f5.png
complex
<table><tr><td rowspan="2">Predictive factor</td><td>Vaccination document</td><td>At least one vaccine dose</td><td>Minimum vaccination</td><td>Basic vaccination</td><td>Extended vaccination</td><td>MMR1</td></tr><tr><td>Weighted percent (%)<sup>a</sup> (95% CI) <sup>b</sup></td><td>Weighted percent (%)<sup>a</sup> (95% CI)<sup>b</sup></td><td>Weighted percent (%)<sup>a</sup> (95% CI)<sup>b</sup></td><td>Weighted percent (%)<sup>a</sup> (95% CI)<sup>b</sup></td><td>Weighted percent (%)<sup>a</sup> (95% CI)<sup>b</sup></td><td>Weighted percent (%)<sup>a</sup> (95% CI)<sup>b</sup></td></tr><tr><td>Gender</td><td><i>n</i> = 250</td><td><i>n</i> = 239</td><td><i>n</i> = 239</td><td><i>n</i> = 239</td><td><i>n</i> = 239</td><td><i>n</i> = 239</td></tr><tr><td>Male</td><td>89 (81&#8211;94)</td><td>79 (70&#8211;86)</td><td>31 (20&#8211;44)</td><td>26 (17&#8211;37)</td><td>17 (10&#8211;29)</td><td>38 (27&#8211;51)</td></tr><tr><td>Female</td><td>83 (67&#8211;92)</td><td>83 (67&#8211;92)</td><td>39 (27&#8211;52)</td><td>30 (18&#8211;44)</td><td>11 (4&#8211;23)</td><td>48 (37&#8211;58)</td></tr><tr><td><i>P</i> value</td><td>0.3143</td><td>0.5779</td><td>0.2558</td><td>0.5160</td><td>0.0587</td><td>0.1706</td></tr><tr><td>Type of settlement</td><td><i>n</i> = 251</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td></tr><tr><td>Mainly houses (Type 1)</td><td>97 (91&#8211;99)</td><td>92 (82&#8211;97)</td><td>44 (26&#8211;63)</td><td>39 (22&#8211;58)</td><td>17 (5&#8211;44)</td><td>45 (28&#8211;64)</td></tr><tr><td>Houses and shacks/tents (Type 2)</td><td>77 (59&#8211;88)</td><td>74 (56&#8211;86)</td><td>28 (15&#8211;46)</td><td>22 (13&#8211;34)</td><td>7 (3&#8211;16)</td><td>35 (24&#8211;49)</td></tr><tr><td>Mainly shacks/tents (Type 3)</td><td>85 (68&#8211;94)</td><td>77 (61&#8211;88)</td><td>34 (20&#8211;51)</td><td>23 (10&#8211;45)</td><td>17 (6&#8211;38)</td><td>48 (33&#8211;63)</td></tr><tr><td><i>P</i> value</td><td>0.0304</td><td>0.0742</td><td>0.3984</td><td>0.2513</td><td>0.4500</td><td>0.4666</td></tr><tr><td>Region (NUTS-1)</td><td><i>n</i> = 251</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td></tr><tr><td>North Greece</td><td>93 (75&#8211;98)</td><td>87 (71&#8211;95)</td><td>37 (22&#8211;54)</td><td>31 (19&#8211;47)</td><td>14 (5&#8211;33)</td><td>44 (31&#8211;59)</td></tr><tr><td>Central Greece</td><td>78 (59&#8211;89)</td><td>76 (60&#8211;86)</td><td>36 (20&#8211;55)</td><td>25 (10&#8211;49)</td><td>15 (5&#8211;38)</td><td>44 (29&#8211;61)</td></tr><tr><td>Attica</td><td>84 (76&#8211;89)</td><td>73 (48&#8211;89)</td><td>29 (18&#8211;44)</td><td>22 (12&#8211;37)</td><td>10 (3&#8211;24)</td><td>37 (23&#8211;54)</td></tr><tr><td>Crete and Aegean islands</td><td>73 (41&#8211;91)</td><td>59 (32&#8211;81)</td><td>25 (12&#8211;46)</td><td>24 (12&#8211;42)</td><td>21 (12&#8211;35)</td><td>25 (12&#8211;46)</td></tr><tr><td><i>P</i> value</td><td>0.1420</td><td>0.2914</td><td>0.7835</td><td>0.6330</td><td>0.8377</td><td>0.7886</td></tr><tr><td>Size of settlement</td><td><i>n</i> = 251</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td></tr><tr><td>&lt;100 families</td><td>88 (75&#8211;95)</td><td>79 (67&#8211;87)</td><td>32 (20&#8211;48)</td><td>21 (11&#8211;37)</td><td>10 (4&#8211;26)</td><td>41 (28&#8211;56)</td></tr><tr><td>&#8805;100 families</td><td>84 (67&#8211;93)</td><td>83 (65&#8211;93)</td><td>38 (25&#8211;54)</td><td>35 (23&#8211;50)</td><td>18 (8&#8211;36)</td><td>45 (33&#8211;57)</td></tr><tr><td><i>P</i> value</td><td>0.6467</td><td>0.6104</td><td>0.5612</td><td>0.1532</td><td>0.3936</td><td>0.7295</td></tr><tr><td>Electricity available to &#8805; 50% of houses in the settlement</td><td><i>n</i> = 251</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td></tr><tr><td>Yes</td><td>89 (78&#8211;95)</td><td>84 (75&#8211;91)</td><td>37 (26&#8211;49)</td><td>29 (19&#8211;42)</td><td>15 (8&#8211;28)</td><td>45 (34&#8211;55)</td></tr><tr><td>No</td><td>73 (52&#8211;87)</td><td>62 (39&#8211;81)</td><td>27 (14&#8211;45)</td><td>19 (9&#8211;35)</td><td>6 (2&#8211;21)</td><td>34 (18&#8211;55)</td></tr><tr><td><i>P</i> value</td><td>0,0615</td><td>0,0312</td><td>0,3369</td><td>0.2660</td><td>0,2001</td><td>0,3313</td></tr><tr><td>Usual service of vaccination</td><td><i>n</i> = 215</td><td><i>n</i> = 207</td><td><i>n</i> = 207</td><td><i>n</i> = 207</td><td><i>n</i> = 207</td><td><i>n</i> = 207</td></tr><tr><td>Hospital</td><td>74 (57&#8211;86)</td><td>69 (54&#8211;81)</td><td>31 (18&#8211;48)</td><td>27 (15&#8211;45)</td><td>17 (7&#8211;37)</td><td>38 (25&#8211;53)</td></tr><tr><td>Primary Health Centre</td><td>93 (80&#8211;98)</td><td>86 (53&#8211;97)</td><td>56 (39&#8211;72)</td><td>40 (13&#8211;74)</td><td>27 (9&#8211;60)</td><td>59 (42&#8211;73)</td></tr><tr><td>Medical-Social Centre</td><td>95 (85&#8211;98)</td><td>89 (75&#8211;96)</td><td>37 (19&#8211;58)</td><td>26 (13&#8211;45)</td><td>2 (0&#8211;10)</td><td>52 (40&#8211;63)</td></tr><tr><td><i>P</i> value</td><td>0,0027</td><td>0,1282</td><td>0,1665</td><td>0.6313</td><td>0,0751</td><td>0,1032</td></tr><tr><td>Distance to usual vaccination service</td><td><i>n</i> = 251</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td><td><i>n</i> = 240</td></tr><tr><td>&#8804;2Km</td><td>93 (87&#8211;97)</td><td>92 (84&#8211;96)</td><td>46 (34&#8211;59)</td><td>34 (20&#8211;51)</td><td>15 (5&#8211;36)</td><td>51 (42&#8211;61)</td></tr><tr><td>&gt;2Km</td><td>80 (64&#8211;90)</td><td>71 (57&#8211;82)</td><td>25 (15&#8211;39)</td><td>22 (13&#8211;36)</td><td>13 (6&#8211;27)</td><td>36 (24&#8211;50)</td></tr><tr><td><i>P</i> value</td><td>0,0159</td><td>0,0015</td><td>0,0226</td><td>0.2321</td><td>0,8590</td><td>0,0676</td></tr><tr><td>Self-reported vaccination barrier</td><td><i>n</i> = 240</td><td><i>n</i> = 229</td><td><i>n</i> = 229</td><td><i>n</i> = 229</td><td><i>n</i> = 229</td><td><i>n</i> = 229</td></tr><tr><td>No</td><td>86 (77&#8211;92)</td><td>88 (78&#8211;94)</td><td>45 (32&#8211;59)</td><td>32 (19&#8211;48)</td><td>16 (8&#8211;30)</td><td>54 (42&#8211;65)</td></tr><tr><td>Yes</td><td>83 (69&#8211;92)</td><td>72 (57&#8211;83)</td><td>23 (11&#8211;40)</td><td>19 (9&#8211;34)</td><td>6 (2&#8211;19)</td><td>31 (19&#8211;46)</td></tr><tr><td><i>P</i> value</td><td>0.5628</td><td>0.0098</td><td>0.0343</td><td>0.1467</td><td>0.0666</td><td>0.0163</td></tr></table>
3b543498c2c690aa68a7a1f1957b6e2b290755b1775a8c4a9d4eb1aa6b5f7569.png
complex
<table><tr><td rowspan="2">Characteristic</td><td rowspan="2">Entire cohort</td><td colspan="3">By distance (m) to nearest A1&#8211;A3 roadway (m)<sup><i>b</i></sup></td></tr><tr><td>&#8805; 200</td><td>51&#8211;199</td><td>0&#8211;50</td></tr><tr><td>Age (years)<sup><i>c</i></sup></td><td>42.0 &#177; 5.1</td><td>42.1 &#177; 5.1</td><td>41.9 &#177; 5.2</td><td>42.0 &#177; 5.3</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.9 &#177; 6.0</td><td>25.8 &#177; 5.9</td><td>26.0 &#177; 6.1</td><td>26.4 &#177; 6.4</td></tr><tr><td>Census tract median income ($10,000)</td><td>6.68 &#177; 2.38</td><td>6.75 &#177; 2.29</td><td>6.66 &#177; 2.47</td><td>6.33 &#177; 2.56</td></tr><tr><td>Census tract median home value ($100,000)</td><td>1.72 &#177; 1.24</td><td>1.67 &#177; 1.08</td><td>1.84 &#177; 1.41</td><td>1.76 &#177; 1.57</td></tr><tr><td>Caucasian race</td><td>94</td><td>94</td><td>93</td><td>93</td></tr><tr><td>Age at menarche (years)</td></tr><tr><td>&lt; 12</td><td>23</td><td>23</td><td>23</td><td>23</td></tr><tr><td>12</td><td>30</td><td>30</td><td>30</td><td>31</td></tr><tr><td>&gt; 12</td><td>46</td><td>47</td><td>46</td><td>46</td></tr><tr><td>Parity</td></tr><tr><td>Nulliparous</td><td>18</td><td>16</td><td>21</td><td>25</td></tr><tr><td>Parous</td><td>82</td><td>84</td><td>79</td><td>75</td></tr><tr><td>Oral contraception use</td></tr><tr><td>Never</td><td>14</td><td>13</td><td>16</td><td>15</td></tr><tr><td>Past</td><td>75</td><td>75</td><td>73</td><td>74</td></tr><tr><td>Current</td><td>10</td><td>10</td><td>10</td><td>10</td></tr><tr><td>Cigarette smoking</td></tr><tr><td>Never</td><td>67</td><td>68</td><td>66</td><td>65</td></tr><tr><td>Current</td><td>9</td><td>8</td><td>10</td><td>10</td></tr><tr><td>Former</td><td>24</td><td>24</td><td>24</td><td>24</td></tr><tr><td>Infertility</td></tr><tr><td>Yes</td><td>4</td><td>4</td><td>4</td><td>4</td></tr><tr><td>No</td><td>94</td><td>94</td><td>94</td><td>94</td></tr><tr><td>Ever performed rotating shift work</td></tr><tr><td>Yes</td><td>69</td><td>69</td><td>69</td><td>70</td></tr><tr><td>No</td><td>31</td><td>31</td><td>31</td><td>30</td></tr><tr><td>Region</td></tr><tr><td>Northeast</td><td>34</td><td>32</td><td>37</td><td>42</td></tr><tr><td>Midwest</td><td>34</td><td>35</td><td>31</td><td>30</td></tr><tr><td>West</td><td>15</td><td>14</td><td>20</td><td>15</td></tr><tr><td>South</td><td>17</td><td>19</td><td>13</td><td>13</td></tr><tr><td colspan="5">Values are mean &#177; SD or percent. <sup><i>a</i></sup>Values are standardized to the age distribution of the study population. <sup><i>b</i></sup>Each cohort member may be in multiple &#173;distance categories over follow-up. <sup><i>c</i></sup>Values are not age-adjusted</td></tr></table>
b8166ae7dbefc920dd1dd8df2bfe70430a6745140b888ae93ca52d69bb142aa5.png
complex
<table><tr><td></td><td>Team response<sup>1</sup></td><td colspan="3">Individual response</td></tr><tr><td></td><td>Number of teams analysed</td><td>Number of questionnaires send</td><td>Number of questionnaires returned</td><td>Number of questionnaires analysed</td></tr><tr><td>Internal medicine</td><td>11</td><td>142</td><td>127</td><td>115</td></tr><tr><td>Surgery</td><td>10</td><td>83</td><td>77</td><td>69</td></tr><tr><td>Radiology</td><td>7</td><td>45</td><td>42</td><td>42</td></tr><tr><td>Total</td><td>28</td><td>270</td><td>246</td><td>226</td></tr></table>
37bb0b26d87d0adab4707fd78026144c1e007ae9e76c2fa36ea94f2e868d68d4.png
simple
<table><tr><td>Query</td><td>SQL</td><td>SQL</td><td>SPARQL</td><td>SPARQL</td></tr><tr><td></td><td>count</td><td>time</td><td>count</td><td>time</td></tr><tr><td></td><td>result</td><td></td><td>result</td><td></td></tr><tr><td>Recovery all Patients</td><td>207.190</td><td>0,060s</td><td>207.190</td><td>0,189s</td></tr><tr><td>Recovery all Therapies</td><td>400.290</td><td>0,132s</td><td>400.290</td><td>0,317s</td></tr><tr><td>Recovery all Diagnosis</td><td>240.088</td><td>0,070s</td><td>240.088</td><td>0,220s</td></tr><tr><td>Recovery all Courses</td><td>108.297</td><td>0,030s</td><td>108.297</td><td>0,155s</td></tr><tr><td>Recovery patients with diagnosis, therapies and courses</td><td>207.190</td><td>1,048s</td><td>207.190</td><td>0,204s</td></tr><tr><td>Recovery all female Patients</td><td>105.714</td><td>0,231s</td><td>105.714</td><td>0,189s</td></tr><tr><td>Recovery all female Patients with more of 60 years old</td><td>62.603</td><td>0,245s</td><td>62.603</td><td>0,192s</td></tr></table>
55cf396bba2a829917a8a05a61bb1e4bf0e3ab719c898ab3e3488ae8c7629411.png
complex
<table><tr><td></td><td></td><td></td><td colspan="3">Error rate</td></tr><tr><td>Individuals</td><td>Missing</td><td>Running time (sec)</td><td>Genotype inference</td><td>Heterozygous switch</td><td>Point-wise</td></tr><tr><td>100</td><td>0.00</td><td>1437</td><td>------<sup>a</sup></td><td>0.4835</td><td>0.1569</td></tr><tr><td>100</td><td>0.05</td><td>1563</td><td>0.1106</td><td>0.4926</td><td>0.1618</td></tr><tr><td>100</td><td>0.10</td><td>1380</td><td>0.1202</td><td>0.4967</td><td>0.1639</td></tr><tr><td>100</td><td>0.15</td><td>1671</td><td>0.1267</td><td>0.4829</td><td>0.1614</td></tr><tr><td>200</td><td>0.00</td><td>4679</td><td>------</td><td>0.4964</td><td>0.1609</td></tr><tr><td>200</td><td>0.05</td><td>4620</td><td>0.0922</td><td>0.4960</td><td>0.1620</td></tr><tr><td>200</td><td>0.10</td><td>4673</td><td>0.0979</td><td>0.4966</td><td>0.1635</td></tr><tr><td>200</td><td>0.15</td><td>4382</td><td>0.1064</td><td>0.4961</td><td>0.1631</td></tr><tr><td>400</td><td>0.00</td><td>9417</td><td>------</td><td>0.5035</td><td>0.1634</td></tr><tr><td>400</td><td>0.05</td><td>9411</td><td>0.0904</td><td>0.5093</td><td>0.1666</td></tr><tr><td>400</td><td>0.10</td><td>9360</td><td>0.0966</td><td>0.4880</td><td>0.1609</td></tr><tr><td>400</td><td>0.15</td><td>8524</td><td>0.1024</td><td>0.4959</td><td>0.1652</td></tr></table>
08a1fb1d24fdaa283de8dcdcf6e4453c36b3ada8e01292721031b7b5a95e250b.png
simple
<table><tr><td>Jeddah A</td><td>Val68Met+Asn126Asp+Ser188Phe</td></tr><tr><td>Jeddah B</td><td>Val68Met+Ser188Phe</td></tr><tr><td>Jeddah C</td><td>Asn126Asp+Ser188Phe</td></tr><tr><td>Jeddah D</td><td>Ile48Thr+Val68Met</td></tr><tr><td>Jeddah E</td><td>Ile48Thr+Ser188Phe</td></tr></table>
4a2a5f8011f315690efd80beedb28cbe1cbf0379203ceb6b745ea9a30c0e349a.png
complex
<table><tr><td>Variables</td><td> </td><td colspan="5">Soft palate</td><td> </td><td colspan="7">Depth of the upper airway</td><td colspan="4">Position of the hyoid bone</td></tr><tr><td> </td><td> </td><td>PM-U</td><td> </td><td>SPT</td><td> </td><td>NL/PM-U</td><td> </td><td>PM-UPW</td><td> </td><td>U-MPW</td><td> </td><td>V-LPW</td><td> </td><td>PASmin</td><td>AH-FH</td><td> </td><td>AH-CV</td><td> </td></tr><tr><td>SNA (&#176;)</td><td>Coefficient</td><td>-0.010</td><td> </td><td>0.111</td><td> </td><td>0.001</td><td> </td><td>0.178</td><td> </td><td>-0.088</td><td> </td><td>0.040</td><td> </td><td>-0.075</td><td>-0.068</td><td> </td><td>0.033</td><td> </td></tr><tr><td> </td><td><i>P</i> value</td><td>0.919</td><td> </td><td>0.252</td><td> </td><td>0.991</td><td> </td><td>0.066</td><td> </td><td>0.365</td><td> </td><td>0.684</td><td> </td><td>0.439</td><td>0.484</td><td> </td><td>0.738</td><td> </td></tr><tr><td>SNB (&#176;)</td><td>Coefficient</td><td>-0.064</td><td> </td><td>0.223</td><td>*</td><td>-0.106</td><td> </td><td>0.119</td><td> </td><td>-0.098</td><td> </td><td>-0.009</td><td> </td><td>-0.099</td><td>-0.032</td><td> </td><td>0.081</td><td> </td></tr><tr><td> </td><td><i>P</i> value</td><td>0.508</td><td> </td><td>0.021</td><td> </td><td>0.276</td><td> </td><td>0.221</td><td> </td><td>0.311</td><td> </td><td>0.925</td><td> </td><td>0.308</td><td>0.742</td><td> </td><td>0.404</td><td> </td></tr><tr><td>ANB (&#176;)</td><td>Coefficient</td><td>0.135</td><td> </td><td>-0.134</td><td> </td><td>0.252</td><td>**</td><td>0.200</td><td>*</td><td>-0.069</td><td> </td><td>0.064</td><td> </td><td>-0.005</td><td>-0.093</td><td> </td><td>-0.029</td><td> </td></tr><tr><td> </td><td><i>P</i> value</td><td>0.162</td><td> </td><td>0.166</td><td> </td><td>0.008</td><td> </td><td>0.038</td><td> </td><td>0.476</td><td> </td><td>0.510</td><td> </td><td>0.958</td><td>0.337</td><td> </td><td>0.769</td><td> </td></tr><tr><td>MnPl/SN (&#176;)</td><td>Coefficient</td><td>0.026</td><td> </td><td>-0.057</td><td> </td><td>0.103</td><td> </td><td>-0.137</td><td> </td><td>0.145</td><td> </td><td>-0.027</td><td> </td><td>0.065</td><td>0.117</td><td> </td><td>-0.043</td><td> </td></tr><tr><td> </td><td><i>P</i> value</td><td>0.788</td><td> </td><td>0.557</td><td> </td><td>0.291</td><td> </td><td>0.157</td><td> </td><td>0.133</td><td> </td><td>0.781</td><td> </td><td>0.506</td><td>0.229</td><td> </td><td>0.657</td><td> </td></tr><tr><td>MxPl/MnPl (&#176;)</td><td>Coefficient</td><td>-0.022</td><td> </td><td>-0.105</td><td> </td><td>0.236</td><td>*</td><td>0.019</td><td> </td><td>0.104</td><td> </td><td>-0.055</td><td> </td><td>-0.064</td><td>0.204</td><td>*</td><td>-0.100</td><td> </td></tr><tr><td> </td><td><i>P</i> value</td><td>0.824</td><td> </td><td>0.281</td><td> </td><td>0.014</td><td> </td><td>0.842</td><td> </td><td>0.285</td><td> </td><td>0.573</td><td> </td><td>0.510</td><td>0.034</td><td> </td><td>0.302</td><td> </td></tr><tr><td>MxMn-DF (mm)</td><td>Coefficient</td><td>0.050</td><td> </td><td>0.274</td><td>**</td><td>-0.079</td><td> </td><td>-0.065</td><td> </td><td>0.094</td><td> </td><td>-0.052</td><td> </td><td>0.023</td><td>0.423</td><td>**</td><td>0.153</td><td> </td></tr><tr><td> </td><td><i>P</i> value</td><td>0.609</td><td> </td><td>0.004</td><td> </td><td>0.417</td><td> </td><td>0.502</td><td> </td><td>0.332</td><td> </td><td>0.592</td><td> </td><td>0.813</td><td>0.000</td><td> </td><td>0.113</td><td> </td></tr><tr><td>TAFH (mm)</td><td>Coefficient</td><td>0.240</td><td>*</td><td>0.180</td><td> </td><td>0.120</td><td> </td><td>0.041</td><td> </td><td>0.086</td><td> </td><td>0.217</td><td>*</td><td>0.188</td><td>0.444</td><td>**</td><td>0.302</td><td>**</td></tr><tr><td> </td><td><i>P</i> value</td><td>0.012</td><td> </td><td>0.063</td><td> </td><td>0.215</td><td> </td><td>0.673</td><td> </td><td>0.373</td><td> </td><td>0.024</td><td> </td><td>0.051</td><td>0.000</td><td> </td><td>0.001</td><td> </td></tr><tr><td>TPFH (mm)</td><td>Coefficient</td><td>0.257</td><td>**</td><td>0.269</td><td>**</td><td>-0.082</td><td> </td><td>0.062</td><td> </td><td>-0.081</td><td> </td><td>0.271</td><td>**</td><td>0.152</td><td>0.348</td><td>**</td><td>0.291</td><td>**</td></tr><tr><td> </td><td><i>P</i> value</td><td>0.007</td><td> </td><td>0.005</td><td> </td><td>0.397</td><td> </td><td>0.521</td><td> </td><td>0.402</td><td> </td><td>0.005</td><td> </td><td>0.117</td><td>0.000</td><td> </td><td>0.002</td><td> </td></tr><tr><td>Y axis/FH (&#176;)</td><td>Coefficient</td><td>0.188</td><td> </td><td>-0.139</td><td> </td><td>0.003</td><td> </td><td>-0.141</td><td> </td><td>-0.115</td><td> </td><td>0.083</td><td> </td><td>-0.030</td><td>0.178</td><td> </td><td>-0.079</td><td> </td></tr><tr><td> </td><td><i>P</i> value</td><td>0.051</td><td> </td><td>0.153</td><td> </td><td>0.978</td><td> </td><td>0.147</td><td> </td><td>0.236</td><td> </td><td>0.395</td><td> </td><td>0.757</td><td>0.065</td><td> </td><td>0.415</td><td> </td></tr><tr><td>Overjet (mm)</td><td>Coefficient</td><td>-0.053</td><td> </td><td>-0.199</td><td>*</td><td>0.140</td><td> </td><td>0.037</td><td> </td><td>-0.057</td><td> </td><td>-0.050</td><td> </td><td>-0.165</td><td>0.096</td><td> </td><td>0.033</td><td> </td></tr><tr><td> </td><td><i>P</i> value</td><td>0.583</td><td> </td><td>0.039</td><td> </td><td>0.150</td><td> </td><td>0.701</td><td> </td><td>0.560</td><td> </td><td>0.608</td><td> </td><td>0.087</td><td>0.322</td><td> </td><td>0.736</td><td> </td></tr><tr><td>Overbite (mm)</td><td>Coefficient</td><td>0.063</td><td> </td><td>-0.034</td><td> </td><td>0.117</td><td> </td><td>0.120</td><td> </td><td>-0.154</td><td> </td><td>-0.076</td><td> </td><td>-0.206</td><td>-0.064</td><td> </td><td>-0.150</td><td> </td></tr><tr><td> </td><td><i>P</i> value</td><td>0.519</td><td> </td><td>0.729</td><td> </td><td>0.229</td><td> </td><td>0.215</td><td> </td><td>0.112</td><td> </td><td>0.436</td><td> </td><td>0.033</td><td>0.510</td><td> </td><td>0.120</td><td> </td></tr><tr><td>OPT-SN (&#176;)</td><td>Coefficient</td><td>0.199</td><td>*</td><td>-0.239</td><td>*</td><td>0.417</td><td>**</td><td>0.038</td><td> </td><td>0.302</td><td>**</td><td>0.353</td><td>**</td><td>0.404</td><td>0.201</td><td>*</td><td>0.326</td><td>**</td></tr><tr><td> </td><td><i>P</i> value</td><td>0.039</td><td> </td><td>0.013</td><td> </td><td>0.000</td><td> </td><td>0.693</td><td> </td><td>0.001</td><td> </td><td>0.000</td><td> </td><td>0.000</td><td>0.037</td><td> </td><td>0.001</td><td> </td></tr><tr><td>c2sp-c4ip-SN (&#176;)</td><td>Coefficient</td><td>0.213</td><td>*</td><td>-0.209</td><td>*</td><td>0.376</td><td>**</td><td>0.013</td><td> </td><td>0.253</td><td>**</td><td>0.336</td><td>**</td><td>0.360</td><td>0.202</td><td>*</td><td>0.278</td><td>**</td></tr><tr><td> </td><td><i>P</i> value</td><td>0.027</td><td> </td><td>0.030</td><td> </td><td>0.000</td><td> </td><td>0.892</td><td> </td><td>0.008</td><td> </td><td>0.000</td><td> </td><td>0.000</td><td>0.036</td><td> </td><td>0.004</td><td> </td></tr><tr><td>Body length (mm)</td><td>Coefficient</td><td>-0.079</td><td> </td><td>0.073</td><td> </td><td>0.206</td><td>*</td><td>0.318</td><td>**</td><td>0.280</td><td>**</td><td>0.136</td><td> </td><td>0.212</td><td>0.210</td><td>*</td><td>0.235</td><td>*</td></tr><tr><td> </td><td><i>P</i> value</td><td>0.414</td><td> </td><td>0.451</td><td> </td><td>0.033</td><td> </td><td>0.001</td><td> </td><td>0.003</td><td> </td><td>0.159</td><td> </td><td>0.028</td><td>0.029</td><td> </td><td>0.014</td><td> </td></tr></table>
0be065abdfff74bc16b16f8bb47428beec02ef7b0662c3a1d161b7ff85a45566.png
simple
<table><tr><td>Days with Instrument</td><td>Clear Nights (N = 2,379)</td><td>MEA &lt; 0&#176; (N = 7,952)</td><td>All Nights (N = 13,790)</td></tr><tr><td>SQM1</td><td>1.005 &#177; 0.012</td><td>1.02 &#177; 0.04</td><td>1.01 &#177; 0.05</td></tr><tr><td>SQM2</td><td>1.168 &#177; 0.017</td><td>1.14 &#177; 0.06</td><td>1.14 &#177; 0.07</td></tr><tr><td>SQM3</td><td>1.000 &#177; 0.010</td><td>1.02 &#177; 0.04</td><td>1.01 &#177; 0.05</td></tr><tr><td>SQM4</td><td>1.079 &#177; 0.010</td><td>1.07 &#177; 0.04</td><td>1.09 &#177; 0.06</td></tr><tr><td>SQM5</td><td>1.027 &#177; 0.008</td><td>1.04 &#177; 0.02</td><td>1.05 &#177; 0.02</td></tr><tr><td>SQM6</td><td>1.014 &#177; 0.006</td><td>1.03 &#177; 0.03</td><td>1.03 &#177; 0.03</td></tr><tr><td>SQM7</td><td>0.880 &#177; 0.004</td><td>0.89 &#177; 0.01</td><td>0.91 &#177; 0.04</td></tr><tr><td>SQM8</td><td>0.835 &#177; 0.006</td><td>0.86 &#177; 0.03</td><td>0.87 &#177; 0.04</td></tr><tr><td>SQM9</td><td>0.908 &#177; 0.007</td><td>0.92 &#177; 0.02</td><td>0.92 &#177; 0.03</td></tr></table>
6f8ca1c860734fb99ee822b099c6027ca29fb2630b68e637a6a325469ddf5eb7.png
complex
<table><tr><td>NHANES, FPED Dataset <sup>1</sup></td><td>USDA-ERS Dataset <sup>2</sup></td></tr><tr><td>Total meat</td><td>Total meat, fish, eggs and nuts</td></tr><tr><td> Meat Cured Meat Poultry Organ meat Seafood from high omega-3 sources Seafood from low omega-3 sources</td><td> Total red meat Total Poultry Total fresh and frozen, canned, and cured fish and shellfish Eggs Peanuts Total tree nuts Coconut</td></tr><tr><td>Meat</td><td>Total red meat</td></tr><tr><td> Beef Veal Pork Lamb Game meat</td><td> Beef Veal Pork Lamb</td></tr><tr><td>Cured Meat</td><td>Category not included in dataset</td></tr><tr><td> Cured or luncheon meat made from beef, pork or poultry</td><td></td></tr><tr><td>Poultry</td><td>Total poultry</td></tr><tr><td> Chicken Turkey Cornish hens Game birds</td><td> Chicken Turkey</td></tr><tr><td>* Two categories of Seafood</td><td>Total fresh and frozen, canned, and cured fish and Shellfish</td></tr><tr><td> Seafood from high omega-3 sourcesFinfishShellfishOther seafood Seafood from low omega-3 sourcesFinfishShellfishOther seafood</td><td> Total fresh and frozen fish and shellfishFresh and frozen fishFresh and frozen shellfish Total canned fish and shellfishCanned salmonCanned sardinesCanned tunaCanned shellfishOther canned fish Cured Fish</td></tr><tr><td>Other Categories in the dataset</td><td>Other Categories in the dataset</td></tr><tr><td> Organ Meat</td><td> Eggs</td></tr><tr><td rowspan="2">Organ meat from beef, veal, pork, lamb, game or poultry </td><td> Peanuts</td></tr><tr><td> Total Tree nutsAlmondsHazelnutsPecansWalnutsMacadamia nutsPistachio nutsOther tree nuts</td></tr><tr><td></td><td> Coconut</td></tr></table>
764ea3a621dd0591c8a9aad190b7717dbb84bad07356236dd58ba2229c529edc.png
simple
<table><tr><td></td><td>Controls</td><td>Snorers</td><td>OSAH, mild</td><td>OSAH, severe</td></tr><tr><td>Subjects (n)</td><td>7</td><td>14</td><td>15</td><td>19</td></tr><tr><td>Age (yrs)</td><td>40 &#177; 8</td><td>49 &#177; 13</td><td>49 &#177; 10</td><td>53 &#177; 8 *</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>24 &#177; 3</td><td>27 &#177; 4</td><td>26 &#177; 3</td><td>29 &#177; 3 *</td></tr><tr><td>FEV1(% pred)</td><td>98 &#177; 10</td><td>96 &#177; 31</td><td>103 &#177; 25</td><td>95 &#177; 26</td></tr><tr><td>FVC (% pred)</td><td>97 &#177; 15</td><td>96 &#177; 24</td><td>100 &#177; 24</td><td>93 &#177; 20</td></tr><tr><td>FEV1/FVC (%)</td><td>88 &#177; 12</td><td>79 &#177; 11</td><td>81 &#177; 11</td><td>86 &#177; 1</td></tr><tr><td>AHI</td><td>2 &#177; 0.4</td><td>4 &#177; 2</td><td>18 &#177; 10</td><td>59 &#177; 16</td></tr></table>
2bf87a0070e4257e1bc28063cae06af1be5bf73fe492954a888d351976413723.png
simple
<table><tr><td>Departments</td><td>Internal Medicine (<i>n</i> = 19)</td><td>Urology (<i>n</i> = 19)</td><td>Total (<i>n</i> = 38)</td></tr><tr><td>Number of beds, mean (SD)</td><td>67 (22)</td><td>18 (9)</td><td>43 (30)</td></tr><tr><td>% Female physicians, mean (SD)</td><td>33 (13)</td><td>17 (15)</td><td>25 (16)</td></tr><tr><td>Teaching hospital department<sup>*</sup></td><td>17 (89)</td><td>12 (63)</td><td>29 (76)</td></tr><tr><td>Residents working at the department</td><td>19 (100)</td><td>16 (84)</td><td>35 (92)</td></tr><tr><td>Microbiological laboratory in the same building as the department</td><td>12 (63)</td><td>8 (42)</td><td>20 (53)</td></tr><tr><td>Reporting of a positive urine culture by phone (incidentally or structurally)</td><td>0</td><td>2 (11)</td><td>2 (5)</td></tr><tr><td>Structural<sup>a</sup> education on antibiotics for residents</td><td>14 (74)</td><td>4 (21)</td><td>18 (47)</td></tr><tr><td>Structural education on antibiotics for senior staff members</td><td>4 (21)</td><td>0</td><td>4 (11)</td></tr><tr><td>Audit and feedback (incidentally<sup>b</sup> or structurally)</td><td></td><td></td><td></td></tr><tr><td>On antibiotic prescriptions<sup>c</sup>, at the department level</td><td>2 (11)</td><td>8 (42)</td><td>10 (26)</td></tr><tr><td>On antibiotic prescriptions<sup>c</sup>, at the individual level</td><td>0</td><td>2 (11)</td><td>2 (5)</td></tr><tr><td>On antibiotic resistance rates of the hospital</td><td>9 (47)</td><td>12 (63)</td><td>21 (55)</td></tr><tr><td>Individual advice (of microbiologist/ pharmacist/ infectious diseases (ID) physician), incidentally or structurally, regarding streamlining therapy on the basis of blood or urine culture result</td><td>16 (84)</td><td>16 (84)</td><td>32 (84)</td></tr><tr><td>Microbiologist and/or ID physician structurally present at ward rounds discussing antibiotic therapy</td><td>6 (32)</td><td>0</td><td>6 (16)</td></tr><tr><td>Quality improvement project concerning antibiotic prescribing in past 3 years</td><td>8 (42)</td><td>7 (37)</td><td>15 (40)</td></tr><tr><td>Changes in antibiotic procedures or policies in past 3 years<sup>d</sup></td><td>13 (68)</td><td>14 (74)</td><td>27 (71)</td></tr></table>
274e673a7470fa42e0d7517989d8b3ca9561c70154bc68939be6c1c768dea18f.png
complex
<table><tr><td rowspan="2">Library ID</td><td rowspan="2">No. of Reads after Trimming</td><td rowspan="2">No. of Exogenous Reads</td><td rowspan="2"><sup>3</sup> No. of Putative Viral Contigs Detected in an Overall Screening</td><td colspan="3"><sup>4</sup> No. of Viral Contigs Detected in an Individual Screening</td></tr><tr><td>&#8804;200 nt</td><td>Between 201 to 999 nt</td><td>&#8805;1000 nt</td></tr><tr><td><sup>1</sup> C1-960</td><td>37,811,400</td><td>3,826,317</td><td>40,187</td><td>76</td><td>41</td><td>7</td></tr><tr><td><sup>1</sup> C1-961</td><td>37,380,448</td><td>3,613,441</td><td>29,483</td><td>74</td><td>37</td><td>9</td></tr><tr><td><sup>1</sup> C1-962</td><td>36,452,005</td><td>3,528,784</td><td>30,834</td><td>72</td><td>32</td><td>6</td></tr><tr><td><sup>1</sup> C1-963</td><td>29,942,484</td><td>3,027,793</td><td>38,028</td><td>54</td><td>25</td><td>2</td></tr><tr><td><sup>1</sup> C4-964</td><td>35,511,705</td><td>3,741,954</td><td>33,719</td><td>10</td><td>4</td><td>4</td></tr><tr><td><sup>1</sup> C4-965</td><td>35,386,080</td><td>3,617,222</td><td>39,012</td><td>24</td><td>13</td><td>0</td></tr><tr><td><sup>2</sup> SN453</td><td>8,091,654</td><td>756,302</td><td>776</td><td>323</td><td>19</td><td>0</td></tr><tr><td><sup>2</sup> SN456</td><td>8,949,837</td><td>1,117,451</td><td>395</td><td>263</td><td>5</td><td>0</td></tr><tr><td><sup>2</sup> SN459</td><td>9,899,316</td><td>1,065,849</td><td>571</td><td>334</td><td>6</td><td>0</td></tr><tr><td><sup>2</sup> SN462</td><td>6,233,982</td><td>836,217</td><td>267</td><td>198</td><td>5</td><td>0</td></tr><tr><td><sup>2</sup> SN464</td><td>9,042,291</td><td>782,698</td><td>821</td><td>178</td><td>29</td><td>0</td></tr><tr><td><sup>2</sup> SN468</td><td>8,843,660</td><td>897,286</td><td>626</td><td>384</td><td>11</td><td>0</td></tr><tr><td><sup>2</sup> SN470</td><td>6,866,756</td><td>1,041,001</td><td>410</td><td>329</td><td>4</td><td>0</td></tr><tr><td><sup>2</sup> SN473</td><td>11,892,105</td><td>1,597,924</td><td>533</td><td>311</td><td>41</td><td>0</td></tr><tr><td><sup>2</sup> SN476</td><td>9,076,165</td><td>917,605</td><td>631</td><td>408</td><td>14</td><td>0</td></tr><tr><td><sup>2</sup> SN479</td><td>11,649,840</td><td>1,232,264</td><td>733</td><td>163</td><td>24</td><td>0</td></tr><tr><td><sup>2</sup> SN483</td><td>8,765,391</td><td>949,445</td><td>471</td><td>326</td><td>13</td><td>0</td></tr><tr><td><sup>2</sup> SN486</td><td>11,001,152</td><td>1,127,439</td><td>555</td><td>242</td><td>13</td><td>0</td></tr><tr><td><sup>2</sup> SN488</td><td>14,231,970</td><td>1,446,481</td><td>783</td><td>507</td><td>20</td><td>0</td></tr><tr><td>Total</td><td>337,028,241</td><td>35,123,473</td><td>218,835</td><td>4276</td><td>356</td><td>28</td></tr></table>
dbd2c7400510bb7b23dc2f219f267afece3e68ab82b19f2238d69a4bc278f219.png
complex
<table><tr><td>miRNA Name</td><td>Consensus Sequence</td><td colspan="2">Fold Change</td></tr><tr><td colspan="2">Up Regulated miRNAs</td><td>3 h</td><td>24 h</td></tr><tr><td>miR-129-5p</td><td>CUUUUUGCGGUCUGGGCUUGC</td><td>19.8</td><td>9.5</td></tr><tr><td>miR-200a-3p</td><td>UAACACUGUCUGGUAACGAUGU</td><td>15.9</td><td>8.8</td></tr><tr><td>miR-297</td><td>AUGUAUGUGUGCAUGUGCAUG</td><td>15.6</td><td>18.6</td></tr><tr><td>miR-200b-3p</td><td>UAAUACUGCCUGGUAAUGAUGA</td><td>14.7</td><td>10.2</td></tr><tr><td>miR-595</td><td>GAAGUGUGCCGUGGUGUGUCU</td><td>10.4</td><td>9.3</td></tr><tr><td>miR-574-5p</td><td>UGAGUGUGUGUGUGUGAGUGUGU</td><td>7.2</td><td>8.6</td></tr><tr><td>miR-647</td><td>GUGGCUGCACUCACUUCCUUC</td><td>4.1</td><td>5.0</td></tr><tr><td>miR-615-3p</td><td>UCCGAGCCUGGGUCUCCCUCUU</td><td>3.9</td><td>4.3</td></tr><tr><td>miR-1224-5p</td><td>GUGAGGACUCGGGAGGUGG</td><td>3.5</td><td>4.2</td></tr><tr><td>miR-1238-3p</td><td>CUUCCUCGUCUGUCUGCCCC</td><td>2.2</td><td>2.2</td></tr><tr><td>miR-196a-5p</td><td>UAGGUAGUUUCAUGUUGUUGGG</td><td>3.1</td><td>-</td></tr><tr><td>miR-616-3p</td><td>AGUCAUUGGAGGGUUUGAGCAG</td><td>3.9</td><td>-</td></tr><tr><td>miR-760</td><td>CGGCUCUGGGUCUGUGGGGA</td><td>3.7</td><td>-</td></tr><tr><td>miR-1275</td><td>GUGGGGGAGAGGCUGUC</td><td>2.1</td><td>-</td></tr><tr><td>miR-146a-5p</td><td>UGAGAACUGAAUUCCAUGGGUU</td><td>-</td><td>13.7</td></tr><tr><td>miR-631</td><td>AGACCUGGCCCAGACCUCAGC</td><td>-</td><td>12.6</td></tr><tr><td>miR-661</td><td>UGCCUGGGUCUCUGGCCUGCGCGU</td><td>-</td><td>7.7</td></tr><tr><td>miR-766-3p</td><td>ACUCCAGCCCCACAGCCUCAGC</td><td>-</td><td>4.6</td></tr><tr><td>miR-1273a</td><td>GGGCGACAAAGCAAGACUCUUUCUU</td><td>-</td><td>2.8</td></tr><tr><td>miR-1202</td><td>GUGCCAGCUGCAGUGGGGGAG</td><td>-</td><td>2.7</td></tr><tr><td>miR-943</td><td>CUGACUGUUGCCGUCCUCCAG</td><td>-</td><td>2.7</td></tr><tr><td>miR-1250-5p</td><td>ACGGUGCUGGAUGUGGCCUUU</td><td>-</td><td>2.6</td></tr><tr><td>miR-1229-3p</td><td>CUCUCACCACUGCCCUCCCACAG</td><td>-</td><td>2.5</td></tr><tr><td colspan="2">Down Regulated miRNAs</td><td></td><td></td></tr><tr><td>miR-301b-3p</td><td>CAGUGCAAUGAUAUUGUCAAAGC</td><td>&#8722;3.3</td><td>&#8722;2.8</td></tr><tr><td>miR-548a-3p</td><td>CAAAACUGGCAAUUACUUUUGC</td><td>&#8722;3.1</td><td>&#8722;3.1</td></tr><tr><td>miR-377-3p</td><td>AUCACACAAAGGCAACUUUUGU</td><td>&#8722;2.1</td><td>&#8722;3.2</td></tr><tr><td>miR-602</td><td>GACACGGGCGACAGCUGCGGCCC</td><td>&#8722;2.1</td><td>-</td></tr><tr><td>miR-802</td><td>CAGUAACAAAGAUUCAUCCUUGU</td><td>&#8722;2.2</td><td>-</td></tr><tr><td>miR-376b-3p</td><td>AUCAUAGAGGAAAAUCCAUGUU</td><td>-</td><td>&#8722;2.9</td></tr><tr><td>miR-216b-5p</td><td>AAAUCUCUGCAGGCAAAUGUGA</td><td>-</td><td>&#8722;2.4</td></tr><tr><td>miR-216a-5p</td><td>UAAUCUCAGCUGGCAACUGUGA</td><td>-</td><td>&#8722;2.4</td></tr><tr><td>miR-410-3p</td><td>AAUAUAACACAGAUGGCCUGU</td><td>-</td><td>&#8722;2.3</td></tr><tr><td>miR-29b-3p</td><td>UAGCACCAUUUGAAAUCAGUGUU</td><td>-</td><td>&#8722;2.1</td></tr></table>
fc9964e19c23518c1bdc3bc722b7e43d14556eb3ce0f8157418fbd5e143ee132.png
complex
<table><tr><td rowspan="2">Cohort and animal identifier</td><td colspan="2">No. of SIV DNA copies per 10<sup>6</sup> cells</td><td colspan="2">No. of SIV RNA copies per &#956;g RNA</td><td colspan="2">Brain M&#934;-QVOA IUPM</td></tr><tr><td>Basal ganglia</td><td>Parietal cortex</td><td>Basal ganglia</td><td>Parietal cortex</td><td>Without wells (&lt;50 copies/ml)</td><td>With wells (&lt;50 copies/ml)</td></tr><tr><td>A1</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>PmA11</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>0.147</td><td>0.917</td></tr><tr><td>PmA12</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>0.036</td><td>0.230</td></tr><tr><td>PmA13</td><td>&lt;10</td><td>64</td><td>&lt;10</td><td>&lt;10</td><td>0.036</td><td>0.110</td></tr><tr><td>A2</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>PmA21</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>1.445</td><td>1.445</td></tr><tr><td>PmA22</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>0.177</td><td>1.309</td></tr><tr><td>PmA23</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>7.362</td><td>7.362</td></tr><tr><td>PmA24</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>&lt;0.021</td><td>&lt;0.021</td></tr><tr><td>PmA25</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>&lt;10</td><td>0.613</td><td>0.613</td></tr></table>
31e8b38154a87a7985a5c75e1ba52ca2c89da0a1e5b5b34c26a7e8615dd1fca3.png
complex
<table><tr><td>Sample</td><td colspan="4">Number of seeds per score category (n)</td><td></td></tr><tr><td></td><td>No germination and seed coat infection (Score = n &#215; 0)</td><td>Seed coat and radical tip infection (Score = n &#215; 1)</td><td>Either seed coat or radical tip infection (Score = n &#215; 2)</td><td>Healthy seed germination (Score = n &#215; 3)</td><td>Total score</td></tr><tr><td>Control (+)</td><td>None</td><td>None</td><td>None</td><td>6</td><td>18</td></tr><tr><td>Control (-)</td><td>5</td><td>1</td><td>None</td><td>None</td><td>1</td></tr><tr><td>10 mg l<sup>-1</sup></td><td>2</td><td>3</td><td>1</td><td>None</td><td>5</td></tr><tr><td>25 mg l<sup>-1</sup></td><td>1</td><td>2</td><td>2</td><td>1</td><td>9</td></tr><tr><td>50 mg l<sup>-1</sup></td><td>None</td><td>None</td><td>2</td><td>4</td><td>16</td></tr><tr><td>100 mg l<sup>-1</sup></td><td>None</td><td>None</td><td>1</td><td>5</td><td>17</td></tr><tr><td>200 mg l<sup>-1</sup></td><td>None</td><td>None</td><td>None</td><td>6</td><td>18</td></tr></table>
a74ee8d4ceb7df914060444cbd5789616f5c197be402d4ae6dac143b18d32298.png
simple
<table><tr><td>Learner</td><td>General practice</td><td>Hospital</td><td>Other</td><td>All</td></tr><tr><td>Doctors</td><td>43 (49%)</td><td>3 (3%)</td><td>-</td><td>46 (52%)</td></tr><tr><td>Nurses</td><td>16 (18%)</td><td>20 (23%)</td><td>4 (5%)</td><td>40 (45%)</td></tr><tr><td>Students</td><td>-</td><td>-</td><td>2 (2%)</td><td>2 (2%)</td></tr></table>
57478455a8b2309e940508eafb4765a0c4e9944e174273c6251e2f1964919bf2.png
simple
<table><tr><td>AMP family</td><td><i>D. melanogaster </i>gene</td><td>HMM state</td><td>Induction</td><td>Average Coverage (Nai&#776;ve)</td><td>Average Coverage (Infected)</td></tr><tr><td>Attacins</td><td>AttA</td><td>strongly induced</td><td>21.59</td><td>1.33</td><td>38.37</td></tr><tr><td></td><td>AttB</td><td>strongly induced</td><td>23.23</td><td>2.26</td><td>70.20</td></tr><tr><td></td><td>AttC</td><td>strongly induced</td><td>35.90</td><td>0.96</td><td>46.29</td></tr><tr><td></td><td>AttD</td><td>ND<sup>1</sup></td><td></td><td></td><td></td></tr><tr><td>Cecropins</td><td>CecA1</td><td>strongly induced</td><td>27.33</td><td>1.18</td><td>43.20</td></tr><tr><td></td><td>CecA2</td><td>strongly induced</td><td>43.80</td><td>0.68</td><td>39.59</td></tr><tr><td></td><td>CecB</td><td>ND</td><td></td><td></td><td></td></tr><tr><td></td><td>CecC</td><td>ND</td><td></td><td></td><td></td></tr><tr><td>Defensins</td><td>Def</td><td>moderately induced</td><td>3.35</td><td>7.68</td><td>34.40</td></tr><tr><td>Diptericins</td><td>Dpt</td><td>strongly induced</td><td>80.26</td><td>2.99</td><td>320.51</td></tr><tr><td></td><td>DptB</td><td>strongly induced</td><td>Inf</td><td>0.00</td><td>30.37</td></tr><tr><td>Metchnikowin</td><td>Mtk</td><td>strongly induced</td><td>23.47</td><td>7.94</td><td>249.23</td></tr><tr><td>Drosocin</td><td>Dro</td><td>strongly induced</td><td>17.07</td><td>28.03</td><td>640.13</td></tr><tr><td>Drosomycins</td><td>Drs</td><td>strongly induced</td><td>6.99</td><td>19.28</td><td>180.39</td></tr><tr><td></td><td>Dro2</td><td>ND</td><td></td><td></td><td></td></tr><tr><td></td><td>Dro3</td><td>ND</td><td></td><td></td><td></td></tr><tr><td></td><td>Dro4</td><td>not regulated</td><td>0.95</td><td>12.74</td><td>10.00</td></tr><tr><td></td><td>Dro5</td><td>ND</td><td></td><td></td><td></td></tr><tr><td></td><td>Dro6</td><td>ND</td><td></td><td></td><td></td></tr><tr><td></td><td>Drs-l</td><td>ND</td><td></td><td></td><td></td></tr></table>
86c4b7e6d66a0f37ccf2d4fec08d020b6b98fda3c638ac7bace767c9df90f425.png
complex
<table><tr><td rowspan="3" colspan="2"></td><td>Home safety only (<i>n</i> = 15)</td><td colspan="2">Home safety + Home exercise (<i>n</i> = 15)</td></tr><tr><td>OT</td><td>OT</td><td>Peer mentor</td></tr><tr><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td></tr><tr><td rowspan="3">Telephone calls</td><td>Number</td><td>3.7 (1.5)</td><td>4.7 (2.2)</td><td>3.1 (3.3)</td></tr><tr><td>Min</td><td>13.9 (6.7)</td><td>21.5 (11.6)</td><td>29.5 (25.4)</td></tr><tr><td>Cost (&#163;)</td><td>19.1 (9.2)</td><td>29.5 (16.0)</td><td>13.3 (11.4)</td></tr><tr><td rowspan="3">Home visits</td><td>Number</td><td>2.3 (0.5)</td><td>3.1 (0.6)</td><td>2.5 (0.5)</td></tr><tr><td>Min</td><td>110.0 (38.5)</td><td>210.7 (82.3)</td><td>175.9 (55.6)</td></tr><tr><td>Cost (&#163;)</td><td>150.7 (52.7)</td><td>288.6 (112.7)</td><td>135.4 (42.9)</td></tr><tr><td rowspan="3">Patient-related non-face-to-face</td><td>Travel (min)</td><td>21.7 (7.8)</td><td>23.9 (7.3)</td><td>144.1 (52.9)</td></tr><tr><td>Notes etc. (min)</td><td>71.3 (34.9)</td><td>115.6 (29.2)</td><td>Not applicable</td></tr><tr><td>Cost (&#163;)</td><td>65.1 (23.5)</td><td>97.7 (21.5)</td><td>64.8 (23.8)</td></tr><tr><td>Travel costs</td><td>Cost (&#163;)</td><td>13.82 (6.7)</td><td>23.5 (13.4)</td><td>20.9 (10.8)</td></tr><tr><td colspan="2">Total average costs (&#163;)</td><td>Mean &#163;248.71</td><td colspan="2">Mean &#163;674.32</td></tr></table>
cc7b181ac14c5c98ffb7446e91dde21805c6e28c2f0cec23e0904a5beedf8388.png
complex
<table><tr><td>Variable</td><td colspan="8">Age group</td></tr><tr><td>Birth cohort</td><td>16-23</td><td>24-31</td><td>32-39</td><td>40-47</td><td>48-55</td><td>56-63</td><td>64-71</td><td>&#916;BMI cohort</td></tr><tr><td>1910-17</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>25.2</td><td>-</td></tr><tr><td>1918-25</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>25.4</td><td><i>25.6</i></td><td>ns</td></tr><tr><td>1926-33</td><td>-</td><td>-</td><td>-</td><td>-</td><td>25.1</td><td><i>25.9</i></td><td>26.0</td><td>0.042*</td></tr><tr><td>1934-41</td><td>-</td><td>-</td><td>-</td><td>24.7</td><td><i>25.4</i></td><td>25.9</td><td><i>26.3</i></td><td>0.067*</td></tr><tr><td>1942-49</td><td>-</td><td>-</td><td>24.0</td><td><i>25.1</i></td><td>25.9</td><td><i>26.3</i></td><td>-</td><td>0.095*</td></tr><tr><td>1950-57</td><td>-</td><td>23.2</td><td><i>24.5</i></td><td>25.6</td><td><i>26.4</i></td><td>-</td><td>-</td><td>0.13*</td></tr><tr><td>1958-65</td><td>22.0</td><td><i>23.6</i></td><td>25.1</td><td><i>26.4</i></td><td>-</td><td>-</td><td>-</td><td>0.17*</td></tr><tr><td>1966-73</td><td><i>22.2</i></td><td>24.0</td><td><i>25.6</i></td><td>-</td><td>-</td><td>-</td><td>-</td><td>0.21*</td></tr><tr><td>1974-81</td><td>22.6</td><td><i>24.4</i></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>0.21*</td></tr><tr><td>1982-89</td><td><i>22.7</i></td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>&#916;BMI age group</td><td>0.032*</td><td>0.049*</td><td>0.068*</td><td>0.071*</td><td>0.056*</td><td>0.033*</td><td>0.046*</td><td> </td></tr><tr><td> </td><td colspan="2">1980/81</td><td colspan="2"><i>1988/89</i></td><td colspan="2">1996/97</td><td colspan="2"><i>2004/05</i></td></tr></table>
f509c49b8f915d21f23116f02d86d4a3172af76edd257011347cc020f413b8a8.png
complex
<table><tr><td> </td><td colspan="2">Artificial data</td><td colspan="2">Biological data</td></tr><tr><td>Scenario characteristics</td><td>1st design</td><td>2nd design</td><td>1st design</td><td>2nd design</td></tr><tr><td>Total cost / expectation</td><td>97443.4</td><td>151629.7</td><td>210917.0</td><td>535524.0</td></tr><tr><td>Total cost / expectation of gains</td><td>60.0</td><td>358.4</td><td>53448.0</td><td>77040.5</td></tr><tr><td>Total cost / expectation of losses</td><td>38024.0</td><td>56660.0</td><td>98376.0</td><td>187600.5</td></tr><tr><td>Total cost / expectation of duplications</td><td>26796.0</td><td>34324.6</td><td>38286.0</td><td>44639.6</td></tr><tr><td>Total cost / expectation of transfers</td><td>32563.4</td><td>60168.3</td><td>17887.0</td><td>223854.8</td></tr><tr><td>Total cost / expectation of the gain_big events</td><td>0.0</td><td>118.4</td><td>2920.0</td><td>2388.6</td></tr><tr><td>Running time</td><td>&lt;1m</td><td>2m</td><td>15m</td><td>41m</td></tr></table>
d650f584304ab44654373db4e0f0d65a59971de95ab702c4fd133830863ed262.png
complex
<table><tr><td>Characteristics</td><td>Number</td><td>Percent</td></tr><tr><td>Age group (years)</td><td></td><td></td></tr><tr><td> 14&#8211;24</td><td>44</td><td>18.0</td></tr><tr><td> 25&#8211;34</td><td>54</td><td>22.1</td></tr><tr><td> 35&#8211;44</td><td>124</td><td>50.8</td></tr><tr><td> 45 and above</td><td>22</td><td>9.0</td></tr><tr><td> Total</td><td>244</td><td>100</td></tr><tr><td>Highest educational level</td><td></td><td></td></tr><tr><td> Primary</td><td>14</td><td>5.7</td></tr><tr><td> Junior High School</td><td>64</td><td>26.2</td></tr><tr><td> Senior High School</td><td>54</td><td>22.1</td></tr><tr><td> Tertiary</td><td>96</td><td>39.3</td></tr><tr><td> Post-Graduate</td><td>14</td><td>5.7</td></tr><tr><td> Uneducated</td><td>2</td><td>0.8</td></tr><tr><td> Total</td><td>244</td><td>100</td></tr><tr><td>Tribe</td><td></td><td></td></tr><tr><td> Akan</td><td>112</td><td>45.9</td></tr><tr><td> Ewe</td><td>58</td><td>23.8</td></tr><tr><td> Ga</td><td>44</td><td>18.0</td></tr><tr><td> Northern</td><td>30</td><td>12.3</td></tr><tr><td> Total</td><td>244</td><td>100</td></tr><tr><td>Parity</td><td></td><td></td></tr><tr><td> Zero</td><td>156</td><td>63.9</td></tr><tr><td> 1 and above</td><td>88</td><td>36.1</td></tr><tr><td> Total</td><td>244</td><td>100</td></tr><tr><td>Body Mass Index</td><td></td><td></td></tr><tr><td> &lt;25</td><td>76</td><td>31.1</td></tr><tr><td> 25&#8211;29.9</td><td>78</td><td>32.0</td></tr><tr><td> 30 and above</td><td>90</td><td>36.9</td></tr><tr><td> Total</td><td>244</td><td>100</td></tr><tr><td colspan="2">Menstrual flow pattern (heavy flow)</td><td></td></tr><tr><td> Yes</td><td>102</td><td>41.8</td></tr><tr><td> No</td><td>142</td><td>58.2</td></tr><tr><td> Total</td><td>244</td><td>100</td></tr><tr><td>Type of menstrual cycle (irregular)</td><td></td><td></td></tr><tr><td> Yes</td><td>164</td><td>67.2</td></tr><tr><td> No</td><td>80</td><td>32.8</td></tr><tr><td> Total</td><td>244</td><td>100</td></tr></table>
3349f2ac508ae2c774ecf142df37c00e3ea45d28e3e37846b406345a8e5936b1.png
complex
<table><tr><td></td><td colspan="4">Maturation - CD27/CD45RA</td><td colspan="4">Differentiation - CD27/CD28</td></tr><tr><td></td><td colspan="2">% KLRG1<sup>+</sup> T<sub>N</sub><sup>a</sup></td><td colspan="2">% KLRG1<sup>+</sup> Memory<sup>a</sup></td><td colspan="2">% KLRG1<sup>+</sup>CD28<sup>+a</sup></td><td colspan="2">% KLRG1<sup>+</sup>CD28<sup>&#8722;</sup></td></tr><tr><td></td><td>Estimate</td><td>95 % CI</td><td>Estimate</td><td>95 % CI</td><td>Estimate</td><td>95 % CI</td><td>Estimate</td><td>95 % CI</td></tr><tr><td rowspan="2">Age (per year extra)</td><td>&#8722;0.84</td><td>&#8722;4.32 &#8211; 2.77</td><td>1.12</td><td>&#8722;2.19 &#8211; 4.53</td><td>1.54</td><td>&#8722;1.73 &#8211; 4.93</td><td>0.05</td><td>&#8722;0.81 &#8211; 0.92</td></tr><tr><td>&#8722;0.16</td><td>&#8722;4.22 &#8211; 4.07</td><td>0.32</td><td>&#8722;3.53 &#8211; 4.32</td><td>0.49</td><td>&#8722;3.16 &#8211; 4.28</td><td>&#8722;0.24</td><td>&#8722;1.24 &#8211; 0.76</td></tr><tr><td rowspan="2">IL-6 (per extra pg/mL)</td><td>&#8722;0.24</td><td>&#8722;17.69 &#8211; 20.92</td><td>&#8722;8.07</td><td>&#8722;22.94 &#8211; 9.68</td><td>3.27</td><td>&#8722;13.80 &#8211; 23.71</td><td>&#8722;0.84</td><td>&#8722;5.53 &#8211; 3.85</td></tr><tr><td>&#8722;2.98</td><td>&#8722;21.71 &#8211; 20.23</td><td>&#8722;7.08</td><td>&#8722;23.90 &#8211; 13.47</td><td>9.10</td><td>&#8722;9.84 &#8211; 32.03</td><td>0.11</td><td>&#8722;5.16 &#8211; 5.38</td></tr><tr><td rowspan="2">suPAR (per extra ng/mL)</td><td>&#8722;13.66</td><td>&#8722;40.90 &#8211; 26.14</td><td>&#8722;21.72</td><td>&#8722;44.54 &#8211; 10.50</td><td>&#8722;18.83</td><td>&#8722;42.12 &#8211; 13.82</td><td>&#8722;5.62</td><td>&#8722;14.38 &#8211; 3.14</td></tr><tr><td>&#8722;15.63</td><td>&#8722;43.65 &#8211; 26.30</td><td>&#8722;20.25</td><td>&#8722;45.09 &#8211; 15.84</td><td>&#8722;17.17</td><td>&#8722;41.55 &#8211; 17.38</td><td>&#8722;4.90</td><td>&#8722;14.36 &#8211; 4.56</td></tr><tr><td rowspan="2">HOMA-IR (per extra 1-unit)</td><td>16.39</td><td>&#8722;17.36 &#8211; 63.93</td><td>18.91</td><td>&#8722;13.42 &#8211; 63.30</td><td>27.27</td><td>&#8722;6.34 &#8211; 72.93</td><td>6.02</td><td>&#8722;1.96 &#8211; 14.01</td></tr><tr><td>35.74</td><td>&#8722;9.23 &#8211; 103.01</td><td>22.91</td><td>&#8722;16.71 &#8211; 81.38</td><td>27.45</td><td>&#8722;10.90 &#8211; 82.29</td><td>6.98</td><td>&#8722;2.65 &#8211; 16.16</td></tr><tr><td rowspan="2">Metabolic syndrome (vs. no metabolic syndrome)</td><td>23.25</td><td>&#8722;34.76 &#8211; 132.83</td><td>46.43</td><td>&#8722;17.97 &#8211; 161.42</td><td>70.88</td><td>&#8722;1.41 &#8211; 196.17</td><td>14.31*</td><td>0.10 &#8211; 28.53</td></tr><tr><td>48.94</td><td>&#8722;29.02 &#8211; 212.55</td><td>41.31</td><td>&#8722;29.88 &#8211; 184.78</td><td>61.77</td><td>&#8722;15.73 &#8211; 210.55</td><td>17.59*</td><td>0.73 &#8211; 34.45</td></tr><tr><td rowspan="2">VAT (per extra cm<sup>2</sup>)</td><td>&#8722;0.10</td><td>&#8722;0.55 &#8211; 0.35</td><td>0.28</td><td>&#8722;0.12 &#8211; 0.70</td><td>0.45*</td><td>0.06 &#8211; 0.84</td><td>0.10</td><td>&#8722;0.00 &#8211; 0.20</td></tr><tr><td>0.14</td><td>&#8722;0.54 &#8211; 0.82</td><td>0.28</td><td>&#8722;0.34 &#8211; 0.90</td><td>0.62*</td><td>0.07 &#8211; 1.16</td><td>0.16*</td><td>0.01 &#8211; 0.31</td></tr><tr><td rowspan="2"><i>l</i>LMI (per extra kg/m<sup>2</sup>)</td><td>66.47*</td><td>10.22 &#8211; 151.43</td><td>36.88</td><td>&#8722;5.52 &#8211; 98.30</td><td>22.54</td><td>&#8722;20.06 &#8211; 87.86</td><td>7.92</td><td>&#8722;2.88 &#8211; 18.71</td></tr><tr><td>59.19</td><td>&#8722;0.55 &#8211; 154.80</td><td>45.52</td><td>&#8722;1.35 &#8211; 114.65</td><td>33.83</td><td>&#8722;13.85 &#8211; 107.92</td><td>10.09</td><td>&#8722;1.22 &#8211; 21.39</td></tr></table>
a8292cee7303394ece742c802881b99d73891b5698daaf4c9e998c4a3e00a9d7.png
complex
<table><tr><td>Included patients</td><td colspan="4">Time ABI measurement<sup>1</sup>(min) Mean (SD)</td></tr><tr><td> </td><td colspan="2">Experienced</td><td colspan="2">Non-experienced</td></tr><tr><td> </td><td>GP<sup>2</sup></td><td>PA<sup>3</sup></td><td>GP<sup>2</sup></td><td>PA<sup>3</sup></td></tr><tr><td>Patient 1</td><td>13.5 (5.9) (n = 47)</td><td>19.7 (9.5) (n = 78)</td><td>18.0 (8.1) (n = 73)</td><td>19.1 (8.1) (n = 206)</td></tr><tr><td>Patient 2</td><td>14.2 (5.9) (n = 47)</td><td>18.8 (8.7) (n = 76)</td><td>16.7 (6.9) (n = 71)</td><td>19.0 (7.3) (n = 201)</td></tr><tr><td>Patient 3</td><td>13.1 (5.4) (n = 43)</td><td>19.6 (10.4) (n = 78)</td><td>17.1 (7.5) (n = 71)</td><td>18.8 (7.3) (n = 205)</td></tr><tr><td>Patient 4</td><td>12.4 (4.7) (n = 45)</td><td>18.4 (7.8) (n = 77)</td><td>16.6 (7.5) (n = 70)</td><td>18.1 (7.1) (n = 205)</td></tr><tr><td>Patient 5</td><td>12.6 (5.8) (n = 47)</td><td>18.4 (6.9) (n = 76)</td><td>16.4 (9.6) (n = 71)</td><td>18.1 (6.9) (n = 202)</td></tr><tr><td>Patient 6 &#8211; 10</td><td>12.8 (5.7) (n = 228)</td><td>17.8 (7.4) (n = 367)</td><td>16.0 (7.8) (n = 354)</td><td>18.0 (7.5) (n = 993)</td></tr><tr><td>Patient 11 &#8211; 15</td><td>12.2 (5.2) (n = 211)</td><td>17.7 (7.3) (n = 355)</td><td>15.3 (7.5) (n = 341)</td><td>17.5 (7.2) (n = 947)</td></tr><tr><td>Patient &#8805; 16</td><td>12.5 (5.4) (n = 200)</td><td>18.0 (7.5) (n = 347)</td><td>15.5 (7.2) (n = 335)</td><td>17.4 (6.9) (n = 936)</td></tr></table>
1bb3869f5837b193526cf0bc7c3fddd7b0117e61027e86d6823f22992f76f3e4.png
complex
<table><tr><td>Instruments</td><td>Domains</td><td>Mean &#177; Standard Deviation</td></tr><tr><td rowspan="4"><i>JSS</i></td><td>Payment&#8211;promotion</td><td>3.38 &#177; 0.65</td></tr><tr><td>Management&#8211;interpersonal relationship</td><td>4.33 &#177; 0.66</td></tr><tr><td>Organization&#8211;communication</td><td>4.41 &#177; 0.70</td></tr><tr><td>Total score</td><td>3.92 &#177; 0.55</td></tr><tr><td rowspan="3"><i>TAS-20</i></td><td>Difficulty describing feelings</td><td>12.97 &#177; 5.48</td></tr><tr><td>Difficulty identifying feelings</td><td>13.90 &#177; 5.18</td></tr><tr><td>Externally oriented thinking</td><td>18.01 &#177; 4.27</td></tr><tr><td></td><td>Total score</td><td>44.89 &#177; 11.56</td></tr></table>
9fbeb0bc90b0f977d4768414d3c8ce1f8e06f2b52c435818dabbde4d578e13b3.png
simple
<table><tr><td>Variable</td><td>Odds ratio</td><td>95 % confidence interval</td><td><i>p</i> value</td></tr><tr><td>Moderate to high side effects (ref: no/low side effects)</td><td>4.84</td><td>1.07&#8211;1.85</td><td>0.04</td></tr></table>
28e5169771a8112a4985dbbd15fb1749cb322078618b90161bcd95dd45e94abe.png
simple
<table><tr><td></td><td>Six County Study Area</td><td>Entire State of Michigan</td></tr><tr><td>Current smoking</td><td>25.1%</td><td>25.1%</td></tr><tr><td>Heavy drinking (60+ drinks/mo)</td><td>2.6%</td><td>3.7%</td></tr><tr><td>Binge drinking (5+ drinks on 1+ occasions in past month)</td><td>7.6%</td><td>11.7%</td></tr><tr><td>Cholesterol never checked</td><td>16.1%</td><td>19.3%</td></tr><tr><td>Ever told cholesterol high (among tested)</td><td>37.4%</td><td>33.0%</td></tr><tr><td>Ever told high blood pressure</td><td>33.6%</td><td>31.4%</td></tr><tr><td>Overweight (BMI &gt;= 27.8 for men, &gt;= 27.3 for women)</td><td>34.6%</td><td>33.4%</td></tr><tr><td>Never had mammogram (among women 40+)</td><td>19.0%</td><td>22.2%</td></tr></table>
a6615d7617ab69c75714751f01eb31c78c93b2157a38b77bf70e84dba81d63b2.png
complex
<table><tr><td colspan="2">Stratification criteria</td></tr><tr><td>Variable</td><td>Criteria</td></tr><tr><td>Student mobility</td><td></td></tr><tr><td>IHE-Yes</td><td>Any respondent declaring at least one study-related trans-border movement</td></tr><tr><td>IHE-No</td><td>Any respondent declaring no study-related trans-border movement</td></tr><tr><td>IHE-North</td><td>Destination countries of international health electives (IHE) are pre-dominantly industrialised countries.(Eligible combinations: n, nn, snn, nns, nsn, nnn)*</td></tr><tr><td>IHE-South</td><td>Destination countries of international health electives (IHE) are pre-dominantly developing countries.(Eligible combinations: s, ss, sn, ns, ssn, sns, nss, sss)*</td></tr><tr><td>Exposure to educational interventions</td><td></td></tr><tr><td>GH-yes</td><td>Any respondent declaring a participation in global health courses.</td></tr><tr><td>GH-no</td><td>Any respondent declaring no participation in global health courses.</td></tr><tr><td>TM-yes</td><td>Any respondent declaring a participation in courses of tropical medicine.</td></tr><tr><td>TM-no</td><td>Any respondent declaring no participation in courses of tropical medicine.</td></tr></table>
4c28d2d75d4d5185383a8b1169fa5c8ef7784851e83f219bdb093576ab0ef4b4.png
complex
<table><tr><td rowspan="3"></td><td rowspan="3">NP</td><td colspan="4">Gestational day 20</td><td colspan="4">Gestational day 50</td></tr><tr><td colspan="2">Endometrium</td><td colspan="2">Chorioallantoic membrane</td><td colspan="2">Endometrium</td><td colspan="2">Chorioallantoic membrane</td></tr><tr><td>H</td><td>A</td><td>H</td><td>A</td><td>H</td><td>A</td><td>H</td><td>A</td></tr><tr><td><i>PCR samples (No.)</i></td><td>5</td><td>30</td><td>19</td><td>26</td><td>20</td><td>29</td><td>6</td><td>27</td><td>4</td></tr><tr><td><i>WB samples (No.)</i></td><td>-</td><td>6</td><td>6</td><td>6</td><td>6</td><td>6</td><td>6</td><td>6</td><td>6</td></tr><tr><td><i>IF samples (No. of sections from different animals)</i></td><td>-</td><td>3</td><td>3</td><td>3</td><td>3</td><td>3</td><td>3</td><td>3</td><td>3</td></tr></table>
6b214fcb83939533a54fd37031777723b4e10de17579e00f5a24c48b4fc4b66b.png
complex
<table><tr><td>Antigens</td><td>Patient (<i>n</i>)</td><td>Control (<i>n</i>)</td><td>Adjusted <i>r</i><sup>2</sup></td><td><i>p</i><sup>a</sup></td></tr><tr><td colspan="5">IL1&#945;</td></tr><tr><td> Male</td><td>1.15&#177;0.42 (124)</td><td>1.21&#177;0.39 (131)</td><td>-0.002</td><td>0.228</td></tr><tr><td> Female</td><td>1.20&#177;0.43 (76)</td><td>1.32&#177;0.39 (89)</td><td>0.009</td><td>0.083</td></tr><tr><td> Combined</td><td>1.17&#177;0.42 (200)</td><td>1.26&#177;0.39 (220)</td><td>0.012</td><td>0.04</td></tr><tr><td colspan="5">IL1&#946;</td></tr><tr><td> Male</td><td>0.70&#177;0.28 (124)</td><td>0.77&#177;0.30 (131)</td><td>0.019</td><td>0.04</td></tr><tr><td> Female</td><td>0.78&#177;0.31 (76)</td><td>0.80&#177;0.33 (89)</td><td>-0.01</td><td>0.788</td></tr><tr><td> Combined</td><td>0.73&#177;0.29 (200)</td><td>0.78&#177;0.31 (220)</td><td>0.011</td><td>0.07</td></tr><tr><td colspan="5">IL6</td></tr><tr><td> Male</td><td>1.13&#177;0.21 (124)</td><td>1.18&#177;0.19 (131)</td><td>0.01</td><td>0.038</td></tr><tr><td> Female</td><td>1.11&#177;0.23 (76)</td><td>1.24&#177;0.22 (89)</td><td>0.065</td><td>0.0008</td></tr><tr><td> Combined</td><td>1.12&#177;0.22 (200)</td><td>1.20&#177;0.21 (220)</td><td>0.034</td><td>0.0001</td></tr><tr><td colspan="5">IL8</td></tr><tr><td> Male</td><td>0.97&#177;0.35 (124)</td><td>1.02&#177;0.29 (131)</td><td>0.003</td><td>0.134</td></tr><tr><td> Female</td><td>0.94&#177;0.33 (76)</td><td>1.12&#177;0.35 (89)</td><td>0.056</td><td>0.003</td></tr><tr><td> Combined</td><td>0.96&#177;0.34 (200)</td><td>1.06&#177;0.32 (220)</td><td>0.021</td><td>0.002</td></tr><tr><td colspan="5">TNF-&#945;</td></tr><tr><td> Male</td><td>0.77&#177;0.40 (124)</td><td>0.95&#177;0.60 (131)</td><td>0.024</td><td>0.005</td></tr><tr><td> Female</td><td>0.85&#177;0.48 (76)</td><td>0.95&#177;0.45 (89)</td><td>-0.002</td><td>0.226</td></tr><tr><td> Combined</td><td>0.80&#177;0.43 (200)</td><td>0.95&#177;0.54 (220)</td><td>0.017</td><td>0.003</td></tr></table>
f09b4e610955ec48715c9f3a378d9fc9d8b95d2c63deca77b5b10c782081313a.png
complex
<table><tr><td>SOA</td><td colspan="2">Compatibility group</td><td colspan="2">Incompatibility group</td></tr><tr><td></td><td><i>d'<sub>id</sub></i></td><td><i>d'<sub>loc</sub></i></td><td><i>d'<sub>id</sub></i></td><td><i>d'<sub>loc</sub></i></td></tr><tr><td colspan="5">EXP. 1</td></tr><tr><td></td><td>2.27<sup>*</sup></td><td>0.12<sup>*</sup></td><td>1.73<sup>*</sup></td><td>&#8722;0.25<sup>*</sup></td></tr><tr><td colspan="5">EXP. 2</td></tr><tr><td>60</td><td>1.74<sup>*</sup></td><td>0.21<sup>*</sup></td><td>1.81<sup>*</sup></td><td>&#8722;0.04</td></tr><tr><td>120</td><td>1.97<sup>*</sup></td><td>0.11</td><td>1.93<sup>*</sup></td><td>0.00</td></tr><tr><td>240</td><td>2.12<sup>*</sup></td><td>0.83</td><td>2.06<sup>*</sup></td><td>&#8722;0.07</td></tr><tr><td>360</td><td>2.20<sup>*</sup></td><td>0.13<sup>*</sup></td><td>2.24<sup>*</sup></td><td>&#8722;0.04</td></tr><tr><td>480</td><td>2.36<sup>*</sup></td><td>0.06<sup>*</sup></td><td>2.30<sup>*</sup></td><td>0.04</td></tr><tr><td>960</td><td>2.26<sup>*</sup></td><td>0.03</td><td>2.27<sup>*</sup></td><td>0.00</td></tr><tr><td>1440</td><td>2.20<sup>*</sup></td><td>0.11<sup>*</sup></td><td>2.27<sup>*</sup></td><td>&#8722;0.03</td></tr><tr><td colspan="5">EXP. 3 (SAT)</td></tr><tr><td>60</td><td>0.21<sup>*</sup></td><td>1.04<sup>*</sup></td><td>0.13</td><td>0.15</td></tr><tr><td>120</td><td>0.19</td><td>0.72<sup>*</sup></td><td>0.50<sup>*</sup></td><td>&#8722;0.18</td></tr><tr><td>240</td><td>0.86<sup>*</sup></td><td>0.39<sup>*</sup></td><td>0.96<sup>*</sup></td><td>&#8722;0.16</td></tr><tr><td>360</td><td>1.71<sup>*</sup></td><td>0.06</td><td>1.82<sup>*</sup></td><td>&#8722;0.19</td></tr><tr><td>480</td><td>2.33<sup>*</sup></td><td>0.10</td><td>2.29<sup>*</sup></td><td>&#8722;0.04</td></tr><tr><td>960</td><td>2.88<sup>*</sup></td><td>&#8722;0.01</td><td>2.72<sup>*</sup></td><td>&#8722;0.02</td></tr><tr><td>1440</td><td>2.90<sup>*</sup></td><td>0.03</td><td>2.88<sup>*</sup></td><td>0.00</td></tr><tr><td colspan="5">EXP. 4 (SAT)</td></tr><tr><td>60</td><td>0.02</td><td>1.14<sup>*</sup></td><td>0.06</td><td>0.22<sup>*</sup></td></tr><tr><td>120</td><td>0.02</td><td>1.21<sup>*</sup></td><td>0.26<sup>*</sup></td><td>&#8722;0.03</td></tr><tr><td>240</td><td>0.63<sup>*</sup></td><td>0.62<sup>*</sup></td><td>0.65<sup>*</sup></td><td>&#8722;0.04</td></tr><tr><td>360</td><td>1.60<sup>*</sup></td><td>0.41<sup>*</sup></td><td>1.61<sup>*</sup></td><td>&#8722;0.14</td></tr><tr><td>480</td><td>2.17<sup>*</sup></td><td>0.16<sup>*</sup></td><td>1.84<sup>*</sup></td><td>&#8722;0.06</td></tr><tr><td>960</td><td>2.22<sup>*</sup></td><td>0.26<sup>*</sup></td><td>2.67<sup>*</sup></td><td>&#8722;0.05</td></tr><tr><td>1440</td><td>2.43<sup>*</sup></td><td>0.14<sup>*</sup></td><td>2.57<sup>*</sup></td><td>&#8722;0.07<sup>*</sup></td></tr></table>
b326d12210c1c355488395e99f138a888ec1c9b8b14de590643b88deb56f41a9.png
simple
<table><tr><td>Scenario</td><td>Parameter</td><td>Settings</td></tr><tr><td>A1&#8211;A5</td><td>Signal to noise (s2n)</td><td>0.01, 0.05, 0.1, 0.15, and 0.20</td></tr><tr><td>B1&#8211;B5</td><td>Mean of significant variables in the case</td><td>10, 15, 20, 25, and 30</td></tr><tr><td>C1&#8211;C5</td><td>Dispersion parameter of significant variables in the case</td><td>0.125, 0.5, 1, 2, and 8</td></tr><tr><td> </td><td>Sample size (+/&#8722;)</td><td>40 (20/20)</td></tr><tr><td> </td><td>Number of variables</td><td>500</td></tr><tr><td> </td><td>Mean of significant variables in the control</td><td>5</td></tr><tr><td> </td><td>Mean of insignificant variables</td><td>5</td></tr><tr><td> </td><td>Dispersion parameter of significant variables in the control</td><td>1</td></tr><tr><td> </td><td>Dispersion parameter of insignificant variables</td><td>1</td></tr></table>
c382088b4d74606902f80009441ace481e0ef6095c9b50d9b991a4997e5d10e5.png
complex
<table><tr><td rowspan="2">Variables</td><td rowspan="2"><i>p</i> value</td><td rowspan="2">OR</td><td colspan="2">95% CI for OR</td></tr><tr><td>Lower</td><td>Upper</td></tr><tr><td colspan="5">Variables associated with diarrhea in children aged more than 6 months</td></tr><tr><td>Starting of breastfeeding</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> After an hour of birth</td><td>0.045</td><td>1.479</td><td>1.009</td><td>2.166</td></tr><tr><td> Within hour (reference category)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Nutritional status of children</td><td>0.029</td><td> </td><td> </td><td> </td></tr><tr><td> Moderate malnutrition</td><td>0.758</td><td>0.909</td><td>0.497</td><td>1.666</td></tr><tr><td> Overweight</td><td>0.209</td><td>0.695</td><td>0.394</td><td>1.227</td></tr><tr><td> Severe malnutrition</td><td>0.018</td><td>1.853</td><td>1.111</td><td>3.089</td></tr><tr><td> Normal (reference category)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Duration of breastfeeding</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Up to 2 years</td><td>0.026</td><td>2.506</td><td>1.114</td><td>5.638</td></tr><tr><td> 2 years or more (reference category)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="5">Variables associated with cough and cold in children aged more than 6 months</td></tr><tr><td>Hand washing before each feed</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Always (reference category)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Sometimes</td><td>0.039</td><td>0.620</td><td>0.394</td><td>0.977</td></tr><tr><td>Nutritional status of child</td><td>0.115</td><td> </td><td> </td><td> </td></tr><tr><td> Moderate malnutrition</td><td>0.590</td><td>1.221</td><td>0.590</td><td>2.527</td></tr><tr><td> Overweight</td><td>0.636</td><td>1.182</td><td>0.591</td><td>2.363</td></tr><tr><td> Severe malnutrition</td><td>0.015</td><td>2.135</td><td>1.159</td><td>3.933</td></tr><tr><td> Normal (reference category)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Washing utensils after each feed</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> After each feed (reference category)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Sometimes</td><td>0.001</td><td>0.457</td><td>0.282</td><td>0.740</td></tr><tr><td>Occupation</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Employed</td><td>0.022</td><td>0.546</td><td>0.325</td><td>0.916</td></tr><tr><td> Housewife (reference category)</td><td> </td><td> </td><td> </td><td> </td></tr></table>
76b59312bc74dfcca241b1fdaacd2056a1702dee5d21ff3729626d4487a90753.png
simple
<table><tr><td>Culture medium/additives</td><td>Manufacturer</td><td>Order no.</td><td>Concentration</td></tr><tr><td>Dulbecco&#8217;s modified Eagle medium (DMEM) with l-glutamine, plus 4.5 g glucose, without NaHCO<sub>3</sub>, without Natriumpyruvate</td><td>Life Technology, Carlsbad, USA</td><td>11966-025</td><td></td></tr><tr><td>Penicillin/streptomycin</td><td>Life Technology, Carlsbad, USA</td><td>15640-055</td><td>100 IU penicillin/100 &#956;g streptomycin/ml</td></tr><tr><td>Ca<sup>2+</sup>/Mg<sup>2+</sup> free Hanks&#8217; balanced salt solution (HBSS)&#8211;buffer</td><td>Life Technology, Carlsbad, USA</td><td>14170-070</td><td></td></tr><tr><td>Fetal calf serum (FCS)</td><td>Life Technology, Carlsbad, USA</td><td>10270-098</td><td>10%</td></tr><tr><td>l-Glutamate</td><td>Life Technology, Carlsbad, USA</td><td>25030-024</td><td>1%</td></tr><tr><td>Ethylenediaminetetraacetic acid (EDTA) solution</td><td>Sigma Aldrich, St. Louis, USA</td><td>E7889</td><td>0.5 M</td></tr><tr><td>l-Ascorbic acid 2-phosphate</td><td>Sigma Aldrich, St. Louis, USA</td><td>A-8960</td><td>1 mmol/l ASC (affinity isolated antibody)</td></tr><tr><td>Dexamethasone</td><td>Serva Bioproducts, Heidelberg, Germany</td><td>18660</td><td>100 nmol/l</td></tr></table>
c2f15e66d4c8b55b19a8a4aaadfe7d5a98d8af8873e318f533f70ce5a429e73d.png
complex
<table><tr><td rowspan="2">Variable (units)</td><td>Low-salt sweat</td><td>Typical Sweat</td><td>Salty sweat</td><td rowspan="2"><i>P</i> value</td></tr><tr><td>&lt;30 mmol&#183;L<sup>&#8722;1</sup> [sweat Na<sup>+</sup>]</td><td>30&#8211;60 mmol&#183;L<sup>&#8722;1</sup> [sweat Na<sup>+</sup>]</td><td>&gt;60 mmol&#183;L<sup>&#8722;1</sup> [sweat Na<sup>+</sup>]</td></tr><tr><td>Number/Frequency</td><td>42/27 %</td><td>84/54 %</td><td>31/20 %</td><td>-</td></tr><tr><td>Men/women</td><td>37/5</td><td>73/11</td><td>31/0</td><td>0.11</td></tr><tr><td>Sweat Na<sup>+</sup> concentration (mmol&#183;l<sup>&#8722;1</sup>)</td><td>21.4 &#177; 6.4*</td><td>43.2 &#177; 8.8</td><td>71.0 &#177; 9.0*&#8224;</td><td>&lt;0.01</td></tr><tr><td>Sweat Cl<sup>&#8722;</sup> concentration (mmol&#183;l<sup>&#8722;1</sup>)</td><td>16.4 &#177; 4.3*</td><td>31.9 &#177; 9.9</td><td>54.4 &#177; 10.7*&#8224;</td><td>&lt;0.01</td></tr><tr><td>Sweat K<sup>+</sup> concentration (mmol&#183;l<sup>&#8722;1</sup>)</td><td>5.9 &#177; 0.9</td><td>5.9 &#177; 0.9</td><td>6.2 &#177; 0.6</td><td>0.26</td></tr><tr><td>Sweat osmolality (mOsm&#183;kg H<sub>2</sub>O<sup>&#8722;1</sup>)</td><td>100.8 &#177; 38.9*</td><td>150.4 &#177; 42.1</td><td>206.3 &#177; 40.3*&#8224;</td><td>&lt;0.01</td></tr><tr><td>Sweat rate (L&#183;h<sup>&#8722;1</sup>)</td><td>0.9 &#177; 0.2</td><td>0.9 &#177; 0.3</td><td>1.0 &#177; 0.2</td><td>0.76</td></tr><tr><td>Sweat NaCl loss (g L<sup>&#8722;1</sup>)</td><td>1.1 &#177; 0.3*</td><td>2.1 &#177; 0.5</td><td>3.5 &#177; 0.6*&#8224;</td><td>&lt;0.01</td></tr><tr><td>Fluid intake (L&#183;h<sup>&#8722;1</sup>)</td><td>0.32 &#177; 0.18</td><td>0.31 &#177; 0.17</td><td>0.33 &#177; 0.15</td><td>0.85</td></tr><tr><td>Na<sup>+</sup> intake (mmol)</td><td>12.3 &#177; 8.1</td><td>11.9 &#177; 9.9</td><td>14.6 &#177; 16.6</td><td>0.81</td></tr><tr><td>Cl<sup>&#8722;</sup> intake (mmol)</td><td>21.3 &#177; 13.0</td><td>20.8 &#177; 15.0</td><td>24.0 &#177; 25.0</td><td>0.72</td></tr><tr><td>K<sup>+</sup> intake (mmol)</td><td>5.1 &#177; 6.0</td><td>4.7 &#177; 7.9</td><td>6.0 &#177; 5.6</td><td>0.85</td></tr><tr><td>Running pace (m&#183;s<sup>&#8722;1</sup>)</td><td>3.0 &#177; 0.4</td><td>3.1 &#177; 0.5</td><td>3.2 &#177; 0.5</td><td>0.18</td></tr><tr><td>Average training distance&#183;week<sup>&#8722;1</sup> (km)</td><td>65.1 &#177; 32.0</td><td>60.5 &#177; 26.7</td><td>64.2 &#177; 24.1</td><td>0.65</td></tr></table>
489205ff846c7fc3e08084f7c6bfd9c8160153cc995ab8cc23412029b091cef6.png
complex
<table><tr><td>Explanatory variable</td><td>Unadjusted OR (95% CI)</td><td>Adjusted OR (95% CI)</td><td>p-value</td></tr><tr><td colspan="4">Age</td></tr><tr><td> 18-24</td><td>1.0</td><td>1.00</td><td> </td></tr><tr><td> 25-30</td><td>0.50 (0.30 - 0.84)<sup>*</sup></td><td>0.89 (0.54 - 1.27)</td><td>0.45</td></tr><tr><td> 31-40</td><td>0.80 (0.39 - 1.62)</td><td>1.02 (0.72 - 1.43)</td><td>0.87</td></tr><tr><td>&gt; 40</td><td>1.05 (0.30 - 3.71)</td><td>0.56 (0.30 - 1.03)</td><td>0.07</td></tr><tr><td colspan="4">Sex</td></tr><tr><td> Male</td><td>1</td><td>1.00</td><td> </td></tr><tr><td> Female</td><td>0.75 (0.46 - 1.23)</td><td>0.71 (0.42 - 1.23)</td><td>0.23</td></tr><tr><td colspan="4">Married</td></tr><tr><td> No</td><td>1</td><td>1.00</td><td> </td></tr><tr><td> Yes</td><td>9.15 (4.82 - 17.38)<sup>*</sup></td><td>2.15 (1.44 - 3.06)</td><td>0.04*</td></tr><tr><td colspan="4">Education</td></tr><tr><td> Certificate</td><td>8.47 (3.57 - 20.11)<sup>*</sup></td><td>1.45 (1.04 - 1.99)</td><td>0.04*</td></tr><tr><td> Diploma</td><td>4.99 (1.94 - 12.84)<sup>*</sup></td><td>2.06 (1.20 - 3.56)</td><td>0.01*</td></tr><tr><td> Degree</td><td>1</td><td>1</td><td> </td></tr><tr><td colspan="4">Religion</td></tr><tr><td> Muslim</td><td>1</td><td>1.00</td><td> </td></tr><tr><td> Christian</td><td>0.65 (0.41 - 1.03)</td><td>0.86 (0.54 - 1.37)</td><td>0.54</td></tr><tr><td> Others</td><td>0.76 (0.34 - 1.66)</td><td>0.84 (0.59 - 1.23)</td><td>0.37</td></tr><tr><td colspan="4">Profession</td></tr><tr><td> Health extension workers</td><td>2.67 (1.57 - 4.55)<sup>*</sup></td><td>2.49 (1.43 - 4.35)</td><td>0.01*</td></tr><tr><td> Health assistants</td><td>2.20 (0.80 - 6.10)</td><td>0.86 (0.61 - 1.23)</td><td>0.37</td></tr><tr><td> Health Officers</td><td>0.88 (0.23 - 3.31)</td><td>1.68 (1.04 - 2.67)</td><td>0.04*</td></tr><tr><td> Nurses</td><td>1</td><td>1</td><td> </td></tr><tr><td colspan="4">Specific training on RH services</td></tr><tr><td> Yes</td><td>1.00</td><td>1.00</td><td> </td></tr><tr><td> No</td><td>4.17 (2.60 - 6.71)<sup>*</sup></td><td>5.27 (1.51 - 5. 89)</td><td>0.01*</td></tr><tr><td colspan="4">Service time in years</td></tr><tr><td>&lt; 10</td><td>1.00</td><td>1.00</td><td> </td></tr><tr><td> 10-20</td><td>2.49 (1.38 - 4.47)<sup>*</sup></td><td>1.07 (1.10- 1.45)</td><td>0.08</td></tr><tr><td>&gt; 20</td><td>3.35 (0.88 - 12.74)</td><td>0.77 (0.50 - 1.10)</td><td>0.28</td></tr><tr><td colspan="4">Involvement in RH provision</td></tr><tr><td> Yes</td><td>1.00</td><td>1.00</td><td> </td></tr><tr><td> No</td><td>1.03 (0.72 - 2.36)</td><td>1.09 (0.79 - 1.47)</td><td>0.67</td></tr><tr><td colspan="4">Family planning utilization status</td></tr><tr><td> Yes</td><td>1.00</td><td>1.00</td><td> </td></tr><tr><td> No</td><td>2.18 (1.38 - 3.44)<sup>*</sup></td><td>1.77 (1.05 - 2.77)</td><td>0.03*</td></tr></table>
2e2a903cece84e7c0cebc2b3447b7f9cc3cc6f1aa531b0dd0624d5ca658f95cf.png
complex
<table><tr><td colspan="2">Fold enrichment (<i>P</i> value)</td><td>&#8593; in Dupl5q cortex</td><td>&#8595; in Dupl5q cortex</td><td>&#8593; In idiopathic ASD cortex</td><td>&#8595; In idiopathic ASD cortex</td></tr><tr><td rowspan="2">All genes</td><td>&#8593; 1500 in DPSC neurons</td><td>1.41(le-6)</td><td>1.06(0.5)</td><td>1.25(0.05)</td><td>1.14(0.3)</td></tr><tr><td>&#8595; 1500 in DPSC neurons</td><td>0.87(0.1)</td><td>0.95(0.6)</td><td>0.97(0.8)</td><td>1.07(0&#8211;6)</td></tr><tr><td rowspan="2">All genes except 15qll-13 genes</td><td>&#8593; 1500 in DPSC neurons</td><td>1.37(le-5)</td><td>1.07(0.4)</td><td>1.26(0.04)</td><td>1.09(0.5)</td></tr><tr><td>&#8595; 1500 in DPSC neurons</td><td>0.88(0.1)</td><td>0.95(0.6)</td><td>0.96(0.8)</td><td>1.08(0.5)</td></tr></table>
0ada91bb78e099698a364d9f5a924d323ee65e13d8a1c31c90136d98c3ac07a2.png
complex
<table><tr><td rowspan="2">Cytological findings</td><td colspan="9">Final histological diagnosis</td></tr><tr><td>SQC</td><td>SCLC</td><td>ADC</td><td>ADC/SQC</td><td>LC/LNC</td><td>Carcinoid</td><td>Other</td><td>Benign</td><td>Total</td></tr><tr><td>SQC</td><td>47</td><td>0</td><td>9</td><td>1</td><td>6</td><td>0</td><td>0</td><td>0</td><td>63</td></tr><tr><td>SCLC</td><td>0</td><td>3</td><td>1</td><td>0</td><td>3</td><td>0</td><td>0</td><td>0</td><td>7</td></tr><tr><td>ADC</td><td>1</td><td>0</td><td>107</td><td>1</td><td>3</td><td>0</td><td>0</td><td>0</td><td>112</td></tr><tr><td>LC/LNC</td><td>0</td><td>0</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td><td>2</td></tr><tr><td>Carcinoid</td><td>0</td><td>0</td><td>3</td><td>0</td><td>1</td><td>13</td><td>0</td><td>0</td><td>17</td></tr><tr><td>Other</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td>Susp.</td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td>Benign</td><td>6</td><td>0</td><td>14</td><td>1</td><td>5</td><td>2</td><td>0</td><td>84</td><td>112</td></tr><tr><td>Total</td><td>54</td><td>3</td><td>136</td><td>3</td><td>20</td><td>15</td><td>0</td><td>84</td><td>315</td></tr></table>
2b6c6ba9d41e1155c87e5e669e3d8d74d698a83508e1a502aa13f8fba6009fe3.png
simple
<table><tr><td>Characteristic</td><td>CTRL</td><td>MUSIC</td><td><i>P</i></td></tr><tr><td>No. of subjects</td><td>11 (4 Lethbridge)</td><td>11 (3 Lethbridge)</td><td></td></tr><tr><td>Sex (M/F)</td><td>5/6</td><td>6/5</td><td>.67</td></tr><tr><td>Age (yrs)</td><td>67.0 (8.1)</td><td>64.1 (4.2)</td><td>.33</td></tr><tr><td>Disease duration (yrs)</td><td>4.5 (3.3)</td><td>6.4 (4.2)</td><td>.23</td></tr><tr><td>MMSE</td><td>28.4 (1.8)</td><td>29.3 (1.3)</td><td>.20</td></tr><tr><td>Hoehn and Yahr</td><td>2.1 (0.4)</td><td>2.3 (0.4)</td><td>.43</td></tr><tr><td>Baecke score</td><td>10.2 (4.8)</td><td>8.9 (3.8)</td><td>.48</td></tr><tr><td>UPDRS (III) score</td><td>20.4 (5.0)</td><td>25.5 (9.3)</td><td>.13</td></tr></table>
f772e58a155211afcdb4f30d3b0e54f05dd5547edbb70dc5081ed02b4868780e.png
simple
<table><tr><td> </td><td>Males</td><td>Females</td></tr><tr><td>Age (years)</td><td>55 &#177; 10</td><td>55 &#177; 11</td></tr><tr><td>Stature (cm)</td><td>177.6 &#177; 5.5</td><td>167.4 &#177; 5.8</td></tr><tr><td>Body mass (kg)</td><td>85.92 &#177; 12.50</td><td>71.43 &#177; 13.56</td></tr><tr><td>BMI</td><td>27.54 &#177; 4.11</td><td>25.63 &#177; 5.50</td></tr></table>
e233231bd7cad2aaa2436b068a7ebaf9b8e5cca68d65dbf654c8e28358858a76.png
simple
<table><tr><td>Parameter</td><td><i>n</i>* (%)</td></tr><tr><td>Gender </td><td>86</td></tr><tr><td> Male</td><td>42 (48.8)</td></tr><tr><td> Female</td><td>44 (51.2)</td></tr><tr><td>Age</td><td>86</td></tr><tr><td> Range, 13.5&#8211;85.4 years</td><td>&#8212;</td></tr><tr><td> Mean, 55.0 years</td><td>&#8212;</td></tr><tr><td> Median, 57.2 years</td><td>&#8212;</td></tr><tr><td>Tumor size</td><td>78</td></tr><tr><td> Range, 2.0&#8211;8.5 cm</td><td>&#8212;</td></tr><tr><td> Mean, 4.9 cm</td><td>&#8212;</td></tr><tr><td> Median, 5.0 cm</td><td>&#8212;</td></tr><tr><td>Tumor location</td><td>86</td></tr><tr><td> Parasagittal-falcine</td><td>26 (30.2)</td></tr><tr><td> Convexity</td><td>35 (40.7)</td></tr><tr><td> Base</td><td>24 (27.9)</td></tr><tr><td> Frontal/frontobasal</td><td>16 (18.6)</td></tr><tr><td>Tumor site</td><td>86</td></tr><tr><td> Left</td><td>37</td></tr><tr><td> Right</td><td>31</td></tr><tr><td> Bilateral</td><td>18</td></tr><tr><td>Duration of signs/symptoms</td><td>80</td></tr><tr><td> Range, 0&#8211;36 months</td><td>&#8212;</td></tr><tr><td> Mean, 7.5 months</td><td>&#8212;</td></tr><tr><td> Median, 4.0 months</td><td>&#8212;</td></tr><tr><td>Presenting signs/symptoms</td><td>83</td></tr><tr><td> Headache</td><td>23 (25.9)</td></tr><tr><td> Hemiparesis</td><td>22 (36.6)</td></tr><tr><td> Seizures</td><td>20 (24.7)</td></tr><tr><td> Behavior changes</td><td>12 (14)</td></tr><tr><td> Cranial nerve palsy </td><td>6 (11.1)</td></tr><tr><td>Behavior changes</td><td>83</td></tr><tr><td> Present</td><td>30 (36.1)</td></tr><tr><td> Absent</td><td>53 (73.9)</td></tr><tr><td>Edema</td><td>58</td></tr><tr><td> Absent</td><td>10 (17.2)</td></tr><tr><td> Mild </td><td>31 (53.4)</td></tr><tr><td> Severe</td><td>17 (29.3)</td></tr><tr><td>Cleavability</td><td>42 </td></tr><tr><td> Cleavable </td><td>18 (42.9)</td></tr><tr><td> Noncleavable</td><td>24 (57.1)</td></tr></table>
f23db6af41004ab85a65c183dd345b95ad25b7d95971f1abf3872897c6365c2e.png
simple
<table><tr><td>SNP</td><td>Chr</td><td>Position</td><td>Related gene</td><td>Minor allele</td><td>MAF in telomere GWAS [13]</td><td>MAF in our data</td><td>Average imputation R-square<sup>1</sup></td><td>Melanoma beta<sup>2</sup></td><td>Melanoma <i>P</i> value<sup>2</sup></td><td>Nevus count beta</td><td>Nevus count <i>P</i> value</td></tr><tr><td>rs10936599</td><td>3</td><td>169492101</td><td><i>TERC</i></td><td>T</td><td>0.252</td><td>0.241</td><td>0.993</td><td>&#8722;0.079</td><td>0.0003</td><td>&#8722;0.020</td><td>0.48</td></tr><tr><td>rs2736100</td><td>5</td><td>1286516</td><td><i>TERT</i></td><td>C</td><td>0.486</td><td>0.506</td><td>0.988</td><td>0.078</td><td>0.02</td><td>&#8722;0.043</td><td>0.08</td></tr><tr><td>rs7675998</td><td>4</td><td>164007820</td><td><i>NAF1</i></td><td>A</td><td>0.217</td><td>0.222</td><td>0.988</td><td>&#8722;0.063</td><td>0.03</td><td>&#8722;0.036</td><td>0.22</td></tr><tr><td>rs9420907</td><td>10</td><td>105676465</td><td><i>OBFC1</i></td><td>C</td><td>0.135</td><td>0.142</td><td>1.000</td><td>0.083</td><td>0.001</td><td>0.051</td><td>0.14</td></tr><tr><td>rs8105767</td><td>19</td><td>22215441</td><td><i>ZNF208</i></td><td>G</td><td>0.291</td><td>0.290</td><td>0.996</td><td>0.028</td><td>0.16</td><td>0.025</td><td>0.34</td></tr><tr><td>rs755017</td><td>20</td><td>62421622</td><td><i>RTEL1</i></td><td>G</td><td>0.131</td><td>0.123</td><td>0.952</td><td>0.026</td><td>0.35</td><td>0.004</td><td>0.92</td></tr><tr><td>rs11125529</td><td>2</td><td>54475866</td><td><i>ACYP2</i></td><td>A</td><td>0.142</td><td>0.134</td><td>0.999</td><td>&#8722;0.004</td><td>0.86</td><td>0.020</td><td>0.56</td></tr></table>
3985bb925faaf79dd880fdcfa7cfd2f8cd79a70d9babbc254b7bb00945d5e0b4.png
simple
<table><tr><td>Antibody</td><td>Staining pattern</td><td>Clone</td><td>Antigen retrieval</td><td>Dilution</td><td>Source</td><td>Interobserver variability (kappa)</td></tr><tr><td>ER</td><td>Nuclear</td><td>SP1</td><td>EDTA pH 9</td><td>1:80</td><td>Immunologic</td><td>0.959</td></tr><tr><td>PR</td><td>Nuclear</td><td>PgR636</td><td>EDTA pH 9</td><td>1:500</td><td>Dako</td><td>0.961</td></tr><tr><td>MLH1</td><td>Nuclear</td><td>G168-15</td><td>EDTA pH 9</td><td>1:40</td><td>BD</td><td>0.894</td></tr><tr><td>PMS2</td><td>Nuclear</td><td>A16-4</td><td>EDTA pH 9</td><td>1:100</td><td>BD</td><td>0.800</td></tr><tr><td>MSH2</td><td>Nuclear</td><td>GB12</td><td>EDTA pH 9</td><td>1:20</td><td>Calbiochem</td><td>0.848</td></tr><tr><td>MSH6</td><td>Nuclear</td><td>EPR3945</td><td>EDTA pH 9</td><td>1:1000</td><td>Abcam</td><td>0.763</td></tr><tr><td>PTEN</td><td>Nuclear and cytoplasmic</td><td>6H2.1</td><td>EDTA pH 9</td><td>1:100</td><td>Dako</td><td>0.724</td></tr><tr><td>IMP3</td><td>Cytoplasmic</td><td>69.1</td><td>EDTA pH 9</td><td>1:50</td><td>Dako</td><td>0.912</td></tr><tr><td>&#946;-Catenin</td><td>Membranous and cytoplasmic</td><td>14/&#946;-catenin</td><td>EDTA pH 9</td><td>1:200</td><td>BD</td><td>0.911</td></tr><tr><td>L1CAM</td><td>Membranous</td><td>14.10</td><td>EDTA pH 9</td><td>1:100</td><td>BioLegend</td><td>0.921</td></tr><tr><td>Ki-67</td><td>Nuclear</td><td>MIB-1</td><td>Citrate pH 6.0</td><td>1:40</td><td>Dako</td><td>0.998</td></tr><tr><td>ARID1A</td><td>Nuclear</td><td>HPA005456</td><td>Citrate pH 6.0</td><td>1:100</td><td>Sigma</td><td>0.796</td></tr><tr><td>Stathmin</td><td>Cytoplasmic</td><td>3351</td><td>Citrate pH 6.0</td><td>1:50</td><td>Cell Signaling</td><td>0.824</td></tr><tr><td>P53</td><td>Nuclear</td><td>DO-7</td><td>Citrate pH 6.7</td><td>1:200</td><td>Immunologic</td><td>0.901</td></tr><tr><td>P16</td><td>Nuclear and cytoplasmic</td><td>MX007</td><td>HIER pH 8.0</td><td>1:60</td><td>Immunologic</td><td>0.779</td></tr></table>
b87370bf4e9ba5dd421be2df6165f6614df394bb4ca59296f87d537a4b0767df.png
simple
<table><tr><td>Source</td><td>Average degree</td><td>Average distance</td><td>Clustering coefficient</td><td>Diameter</td></tr><tr><td>Figure 4 (NESG IDs)</td><td>19</td><td>2.7</td><td>0.43</td><td>6</td></tr><tr><td>Figure 4 (JCSG IDs)</td><td>45</td><td>1.5</td><td>0.46</td><td>3</td></tr><tr><td>Figure 4 (TB IDs)</td><td>6.7</td><td>2.0</td><td>0.46</td><td>4</td></tr><tr><td>Figure 5a (DNA pol IDs)</td><td>15</td><td>3.1</td><td>0.44</td><td>7</td></tr><tr><td>Figure 5b (RNA pol IDs)</td><td>13</td><td>3.1</td><td>0.44</td><td>7</td></tr><tr><td>Figure 6a (PSI IDs)</td><td>24</td><td>2.6</td><td>0.37</td><td>7</td></tr><tr><td>Figure 6b (PDB IDs 1)</td><td>6.1</td><td>3.9</td><td>0.31</td><td>9</td></tr><tr><td>Figure 6b (PDB IDs 2)</td><td>6.7</td><td>3.8</td><td>0.33</td><td>10</td></tr></table>
3eab2bdd222c486b84bb6504816bf652e70976fb137d0b4f6e8973b48f016e47.png
complex
<table><tr><td></td><td colspan="9">Path coefficient</td></tr><tr><td></td><td colspan="3">To HOMA-IR</td><td colspan="3">To leptin</td><td colspan="3">To BMI</td></tr><tr><td></td><td><i>b</i></td><td>SE</td><td>&#946;</td><td><i>b</i></td><td>SE</td><td>&#946;</td><td><i>b</i></td><td>SE</td><td>&#946;</td></tr><tr><td>Left VS</td><td>4.54</td><td>1.38</td><td>0.62**</td><td>0.50</td><td>9.63</td><td>0.01</td><td>14.28</td><td>9.97</td><td>0.31</td></tr><tr><td>HOMA-IR</td><td></td><td></td><td></td><td>3.67</td><td>1.35</td><td>0.67*</td><td>&#8722;1.42</td><td>1.7</td><td>&#8722;0.23</td></tr><tr><td>Leptin</td><td></td><td></td><td></td><td></td><td></td><td></td><td>0.82</td><td>0.27</td><td>0.72**</td></tr><tr><td>Total</td><td></td><td></td><td></td><td></td><td></td><td></td><td>21.96</td><td>9.58</td><td>0.48*</td></tr></table>
3ce33e6dc5c4e77b65fea214ce50d32d1a91adfd85081165ce316b75b6b4542f.png
complex
<table><tr><td></td><td></td><td>Meters above sea level (masl)<sup>c</sup></td><td></td><td>Mean annual temperature(matp)<sup>d</sup></td><td>Mean annualrainfall (mar)<sup>e</sup></td><td>Buffaloes tested</td><td colspan="2">Seropositivity to<i>T. gondii</i></td></tr><tr><td>Region<sup>a</sup></td><td colspan="2">Municipality<sup>b</sup></td><td colspan="3">Climate</td><td>No.</td><td>No.</td><td>%</td></tr><tr><td>Olmeca</td><td>Las Choapas</td><td>10</td><td>Warm</td><td>27.0&#176;C</td><td>2900 mm</td><td>58</td><td>21</td><td>36.2</td></tr><tr><td></td><td>Sayula de Alema&#769;n</td><td>80</td><td>Warm</td><td>27.0&#176;C</td><td>1650 mm</td><td>156</td><td>93</td><td>59.6</td></tr><tr><td></td><td>All</td><td></td><td></td><td></td><td></td><td>214</td><td>114</td><td>53.3</td></tr><tr><td>Papaloapan</td><td>Isla</td><td>60</td><td>Warm-humid</td><td>24.9&#176;C</td><td>2316 mm</td><td>59</td><td>23</td><td>39.0</td></tr><tr><td></td><td>J. Rodriguez Clara</td><td>95</td><td>Warm</td><td>25.0&#176;C</td><td>1266 mm</td><td>66</td><td>28</td><td>42.4</td></tr><tr><td></td><td>All</td><td></td><td></td><td></td><td></td><td>125</td><td>51</td><td>40.8</td></tr><tr><td>All</td><td></td><td></td><td></td><td></td><td></td><td>339</td><td>165</td><td>48.7</td></tr></table>
b5070c7cc33304bcf7037992e1cb9a58d0f21420e57bab1b045f26cca06f248b.png
complex
<table><tr><td colspan="4">Cell line</td></tr><tr><td><i>In vitro</i></td><td>Single BR (&#956;g/ml)</td><td>Single NAC (mM)</td><td>Combination (BR + NAC)</td></tr><tr><td>LS174T</td><td>20, 50</td><td>5, 10</td><td>20 + 5, 20 + 10, 50 + 5, 50 + 10</td></tr><tr><td>MKN45</td><td>100, 200</td><td>5, 10</td><td>100 + 5, 100 + 10, 200 + 5, 200 + 10</td></tr><tr><td>KATOIII</td><td>50, 100</td><td>50, 100</td><td>50 + 50, 50 + 100, 100 + 50, 100 + 100</td></tr><tr><td><i>In Vivo</i></td><td>Single BR (mg/kg)</td><td>Single NAC (mg/kg)</td><td>Combination (BR+NAC)</td></tr><tr><td>LS174T</td><td>3, 6</td><td>300, 500</td><td>3 + 300, 3 + 500, 6 + 300, 6 + 500</td></tr><tr><td>MKN45</td><td>3, 6</td><td>300, 500</td><td>3 + 300, 3 + 500, 6 + 300, 6 + 500</td></tr></table>
266aca250b3cef77961cbd06a763687b2403b37e75962a6cf12f4a1b588a6edc.png
complex
<table><tr><td rowspan="2"></td><td colspan="2">Young-old</td><td colspan="2">Old-old</td></tr><tr><td>Incidence rate</td><td>95% CI</td><td>Incidence rate</td><td>95% CI</td></tr><tr><td colspan="5">Sex</td></tr><tr><td> Male</td><td>9.3</td><td>8.3&#8211;10.4</td><td>36.2</td><td>32.8&#8211;39.9</td></tr><tr><td> Female</td><td>9.3</td><td>8.4&#8211;10.5</td><td>43.9</td><td>40.7&#8211;47.4</td></tr><tr><td colspan="5">Age</td></tr><tr><td> 65&#8211;69</td><td>5.5</td><td>4.8&#8211;6.4</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td> 70&#8211;74</td><td>14.3</td><td>13.0&#8211;15.8</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td> 75&#8211;79</td><td>&#8211;</td><td>&#8211;</td><td>31.3</td><td>28.8&#8211;34.1</td></tr><tr><td> 80&#8211;84</td><td>&#8211;</td><td>&#8211;</td><td>51.5</td><td>46.3&#8211;57.3</td></tr><tr><td>&#8805; 85</td><td>&#8211;</td><td>&#8211;</td><td>83.3</td><td>71.8&#8211;96.8</td></tr><tr><td colspan="5">Educational attainment</td></tr><tr><td>&lt; 10 yrs</td><td>10.2</td><td>9.2&#8211;11.3</td><td>42.6</td><td>39.4&#8211;45.9</td></tr><tr><td>&#8805; 10 yrs</td><td>8.9</td><td>7.8&#8211;10.1</td><td>36.2</td><td>32.6&#8211;40.1</td></tr></table>
6ad6c34a01639f159b4c2e778c99abda0ad2506ee2ad8477c85b1d7a4833251f.png
simple
<table><tr><td></td><td>Lattice IV: Orthorhombic <i>P</i></td><td>Lattice V: Hexagonal <i>P</i></td></tr><tr><td></td><td>Cell 4</td><td>Cell 5</td></tr><tr><td><i>a</i>(A&#778;)</td><td> 5.0</td><td> 10.0</td></tr><tr><td><i>b</i>(A&#778;)</td><td> 6.123724</td><td> 10.0</td></tr><tr><td><i>c</i>(A&#778;)</td><td> 8.660254</td><td> 6.123724</td></tr><tr><td><i>&#945;</i> (&#176;)</td><td> 90.0</td><td> 90.0</td></tr><tr><td><i>&#946;</i> (&#176;)</td><td> 90.0</td><td> 90.0</td></tr><tr><td><i>&#947;</i> (&#176;)</td><td> 90.0</td><td> 120.0</td></tr><tr><td><i>V</i>(A&#778;<sup>3</sup>)</td><td> 265.17</td><td> 530.33</td></tr><tr><td><i>c/a</i></td><td> 1.7320</td><td> 0.6124</td></tr><tr><td><i>c/b</i></td><td> 1.4142</td><td></td></tr></table>
e56d805dd4114858d2fe714dd2f35642073d9f61207ce84d9d7fadd8e65e2826.png
simple
<table><tr><td> </td><td>Vegetarian (n = 44) % (n)</td><td>Omnivorous (n = 44) % (n)</td><td>p</td></tr><tr><td>MSyn</td><td>15.9 (7)</td><td>52.3 (23)</td><td>&lt; 0.001</td></tr><tr><td>WC (&#8805; 90 cm)</td><td>20.5 (9)</td><td>63.6 (28)</td><td>&lt; 0.001</td></tr><tr><td>SBP (&#8805; 130 mm Hg)</td><td>22.7 (10)</td><td>45.5 (20)</td><td>0.025</td></tr><tr><td>DBP (&#8805; 85 mm Hg)</td><td>13.6 (6)</td><td>40.9 (18)</td><td>0.004</td></tr><tr><td>TG (&#8805; 150 mg/dL)</td><td>25.0 (11)</td><td>45.5 (20)</td><td>0.045</td></tr><tr><td>HDL-c (&lt; 40 mg/dL)</td><td>22.7 (10)</td><td>36.4 (16)</td><td>0.16</td></tr><tr><td>FSG (&#8805; 100 mg/dL)</td><td>27.3 (12)</td><td>63.6 (28)</td><td>0.001</td></tr></table>
7c8bd779ce36ab3bade6ac315ea71201c8c1139abe4215a0c50875ea4d2ffc86.png
simple
<table><tr><td> </td><td>Total (n = 355)</td><td>Odds ratio (95% confidential interval)</td><td>P-Value</td></tr><tr><td>Age (years)</td><td> </td><td> </td><td> </td></tr><tr><td>&lt;=20</td><td>83</td><td>1.00</td><td> </td></tr><tr><td>21-40</td><td>142</td><td>6.226 (0.88, 44.14)</td><td>0.067</td></tr><tr><td>41-60</td><td>99</td><td>6.960 (1.39, 34.79)</td><td>0.018</td></tr><tr><td>60+</td><td>31</td><td>4.505 (0.91, 22.30)</td><td>0.065</td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td></tr><tr><td>Male</td><td>192</td><td>1.00</td><td> </td></tr><tr><td>Female</td><td>163</td><td>1.09 (0.45, 2.66)</td><td>0.835</td></tr><tr><td>Education</td><td> </td><td> </td><td> </td></tr><tr><td>Higher secondary</td><td>164</td><td>1.00</td><td> </td></tr><tr><td>Degree-PG</td><td>191</td><td>0.846 (0.34, 2.12)</td><td>0.721</td></tr><tr><td>Geographic location</td><td> </td><td> </td><td> </td></tr><tr><td>Rural</td><td>249</td><td>1.00</td><td> </td></tr><tr><td>Urban</td><td>106</td><td>1.399 (0.68, 2.87)</td><td>0.36</td></tr><tr><td>Stakeholders</td><td> </td><td> </td><td> </td></tr><tr><td>Students</td><td>124</td><td>1.00</td><td> </td></tr><tr><td>Teachers</td><td>105</td><td>0.577 (0.11, 3.07)</td><td>0.519</td></tr><tr><td>Persons engaged in social service</td><td>76</td><td>0.160 (0.05, 0.53)</td><td>0.003</td></tr><tr><td>Kin of the family members</td><td>50</td><td>1.301 (0.26, 6.48)</td><td>0.748</td></tr></table>
4902ba27d548c89ee2238eab77b3225bc19b09272b9f442865598baf3e097f95.png
complex
<table><tr><td rowspan="2">Experiment <sup>a</sup></td><td colspan="3">Coded Values <sup>b</sup></td><td colspan="3">Planned Values <sup>c</sup></td></tr><tr><td><i>t</i></td><td><i>V</i></td><td><i>H</i></td><td>Agitation Time (min)</td><td>ACN (mL)</td><td>Homogenization Time (s)</td></tr><tr><td>1</td><td>1</td><td>0</td><td>0</td><td>30</td><td>10.5</td><td>10.0</td></tr><tr><td>2</td><td>0.5</td><td>0.866</td><td>0</td><td>25</td><td>13.5</td><td>10.0</td></tr><tr><td>3</td><td>0.5</td><td>0.289</td><td>0.817</td><td>25</td><td>11.5</td><td>14.4</td></tr><tr><td>4</td><td>&#8722;1</td><td>0</td><td>0</td><td>10</td><td>10.5</td><td>10.0</td></tr><tr><td>5</td><td>&#8722;0.5</td><td>&#8722;0.866</td><td>0</td><td>15</td><td>7.5</td><td>10.0</td></tr><tr><td>6</td><td>&#8722;0.5</td><td>&#8722;0.289</td><td>&#8722;0.817</td><td>15</td><td>9.5</td><td>5.6</td></tr><tr><td>7</td><td>0.5</td><td>&#8722;0.866</td><td>0</td><td>25</td><td>7.5</td><td>10.0</td></tr><tr><td>8</td><td>0.5</td><td>&#8722;0.289</td><td>&#8722;0.817</td><td>25</td><td>9.5</td><td>5.6</td></tr><tr><td>9</td><td>&#8722;0,5</td><td>0.866</td><td>0</td><td>15</td><td>13.5</td><td>10.0</td></tr><tr><td>10</td><td>0</td><td>0.577</td><td>&#8722;0.817</td><td>20</td><td>12.5</td><td>5.6</td></tr><tr><td>11</td><td>&#8722;0.5</td><td>0.289</td><td>0.817</td><td>15</td><td>11.5</td><td>14.4</td></tr><tr><td>12</td><td>0</td><td>&#8722;0.577</td><td>0.817</td><td>20</td><td>8.5</td><td>14.4</td></tr><tr><td>13</td><td>0</td><td>0</td><td>0</td><td>20</td><td>10.5</td><td>10.0</td></tr><tr><td>14</td><td>0</td><td>0</td><td>0</td><td>20</td><td>10.5</td><td>10.0</td></tr><tr><td>15</td><td>0</td><td>0</td><td>0</td><td>20</td><td>10.5</td><td>10.0</td></tr></table>
91906da148f35d264576e06c496cb489ded980789932041cdd9fe0fa3f2017a1.png
complex
<table><tr><td> </td><td>Nondiabetics</td><td>Diabetics</td><td>Univariate (<i>P</i>)</td></tr><tr><td>Median age (Years)</td><td>48.0</td><td>52.5</td><td>0.207</td></tr><tr><td>T </td><td> </td><td> </td><td> </td></tr><tr><td> 1</td><td>27 (12%) </td><td>4 (9%) </td><td rowspan="4">0.684</td></tr><tr><td> 2</td><td>77 (34%) </td><td>12 (29%) </td></tr><tr><td> 3</td><td>54 (24%) </td><td>14 (35%) </td></tr><tr><td> 4</td><td>67 (30%)</td><td>10 (27%)</td></tr><tr><td>N </td><td> </td><td> </td><td> </td></tr><tr><td> 0</td><td>41 (18%) </td><td>9 (23%) </td><td rowspan="4">0.695</td></tr><tr><td> 1</td><td>95 (42%) </td><td>14 (34%) </td></tr><tr><td> 2</td><td>56 (25%) </td><td>8 (20%) </td></tr><tr><td> 3</td><td>33 (15%)</td><td>9 (23%)</td></tr><tr><td>Grade </td><td> </td><td> </td><td> </td></tr><tr><td> 1</td><td>29 (13%) </td><td>7 (18%) </td><td rowspan="3">0.087</td></tr><tr><td> 2</td><td>81 (36%) </td><td>20 (49%) </td></tr><tr><td> 3</td><td>115 (51%)</td><td>13 (33%)</td></tr><tr><td>Hormone receptor </td><td> </td><td> </td><td> </td></tr><tr><td> Positive</td><td>112 (49%) </td><td>28 (70%) </td><td rowspan="2">0.018</td></tr><tr><td> Negative</td><td>113 (51%)</td><td>12 (30%)</td></tr><tr><td>HER2 </td><td> </td><td> </td><td> </td></tr><tr><td>Positive </td><td>60 (27%) </td><td>5 (13%) </td><td rowspan="2">0.079</td></tr><tr><td>Negative</td><td>165 (73%)</td><td>35 (87%)</td></tr><tr><td>Triple-negative </td><td> </td><td> </td><td> </td></tr><tr><td>Positive </td><td>59 (26%) </td><td>7 (18%) </td><td rowspan="2">0.262</td></tr><tr><td>Negative</td><td>166 (74%)</td><td>33 (82%)</td></tr><tr><td>Metastatic site </td><td> </td><td> </td><td> </td></tr><tr><td>Single </td><td>122 (54%) </td><td>18 (45%) </td><td rowspan="2">0.306</td></tr><tr><td>Multiple</td><td>103 (46%)</td><td>22 (55%)</td></tr><tr><td>Type of metastases </td><td> </td><td> </td><td> </td></tr><tr><td>Nonvisceral </td><td>86 (38%) </td><td>16 (40%) </td><td rowspan="2">0.790</td></tr><tr><td>Visceral</td><td>139 (62%)</td><td>24 (60%)</td></tr><tr><td>Median BMI at recurrence</td><td>26.8</td><td>27.5</td><td>0.359</td></tr></table>
e90835802c6b7f3cbd82703347d6f81a0ddf91d96c8388e0513daa6a5b93b342.png
complex
<table><tr><td></td><td colspan="3">RATER 1</td><td colspan="3">RATER 2</td><td colspan="3">RATER 3</td></tr><tr><td></td><td>BIAS</td><td>SD</td><td>95% LA</td><td>BIAS</td><td>SD</td><td>95% LA</td><td>BIAS</td><td>SD</td><td>95% LA</td></tr><tr><td>Weight Bearing Arch Height</td><td>-0.09</td><td>0.24</td><td>-0.57 &#8211; 0.39</td><td>0.02</td><td>0.17</td><td>-0.31 &#8211; 0.35</td><td>-0.08</td><td>0.13</td><td>-0.33 &#8211; 0.18</td></tr><tr><td>Weight Bearing Foot Length</td><td>0.03</td><td>0.76</td><td>-1.46 &#8211; 1.52</td><td>-0.01</td><td>0.25</td><td>-0.51 &#8211; 0.48</td><td>-0.00</td><td>0.08</td><td>-0.16 &#8211; 0.16</td></tr><tr><td>Non-Weight Bearing Arch Height</td><td>0.07</td><td>0.20</td><td>-0.32 &#8211; 0.46</td><td>0.03</td><td>0.30</td><td>-0.56 &#8211; 0.62</td><td>0.21</td><td>0.33</td><td>-0.44 &#8211; 0.86</td></tr><tr><td>Non-WeightBearing FootLength</td><td>-0.03</td><td>0.19</td><td>-0.40 &#8211; 0.34</td><td>-0.05</td><td>0.20</td><td>-0.43 &#8211; 0.33</td><td>0.11</td><td>0.20</td><td>-0.29 &#8211; 0.51</td></tr><tr><td>AH Difference</td><td>0.16</td><td>0.28</td><td>-0.38 &#8211; 0.70</td><td>0.01</td><td>0.37</td><td>-0.71 &#8211; 0.73</td><td>0.29</td><td>0.40</td><td>-0.49 &#8211; 1.07</td></tr></table>
4720886f9d9fdc0642181c9d68673c63d1d38b1c3f219192148d0ee08be48a92.png
complex
<table><tr><td rowspan="2">Criterion</td><td>Duration of symptoms</td><td></td><td rowspan="2">Significance (<i>P</i>)</td></tr><tr><td>&#8804;48 months</td><td>&gt;48 months</td></tr><tr><td>Age</td><td>39.22 &#177; 12.39</td><td>27.78 &#177; 6.732</td><td>0.0638*</td></tr><tr><td>Gender (f/m)</td><td>3/8</td><td>3/1</td><td>0.7552<sup>#</sup></td></tr><tr><td>ICRS score</td><td>3.43 &#177; 0.53</td><td>3.62 &#177; 0.52</td><td>0.4623*</td></tr><tr><td>Defect size</td><td>3.68 &#177; 1.34</td><td>3.97 &#177; 1.67</td><td>0.4437*</td></tr><tr><td>KOSS (MRI)</td><td>5.86 &#177; 1.57</td><td>8.25 &#177; 1.98</td><td>0.0202*</td></tr><tr><td>Henderson score</td><td>2.00 &#177; 0.82</td><td>2.87 &#177; 1.36</td><td>0.1697*</td></tr><tr><td>Kellgren-Lawrence score</td><td>1.00 &#177; 0.58</td><td>0.87 &#177; 0.83</td><td>0.7023*</td></tr><tr><td>Duration of symptoms (months)</td><td>23.43 &#177; 16.36</td><td>76.50 &#177; 23.95</td><td>0.0010*</td></tr><tr><td>Krenn score</td><td>2.00 &#177; 1.41</td><td>2.25 &#177; 1.03</td><td>0.5048*</td></tr><tr><td>BMP-2-Syn</td><td>2.28 &#177; 1.89</td><td>2.37 &#177; 2.06</td><td>1.0000*</td></tr><tr><td>BMP-2-C</td><td>2.43 &#177; 1.90</td><td>2.25 &#177; 1.58</td><td>0.9500*</td></tr><tr><td>BMPR-1A-Syn</td><td>5.00 &#177; 1.00</td><td>4.75 &#177; 0.89</td><td>0.6171*</td></tr><tr><td>BMPR-1A-C</td><td>2.57 &#177; 1.62</td><td>2.62 &#177; 2.37</td><td>0.9000*</td></tr><tr><td>Mankin score</td><td>8.00 &#177; 2.00</td><td>7.375 &#177; 3.02</td><td>0.8590*</td></tr><tr><td>Pritzker score</td><td>3.43 &#177; 0.79</td><td>3.62 &#177; 1.51</td><td>0.9497*</td></tr></table>
c77ed5356041f3d0ef9267363d190dd791ec33e03e9eca2d967d6790701a23ef.png
complex
<table><tr><td> </td><td>Sensitivity</td><td>Specificity</td><td>Accuracy<sup>1</sup></td><td>Kappa</td></tr><tr><td> </td><td>P(CH = 1|SR = 1)</td><td>P(CH = 0|SR = 0)</td><td>(overall agreement)</td><td> </td></tr><tr><td>Full sample</td><td>0.90</td><td>0.80</td><td>0.83</td><td>0.66</td></tr><tr><td colspan="5">Age</td></tr><tr><td> 25-34</td><td>0.71</td><td>0.88</td><td>0.85</td><td>0.64</td></tr><tr><td> 35-49</td><td>0.86</td><td>0.81</td><td>0.82</td><td>0.57</td></tr><tr><td> 50+</td><td>0.95</td><td>0.69</td><td>0.83</td><td>0.83</td></tr><tr><td colspan="5">Gender</td></tr><tr><td> Females</td><td>0.88</td><td>0.83</td><td>0.85</td><td>0.66</td></tr><tr><td> Males</td><td>0.9</td><td>0.8</td><td>0.8</td><td>0.59</td></tr><tr><td colspan="5">Marital Status</td></tr><tr><td> Currently Married</td><td>0.90</td><td>0.82</td><td>0.84</td><td>0.65</td></tr><tr><td> Not Married</td><td>0.89</td><td>0.80</td><td>0.83</td><td>0.65</td></tr><tr><td colspan="5">Race/ethnicity</td></tr><tr><td> Latino</td><td>0.89</td><td>0.85</td><td>0.86</td><td>0.65</td></tr><tr><td> non-Hispanic White</td><td>0.90</td><td>0.77</td><td>0.81</td><td>0.65</td></tr><tr><td> non-Hispanic Black</td><td>0.90</td><td>0.79</td><td>0.83</td><td>0.66</td></tr><tr><td colspan="5">Education</td></tr><tr><td> &lt;12</td><td>0.92</td><td>0.79</td><td>0.83</td><td>0.65</td></tr><tr><td> 12</td><td>0.79</td><td>0.82</td><td>0.81</td><td>0.65</td></tr><tr><td> 12+</td><td>0.86</td><td>0.82</td><td>0.83</td><td>0.66</td></tr><tr><td colspan="5">Annual Household Income</td></tr><tr><td> &lt;$10,000</td><td>0.77</td><td>0.83</td><td>0.81</td><td>0.66</td></tr><tr><td> $10,000-19,999</td><td>0.92</td><td>0.83</td><td>0.86</td><td>0.65</td></tr><tr><td> $20,000-34,999</td><td>0.89</td><td>0.79</td><td>0.81</td><td>0.65</td></tr><tr><td> $35,000+</td><td>0.97</td><td>0.77</td><td>0.83</td><td>0.66</td></tr></table>
8b8154dec1651355bf379b37f49b99dc197b5e82051b389c6b6b7d47cdec4439.png
simple
<table><tr><td>In silico SNP performance assessment</td><td>F0</td><td>F1</td><td>F2</td><td>F3</td><td>F4</td></tr><tr><td># of SNPs</td><td>66,254</td><td>21,944</td><td>10,032</td><td>3,187</td><td>1,329</td></tr><tr><td># of contigs with SNPs</td><td>9,579</td><td>5,058</td><td>2,057</td><td>1,651</td><td>998</td></tr><tr><td># of SNPs submitted to the ADT</td><td>621</td><td>605</td><td>583</td><td>367</td><td>547</td></tr><tr><td># of SNPs with ADT Score &#8805; 0.6</td><td>598</td><td>572</td><td>557</td><td>353</td><td>525</td></tr><tr><td>% of SNPs with ADT Score &#8805; 0.6</td><td>96.3</td><td>94.5</td><td>95.5</td><td>96.2</td><td>96.0</td></tr><tr><td># of SNPs with ADT Score &#8805; 0.9</td><td>314</td><td>316</td><td>297</td><td>177</td><td>291</td></tr><tr><td>% of SNPs with ADT Score &#8805; 0.9</td><td>50.6</td><td>52.2</td><td>50.9</td><td>48.2</td><td>53.2</td></tr><tr><td># of SNPs tested by the GGGT</td><td>96</td><td>96</td><td>108</td><td>108</td><td>288</td></tr></table>